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ABSTRACT 
 
With over 32 million tendon and ligament injuries in the US each year with associated costs of 
$30 billion, the need for viable tendon repair strategies is becoming increasingly important. 
Current surgical and tissue engineering approaches have had limited success; repeat injuries and 
generally poor clinical outcomes are common with failure rates as high as 94%. This thesis 
discusses the development of collagen-glycosaminoglycan (CG) biomaterial scaffolds for tendon 
tissue engineering. Key elements incorporated into the design of these biomaterials include an 
aligned microstructure to mimic healthy tendon, integration of therapeutic biomolecules to 
increase tendon cell migration and metabolic activity, and enhancement of construct mechanical 
competence through the addition of a novel CG membrane shell. CG scaffolds have been utilized 
to regenerate a variety of tissues, including dermis, peripheral nerves, conjunctiva, and cartilage. 
These materials have numerous advantages as tissue engineering scaffolds, including high 
porosity (> 95%) and an abundance of native ligands for cells to attach onto. CG scaffolds are 
manufactured by freeze-drying a suspension of collagen and glycosaminoglycan co-precipitate. 
The freezing step results in an interpenetrating network of ice crystals surrounded by CG 
content; sublimation leaves behind a scaffold with interconnected pores. This thesis describes the 
development of specialized freeze-drying techniques that utilize unidirectional heat transfer to 
produce scaffolds with aligned pores that mimic the native microstructure of tendon. Modulation 
of the final freezing temperature enables fabrication of a series of aligned CG scaffolds with 
constant relative density but a wide range of pore sizes (55-243 µm). The addition of 
chemotactic growth factors to aligned CG scaffolds is also shown to enhance tendon cell 
migration, viability, and metabolic activity. This thesis also details the creation of CG scaffold-
membrane core-shell composites with improved mechanical integrity for tendon tissue 
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engineering. While CG scaffolds possess many advantageous qualities for tissue engineering 
applications, their mechanical properties are typically orders of magnitude lower than native 
tendon. Taking inspiration from core-shell composites like plant stems in nature, scaffold-
membrane composites composed of a low density aligned CG scaffold core surrounded by a high 
density CG membrane shell were synthesized. Fabrication and characterization of the novel CG 
membrane is discussed in detail. The addition of an optimized membrane shell is shown to 
increase scaffold tensile elastic modulus by a factor of 36 while also maintaining adequate 
permeability to support tendon cell viability after 14 days of in vitro culture. 
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CHAPTER 1: INTRODUCTION AND BACKGROUND1
 
 
1.1 Collagen-GAG Scaffolds as ECM Analogs 
The extracellular matrix (ECM) is a complex macromolecular structure composed of a fibrillar 
network of structural proteins (collagens, elastin, etc.), proteoglycans (polypeptide core with 
attached polysaccharide chains called glycosaminoglycans (GAGs)), specialized proteins for cell 
adhesion (fibronectin, laminin, etc.) and other tissue-specific materials such as apatite in bone. 
The ECM defines the physical morphology of tissues and the local environment in which cells 
reside. In addition to serving as a physical support structure and insoluble regulator of cell 
activity, the ECM is a reservoir for numerous soluble regulators of cell behavior. 
 
Tissue engineering scaffolds are utilized as ECM analogs to heal or modify tissues in a defined 
manner. In order to be successful, these scaffolds must be able to mimic key aspects of the native 
ECM and support normal cell behaviors. As an analog of the native ECM, collagen-
glycosaminoglycan (collagen-GAG) materials possess several vital characteristics for successful 
tissue engineering scaffolds, including three-dimensionality with interconnected pores, tunable 
degradation and resorption rates, surface ligands for cell adhesion, and mechanical integrity 
(Harley and Gibson, 2008, Liu et al., 2008). Since their inception these materials have been 
utilized in a variety of tissue engineering studies, both in vivo as regenerative templates for skin, 
peripheral nerves, conjunctiva, and cartilage (Yannas, Lee et al. 1989; Yannas 1990; Yannas 
2001; Harley, Spilker et al. 2004) as well as in vitro as three-dimensional microenvironments to 
probe more fundamental questions about cell behaviors and cell-matrix interactions. Scaffold 
microstructure (porosity, mean pore size, pore shape, interconnectivity, specific surface area) 
                                                 
1 This chapter has been adapted from the following publication: 
Caliari, S. R. and B. A. C. Harley (in press). Collagen-GAG Materials. Comprehensive Biomaterials. P. Ducheyne, 
D. W. Hutmacher, J. Kirkpatrick and K. Healy. New York, Elsevier. 
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(Yannas, Lee et al. 1989; Wake, Patrick et al. 1994; Nehrer, Breinan et al. 1997; Yannas 2001; 
Zeltinger, Sherwood et al. 2001; O'Brien, Harley et al. 2005; Jaworski and Klapperich 2006; 
Harley, Kim et al. 2008; Tierney, Haugh et al. 2009; Tierney, Jaasma et al. 2009; Murphy, 
Haugh et al. 2010) and mechanical properties (Young’s modulus, yield stress) (Pelham and 
Wang 1997; Grinnell, Ho et al. 1999; Torres, Freyman et al. 2000; Freyman, Yannas et al. 2001; 
Grinnell, Ho et al. 2003; Engler, Bacakova et al. 2004; Jiang and Grinnell 2005; Peyton and 
Putnam 2005; Yeung, Georges et al. 2005; Zaman, Trapani et al. 2006) have been shown to be 
key factors that can influence cell behaviors such as adhesion, motility, contraction, stem cell 
differentiation, gene expression, and overall bioactivity (Yannas 2001).  
 
This chapter will provide an introduction to, and overview of, the development and application 
of collagen-GAG (CG) materials. It begins with an overview of the structure and biochemistry of 
both collagen and glycosaminoglycans and will consider questions concerning the 
immunogenicity, antigenicity, and regulatory compliance of CG biomaterials. It will continue 
with a summary of fabrication techniques used to make a wide range of collagen-GAG materials, 
including mineralized and non-mineralized (type I and II) scaffolds. Characterization of 
collagen-GAG materials, notably microstructural, mechanical, and chemical properties, and the 
use of modeling approaches to describe these features will then be covered. This will be followed 
by details of in vitro applications of CG scaffolds for investigation of cell adhesion, motility, 
contraction, stem cell differentiation, gene expression, and mechanotransduction. In vivo 
applications of CG materials as ECM analogs for regeneration of a wide variety of tissues, 
notably skin, peripheral nerves, conjunctiva, cartilage, and bone will also be reviewed. Finally, 
tendon physiology and pathology will be discussed to set the stage for the remainder of the 
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thesis, which will describe the fabrication and characterization of CG materials for tendon tissue 
engineering.  
 
1.1.1 Collagen 
Collagen is the major organic component of the natural ECM (Lodish, Berk et al. 2000; Berisio, 
De Simone et al. 2009; Carter and Raggio 2009; Shoulders and Raines 2009). To date, 29 types 
of collagen have been identified (Carter and Raggio 2009; Shoulders and Raines 2009), although 
90% of collagen in the human body is fibrillar (main types: I, II, III, and V). Type I collagen is 
the major structural component of the ECM in a wide variety of tissues such as skin, tendon, 
ligament, and bone. Type II collagen is found principally in cartilage; type III is found in skin, 
blood vessels, and intestines; type V is a component of bone, skin, cornea, and other tissues 
(Shoulders and Raines 2009).  
 
Like all proteins, collagen is defined by four levels of organization: primary, secondary, tertiary, 
and quaternary. The primary structure of collagen is highly conserved among mammals and 
follows a Gly-X-Y pattern characterized by the presence of a glycine every third residue with X 
and Y representing other amino acids (Figure 1.1(a)). Common residues in these X and Y 
positions are proline (28% of total residues) and hydroxyproline (38%) respectively (Yannas 
1972; Lodish, Berk et al. 2000; Berisio, De Simone et al. 2009; Carter and Raggio 2009; 
Shoulders and Raines 2009). These amino acids form left-handed, polyproline II-type 
polypeptide chains that define the secondary structure. Three of these polypeptide chains come 
together in a coiled, helical manner to form a right-handed triple helix termed tropocollagen. The 
tropocollagen molecule is the fundamental organizational unit of collagen and defines its tertiary 
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structure (Figure 1.1(b)) (Yannas 1972; Carter and Raggio 2009; Shoulders and Raines 2009), 
with dimensions of approximately 280 nm in length and 1.5 nm in diameter (Yannas 1972; 
Shoulders and Raines 2009). Each of the three polypeptide units, or alpha units, contains 1050 
amino acids (Lodish, Berk et al. 2000). Typically, two of these units have very similar sequences 
and are termed α1 chains while the dissimilar third chain is denoted as α2. Glycine is the only 
amino acid with a small enough side group (single hydrogen) to fit within the tight packing of 
the triple helix, thus necessitating its presence at every third residue. While the glycines face 
inward due to steric constraints, the proline and hydroxyproline groups face outwards and help 
stabilize the overall triple helix structure via hydrogen bonding (Lodish, Berk et al. 2000; 
Shoulders and Raines 2009).  
 
For tissues composed of type I collagen (bone, tendon, ligament, etc.), tropocollagen molecules 
assemble into fibrils up to 500 nm in diameter and 1 cm in length (quaternary structure). 
Fibrillogenesis and subsequent crosslinking is aided by the presence of nonhelical residues on 
each end of tropocollagen molecules called collagen telopeptides (Lodish, Berk et al. 2000; 
Shoulders and Raines 2009). These ends contain lysyl residues that promote covalent 
crosslinking between opposing ends of adjacent tropocollagen molecules. This crosslinking 
insures the stability of the fibrillar structure. Each tropocollagen molecule is displaced from its 
laterally adjacent partner by 67 nm. This periodic organization is the key feature of the 
quaternary structure (Figure 1.1(c)) (Lodish, Berk et al. 2000; Shoulders and Raines 2009). 
Fibrils band together to form higher order fiber bundles that are tissue specific. For example, 
tendon is composed of uniaxially aligned, crimped fiber bundles. It is important to note that the 
banding (quaternary structure) of collagen is abolished as a result of acid co-precipitation during 
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fabrication of collagen-GAG materials, limiting platelet aggregation in vivo (Yannas and Burke 
1980; Yannas 2001). The destruction of the quaternary structure is accomplished without 
denaturing the collagen to gelatin. Gelatin is the amorphous form of collagen, having the same 
amino acid sequence but lacking the triple helical character of collagen. Gelatin can be formed 
by heating hydrated collagen past a critical temperature of 75-105oC. The exact temperature is 
dependent on collagen type, species, and hydration level. Dry collagen is denatured when heated 
over 150oC (Yannas 1972; Yannas and Burke 1980). 
 
1.1.2 Glycosaminoglycans 
Glycosaminoglycans (GAGs) are long, repeating disaccharides that are linked to protein cores to 
form proteoglycans (Figure 1.2) (Raman, Sasisekharan et al. 2005). GAGs serve as a crucial 
component of the native ECM and influence various biological functions including cell 
migration, division, angiogenesis, collagen fibrillogenesis, and the presentation of soluble factors 
(Lodish, Berk et al. 2000; Raman, Sasisekharan et al. 2005; Lamari and Karamanos 2006; Bi, 
Ehirchiou et al. 2007). These macromolecules are strongly negatively charged due the presence 
of sulfate groups, resulting in large associated osmotic pressures and allowing them to 
significantly swell in water. These properties are responsible for the high compressive modulus 
and excellent resistance to repeated deformation seen in GAG-rich tissues such as articular 
cartilage (Kiani, Chen et al. 2002). The main GAG component of aggrecan, the chief 
proteoglycan in articular cartilage, is chondroitin sulfate, the most common GAG found in 
humans and also in collagen-GAG materials (Yannas and Burke 1980; Lodish, Berk et al. 2000; 
Roughley 2006). Other common classes of GAGs include dermatan sulfate (a derivative of 
chondroitin sulfate), heparin sulfate and heparin, keratan sulfate, and hyaluronic acid (Lodish, 
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Berk et al. 2000; Yoon and Halper 2005; Lamari and Karamanos 2006). Chondroitin sulfate, like 
other GAGs, is composed of a disaccharide repeat unit consisting of a acidic sugar-like molecule 
and a sulfated amino sugar (the exception is hyaluronic acid, which is not sulfated) (Raman, 
Sasisekharan et al. 2005).  For chondroitin sulfate these sugars are D-glucuronic acid and N-
acetyl galactosamine respectively (Lodish, Berk et al. 2000). 
 
1.1.3 Collagen-GAG material development 
CG materials were developed in the 1970's through a collaborative effort between Ioannis 
Yannas, a professor at Massachusetts Institute of Technology, and John F. Burke, a surgeon at 
Massachusetts General Hospital. Burke's search for treatments of traumatic burns coupled with 
Yannas' background in collagen biochemistry led to the development of a CG membrane that 
was one of the first bioactive materials designed for a tissue engineering application, in this case 
the regeneration of full-thickness skin wounds. Collagen is a well characterized biopolymer and 
was chosen as a model material due in part to its controllable biodegradability, relative weak 
antigenicity/immunogenicity, and overall history in clinical applications (Yannas and Burke 
1980; Lynn, Yannas et al. 2004). GAGs were incorporated into the collagen material for several 
reasons beyond that of ECM chemistry and biomimicry. First, although the biodegradation rate 
of collagen can be adjusted over a wide range of values via crosslinking, heavy crosslinking 
leaves the material brittle and stiff. The co-polymerization of collagen with GAG results in a 
material more resistant to degradation, thereby reducing the need for heavy crosslinking (Yannas 
and Burke 1980). The addition of GAG was shown to significantly improve material mechanics, 
including elastic modulus and fracture energy (Yannas and Burke 1980). SEM imaging also 
showed that scaffolds made with collagen and GAG exhibit a more open pore structure than 
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scaffolds made from collagen alone, a critical design requirement to insure adequate cell 
migration and permeability throughout the entire construct. The addition of GAG also gives CG 
materials their unique hemostatic properties discussed earlier, limiting platelet aggregation 
normally associated with collagen (Yannas and Burke 1980). 
 
1.1.4 Antigenicity and immunogenicity of collagen-GAG materials 
Collagen has been used in a variety of medical capacities, including sutures, skin and bone 
grafts, and for cosmetic purposes (Snyder 1976; Mehlisch 1989; Yannas, Lee et al. 1989; Lynn, 
Yannas et al. 2004). The collagen source for these applications as well as collagen-GAG 
biomaterials has typically been bovine skin or tendon. Collagens from these sources have 
consistently displayed low antigenicity (ability to interact with antibodies) and immunogenicity 
(ability to induce immune response), with adverse immune responses occurring even less 
frequently than nickel or latex allergies (Lynn, Yannas et al. 2004). The majority of adverse 
responses arise from pre-existing allergies (only 2-4% of population), but even in these cases, 
local inflammation and granulation subsides after several months to one year (Cooperman and 
Michaeli 1984; Charriere, Bejot et al. 1989; Lynn, Yannas et al. 2004). GAGs on their own have 
been utilized in orthopedic implants and more recently as dietary supplements to improve joint 
health. They are weak antigens and break down into oligosaccharides that can be cleared by 
native biological processes (Yannas and Burke 1980). In addition, there is little evidence that the 
copolymerization of collagen and GAG increases antigenicity or immunogenicity of collagen on 
its own (Lynn et al., 2004). With over 1500 human cases, collagen-GAG skin grafts have not had 
an adverse response to date (Yannas, Lee et al. 1989; Lynn, Yannas et al. 2004). With their long 
clinical history, collagen-GAG materials are regulatory compliant in both the US and Europe. 
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1.2 Fabrication of Collagen-GAG Materials 
1.2.1 CG scaffold fabrication: lyophilization 
CG scaffolds are typically created via freeze-drying of a suspension consisting of co-precipitated 
type I collagen and the glycosaminoglycan chondroitin sulfate in a solution of weak acetic acid 
(Yannas 2001). Hyaluronic acid (HA) has been used as an alternative to chondroitin sulfate in 
CG scaffolds for cartilage tissue engineering (Tang, Vickers et al. 2007). Typical solids 
concentration for these suspensions are 0.5-1% w/v collagen and 0.05-0.1% w/v GAG. These 
values have been traditionally selected so that the resultant scaffolds have high porosities to 
enable rapid cellular infiltration and diffusive transport processes, but also because of the 
inherent difficulty in processing collagen-GAG suspensions with higher solids content without 
denaturing the collagen due to the increased temperature and shear stresses required for complete 
mixing of the collagen-GAG content at high weight or volume percentages. The suspension is 
homogenized at 4oC to prevent collagen gelatinization, degassed under vacuum to remove air 
bubbles introduced during mixing, and then freeze-dried to produce the porous CG scaffold 
(Harley and Gibson 2008). During lyophilization, the CG suspension is frozen at a specified 
temperature (O'Brien, Harley et al. 2004), resulting in a continuous, interpenetrating network of 
ice crystals intertwined with CG co-precipitate. Sublimation of the ice crystals produces a highly 
porous scaffold whose microstructure is formed by individual fibers of CG called struts (Figure 
1.3). These scaffolds resemble low-density, open-cell foams, with an interconnected network of 
struts and relative densities (ρ*/ρs) typically significantly less than 10%. Relative density is 
calculated as ratio of the density of the porous material (ρ*) to the density of the solid it is 
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constructed from (ρs). Porosity, another key parameter used to describe porous biomaterials, can 
be calculated from scaffold relative density: porosity = 1- ρ*/ρs. 
 
1.2.2 Modifications to CG scaffold during fabrication 
Scaffolds for certain applications, such as peripheral nerve and bone regeneration, have been 
created from CG suspension with considerably higher solids content (5-10% w/v). Peripheral 
nerve scaffolds have been fabricated from high solids content CG suspension produced using 
plasticating extruders to homogenize the CG suspension (Harley et al., 2004). Vacuum filtration 
has also been used to remove solvent from homogenized collagen-GAG (both mineralized and 
non-mineralized) suspensions, hence increasing scaffold relative density. Non-mineralized CG 
suspensions were created with relative densities as high as 2.5% w/v while still enabling 
fabrication of bioactive, porous CG scaffold structure (Kanungo and Gibson 2010); Mineralized 
CG suspensions with relative densities as high as 18% w/v were also created in this manner 
(Kanungo and Gibson 2009). These densified scaffolds have been created in order to improve 
mechanical properties and slow biodegradation rates relative to non-densified suspensions 
(Kanungo and Gibson 2009; Kanungo and Gibson 2010). These techniques could be useful for 
the development of more mechanically robust scaffolds aimed to treat orthopedic tissues such as 
tendon. 
1.2.2.1 Relative density 
 
During the freeze-drying process, modifying CG suspension thermal profiles enables fabrication 
of CG scaffolds with a wide range of pore sizes and shapes. Pore size is governed by the final 
1.2.2.2 Pore size and shape 
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freezing temperature, where lower temperatures lead to smaller pores (Chang, Yannas et al. 
1990; O'Brien, Harley et al. 2004). Final freezing temperature and degree of undercooling 
control the rate of ice crystal nucleation in the suspension. Longer solidification times lead to 
more significant coarsening, where ice crystals aggregate to reduce their surface energy, 
resulting in larger pores (O'Brien, Harley et al. 2005; Murphy, Haugh et al. 2010). Scaffolds with 
equiaxed pores can be fabricated using a constant cooling rate technique that results in 
homogenous cooling, solidification, and pore formation throughout the CG suspension (O'Brien, 
Harley et al. 2004). Using this method combined with final freezing temperatures ranging from -
10oC to -60oC, CG scaffolds have been fabricated with pore sizes from 85–325 µm but with 
constant relative density (ρ*/ρs = 0.006) (Table 1.1) (O'Brien, Harley et al. 2005; Murphy, Haugh 
et al. 2010). More heterogeneous solidification processes at lower temperatures (-80oC) have also 
been used to fabricate CG scaffolds with pore sizes as low as 10-20 µm (Yannas, Lee et al. 1989; 
Chang, Yannas et al. 1990; Chamberlain, Yannas et al. 1998). 
 
Tubular CG scaffolds with uniform pore microstructures have been fabricated by injecting high 
solids content CG suspension into a tubular mold with a rotating mandrel. Recently a spinning 
technique to create radially patterned CG scaffold tubes has been developed (Harley, Hastings et 
al. 2006). The CG suspension placed into a cylindrical copper mold and spun at high angular 
velocities (> 5000 rpm), resulting in radial sedimentation of the CG solids. The suspension is 
then flash frozen in liquid nitrogen, resulting in the creation of small ice crystals within the CG 
suspension that don't interrupt the sedimentation. By varying the angular velocity and spinning 
time, solid cylinders or hollow tubes of variable inner diameter and tube wall microstructure can 
be created. These tubes display a radially aligned pore structure and a gradient of porosity along 
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the tube radius (Figure 1.4). A modeling framework has also been recently developed that 
describes this sedimentation process using Lamm differential equations for collagen 
concentration that balances sedimentation and diffusion forces to determine scaffold tube 
geometry as a function of spinning conditions (Sannino, Silvestri et al. 2010). These scaffolds 
are currently being investigated as substrates to limit the inward migration of exogenous 
contractile cells into and through the tube wall for a peripheral nerve regeneration application.  
 
Crosslinking improves the mechanical competence (e.g. Young's modulus, yield stress) and 
decreases the degradation rate of CG scaffolds independent of the chemical and microstructural 
characteristics (Yannas and Tobolsky 1967; Harley, Spilker et al. 2004; Harley, Leung et al. 
2007). The three most common crosslinking techniques are the physically based dehydrothermal 
(DHT) and ultraviolet (UV) processes and the chemically based carbodiimide (EDAC) process. 
DHT and EDAC in particular have been used extensively for in vitro and in vivo applications 
(Yannas, Lee et al. 1989; Harley, Leung et al. 2007). DHT processing involves heating of the CG 
material under vacuum for a specified amount of time (typically 105-120°C, <50 mTorr, 24-48 
h) in order to remove residual moisture and introduce covalent crosslinks within the CG struts. 
Increasing the DHT crosslinking temperature and duration has been shown to increase 
compressive modulus by up to 2-fold and tensile modulus by up to 3.8-fold (Harley, Leung et al. 
2007; Haugh, Jaasma et al. 2009). While increased crosslink density was correlated with 
increasing compressive modulus, higher denaturation levels led to higher tensile modulus, but 
also led to reduced ultimate stress and strain to failure (Haugh, Jaasma et al. 2009). EDAC 
processing utilizes carbodiimide chemistry to translate carboxyl (COOH) groups into unstable 
amine-reactive esters. This intermediate can be stabilized by N-hydroxysulfosuccinimide (NHS), 
1.2.2.3 Crosslinking 
 12 
leading to the formation of stable amide crosslinks (Olde Damink, Dijkstra et al. 1996). 
Increasing the ratio of EDAC and NHS to COOH increases the degree of crosslinking (Olde 
Damink, Dijkstra et al. 1996; Harley, Leung et al. 2007). Both DHT and EDAC methods 
maintain the integrity of the open pore structure of the material by introducing crosslinks within 
the CG struts only (Harley, Leung et al. 2007). 
 
1.2.3 CGCaP scaffold fabrication 
In addition to solidification-induced structural modifications, the CG construct can be chemically 
modified to create collagen composites for specific regenerative medicine applications. 
Mineralized CG scaffolds are of particular interest for orthopedic applications due to their 
potential to mimic the native biochemistry of bone: interpenetrating collagenous matrix (organic) 
and CaP (mineral) content. The addition of a mineral phase to the classic CG scaffold archetype 
allows for the development of materials with the requisite biochemical and biomechanical 
properties for bone and osteochondral tissue engineering. Mineralized CG scaffolds have been 
created via two distinct mechanisms: coating a fully formed CG scaffold with a mineral shell, or 
synthesizing a mineralized CG chemistry in liquid phase prior to freeze-drying. 
 
Mineralized CG (CGCaP) materials for bone and osteochondral tissue engineering can be 
fabricated from a triple co-precipitate of collagen, GAG, and calcium phosphate (CaP). These 
scaffolds are synthesized from a suspension produced via a concurrent mapping technique that 
allows for simultaneous modulation of collagen-GAG suspension pH as well as the CaP mass 
fraction (0-80 wt%), a range that covers a host of physiologically relevant tissues including 
subchondral bone (75%) and cartilage. This method is particularly powerful because it does not 
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require the use of harmful titrants or additives that would be difficult to dissociate from the 
freeze-dried matrix (Lynn and Bonfield 2005; Harley, Lynn et al. 2010; Lynn, Best et al. 2010). 
Concurrent mapping uses 3D maps of pH and CaP mass yield derived from experimental data to 
determine the concentration of CaP needed to achieve a specific mass fraction, given the 
concentrations of collagen and GAG as well as the pH of the suspension (Lynn, Best et al. 2010). 
This method yields nanocrystallite CaP content, precipitated within the CG struts, rather than 
coating the CaP on the CG content. This approach also enables the phase of the CaP mineral to 
be adjusted via hydrolytic conversion from the original brushite phase to either octacalcium 
phosphate or apatite, two biologically-relevant CaP phases, without altering the pore structure of 
the scaffold (Harley, Lynn et al. 2010). Conversion from brushite to apatite results in a scaffold 
that is less soluble and has altered bone-bonding effectiveness (Clarke, Graves et al. 1993; 
Sasano, Kamakura et al. 1995; Itoh, Kikuchi et al. 2001). Modified freeze-drying profiles have 
been developed to enable fabrication of CGCaP scaffolds with homogeneous microstructure (85 
± 3% porosity), highly interconnected pores, and tunable mean pore sizes from 56-1085 µm 
(Figure 1.5) (Harley, Lynn et al. 2010). Mineralized CG scaffolds, either produced by coating 
the CG scaffold with a mineral component or by precipitating nanocrystallites of CaP mineral 
into the CG content prior to fabrication, successfully mesh the advantageous microstructural and 
biochemical properties of standard CG scaffolds with the mechanical integrity and bone-bonding 
properties of calcium phosphate mineral in a manner reminiscent of the chemical composition of 
native bone (Kikuchi, Itoh et al. 2001) to produce a promising class of scaffolds for orthopedic 
application. 
 
1.2.4 Multicompartment CG scaffold fabrication 
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The CGCaP scaffold technology has been used as the basis for creating multiphase collagen 
scaffolds for the repair of interfacial tissues, notably osteochondral defects. A liquid phase co-
synthesis method was created to fabricate multicompartment CG scaffolds. The 
multicompartment scaffold was designed to be a single biomaterial construct containing multiple 
regions ('compartments'), each with distinct microstructural, chemical, and mechanical properties 
that are connected via a continuous interface between regions. The initial multiphase scaffold 
developed via this approach contains an osseous compartment for subchondral bone regeneration 
(type I collagen, chondroitin sulfate, and CaP) and a cartilagenous compartment for cartilage 
regeneration (type II collagen and chondroitin sulfate). A key feature of this design is that by 
avoiding discrete interfaces between scaffold compartments that would require external fixation 
(sutures, glue, etc.) these materials reduce the potential for stress concentrations and resultant 
delamination at the interface (Genin, Kent et al. 2009). The continuous interface is created by 
layering the cartilaginous compartment and the osseous compartment suspensions in a 
conventional freeze-drying mold, but then incorporating a processing step to enable partial 
diffusive mixing between the two suspensions near their interface. Once the region of 
interdiffusion was created between the suspension layers, freeze-drying was used to form the 
final multicompartment scaffold microstructure (Figure 1.6) (Harley, Lynn et al. 2010). The 
continuous interface between scaffold regions is critical for the recapitulation of native 
interfacial physiology for tissues such as cartilage and tendon (Harley, Lynn et al. 2010). The 
differential chemistry, microstructure, and mechanics of the osseous and cartilaginous 
compartments enable these layered scaffolds to exhibit compressive deformation behavior that 
mimics behavior observed in natural articular joints (Harley, Lynn et al. 2010). These layered 
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scaffolds are currently the subject of numerous in vitro and in vivo experiments for various 
orthopedic tissue engineering applications.  
 
 
1.3 Characterization of Collagen-GAG Materials 
Experimental characterization of properties such as chemistry, pore morphology (size/shape), 
relative density, permeability, and mechanics of a number of collagen-GAG scaffold variants has 
been undertaken; such experimental characterization has also been supplemented by modeling 
approaches allowing for a more complete understanding of the microenvironmental cues 
presented within the CG structure to distinct cells or populations of cells. 
 
1.3.1 Microstructure: experimental measurement and modeling 
CG microstructure (pore size and morphology) is typically assessed using a stereological 
approach. Longitudinally and transversely oriented scaffold samples are embedded in 
glycolmethacrylate, sectioned, stained, and observed using optical microscopy. Using a linear 
intercept approach in any standard image analysis software package, a best-fit ellipse 
representative of the mean pore morphology is created. Dimensions of the ellipse (major and 
minor axis) are used to calculate an equivalent mean diameter and aspect ratio (O'Brien, Harley 
et al. 2004; O'Brien, Harley et al. 2005; Harley, Freyman et al. 2007; Caliari and Harley in 
preparation). Micro-computed tomography (µCT) has also been utilized to analyze pore 
microstructure (O'Brien, Harley et al. 2004; O'Brien, Harley et al. 2005; Harley, Freyman et al. 
2007), though it often requires significant use of contrast agents to allow sufficient visualization 
of the non-mineralized collagen-GAG content. Most recently, µCT analysis has been used to 
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create a computational model of the CG microstructure for use in analysis of shear stresses on 
cells in dynamic culture conditions (Figure 1.7) (Jungreuthmayer, Jaasma et al. 2009). 
 
Cellular solids modeling approaches have proven to be a useful tool in the description and 
characterization of CG scaffold pore geometry and microstructural properties (pore shape, 
specific surface area) (Gibson, Ashby et al. 2010). The complex geometry of foams (and 
scaffolds) is difficult to model exactly; instead, dimensional arguments can be used to model 
salient microstructural features without incorporating exact cell geometries using the cellular 
solids modeling framework. CG scaffolds have been primarily modeled as a low density, open-
cell foam using a tetrakaidecahedral (14-sided polyhedron) unit cell. Modeling microstructural 
features of CG scaffolds in this manner is possible because the mean pore structure of it and a 
variety of other low-density, open-cell foams has been observed to have a number of consistent 
features, notably approximately 14 faces per unit cell, 5.1 edges per face, and vertices that are 
nearly tetrahedral (Williams 1968; Gibson, Ashby et al. 2010).  The tetrakaidecahedron packs to 
fill space, nearly satisfies minimum surface energy requirements, and approximates the structural 
features of many experimentally characterized low density, open-cell foams (Figure 1.8) 
(Thompson 1887; Gibson, Ashby et al. 2010). Application of modeling approaches using the 
tetrakaidecahedral unit cell with CG scaffolds has led to estimations of a number of key 
microstructural features of the CG scaffolds, many of which will be discussed throughout this 
chapter. The first microstructural element described using cellular solids approaches was the 
scaffold specific surface area (SA/V), the total surface area divided by the volume of the 
scaffold. Specific surface area describes the relative amount of surface available for cells to 
attach, and has been shown to be an integral factor affecting overall scaffold bioactivity (O'Brien, 
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Harley et al. 2005; Murphy, Haugh et al. 2010). For a low density, open-cell foam with an 
interconnected pore structure and edges of circular cross-section modeled using the discussed 
approaches, specific surface area is related to the mean pore size (d) and the relative density 
(ρ*/ρs) (O'Brien, Harley et al. 2005; Gibson, Ashby et al. 2010): 
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1.3.2 Permeability: experimental measurement and modeling 
Permeability of tissue engineering scaffolds is a critical design parameter to be controlled as it 
influences the diffusion of cytokines, nutrients, and waste throughout the scaffold prior to 
material vascularization; further, biomaterial permeability has also been shown to significant 
impact  cell migration processes and scaffold biodegradation rates, amongst others (Agrawal, 
McKinney et al. 2000). Material permeability also affects fluid pressure fields and shear stresses 
within the construct, additional potential stimuli for functional adaptation (Prendergast, Huiskes 
et al. 1997). Permeability of tissue engineering scaffolds is dictated by a variety of 
microstructural characteristics including porosity, pore size and orientation, pore 
interconnectivity, fenestration size and shape, specific surface area, and applied strain. 
Permeability of low porosity foams (porosity < 90%) has previously been modeled and measured 
experimentally (Levick 1987). However, such models are not applicable to highly porous 
materials that are typically used in tissue engineering, such as CG scaffolds (porosity > 99%); 
here, material permeability has conventionally measured empirically with no associated 
modeling framework to describe the results. A series of CG scaffolds with constant relative 
density (ρ*/ρs = 0.006) were used to both characterize CG scaffold permeability as a function of 
pore size (96–151 µm) and applied compressive strain (0-40%), but also to calibrate a cellular 
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solids-based model of the permeability of low-density, open-cell foams. As with specific surface 
area, a low density, open-cell foam cellular solids model was successfully created to describe the 
permeability (k) of the entire class of CG scaffolds as a function of the scaffold mean pore size 
(d), percent compression (applied strain: ε), relative density (ρ*/ρs), and a single dimensionless 
system constant (A’) (O'Brien, Harley et al. 2007): 
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Experimental and modeling analyses showed that CG scaffold permeability increases with 
increasing pore size and decreases with increasing compressive strain (Figure 1.9). The 
experimentally measured and theoretically predicted scaffold permeability values showed 
excellent agreement with the need for only a single fitting constant (A') to describe the entire 
class of scaffolds, again validating the use of the model tetrakaidecahedral unit cell for 
describing microstructural features of CG scaffolds (O'Brien, Harley et al. 2007). These results 
also suggested that cellular solids modeling techniques can be used to predict scaffold 
permeability under a wide range of physiological loading conditions and experimentally relevant 
pore microstructures (size, relative density).  
 
1.3.3 Mechanical properties: experimental measurement and modeling 
The mechanical properties of a range of biomaterials have been shown to significantly impact 
cell behaviors including adhesion, proliferation, differentiation, and overall bioactivity (Pelham 
and Wang 1997; Grinnell, Ho et al. 1999; Torres, Freyman et al. 2000; Freyman, Yannas et al. 
2001; Yannas 2001; Grinnell, Ho et al. 2003; Engler, Bacakova et al. 2004; Jiang and Grinnell 
2005; Peyton and Putnam 2005; Yeung, Georges et al. 2005; Zaman, Trapani et al. 2006; Harley, 
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Kim et al. 2008). The mechanical properties of a number of CG scaffold variants have been 
tested in tension and compression; further the elastic modulus of the individual struts that define 
the scaffold network has also been characterized (Harley, Leung et al. 2007) (Table 1.2). The 
mechanical behavior of CGCaP scaffolds under compression as well as the modulus of the 
individual mineralized struts has also been evaluated (Kanungo, Silva et al. 2008; Harley, Lynn 
et al. 2010) (Table 1.2, 1.3). These results offer insight to the mechanical properties of a 
standardized set of CG materials.  
 
Cellular solids modeling has been shown to be a powerful tool to aid the analysis of the 
mechanical properties of CG biomaterials. The cellular nature of CG scaffolds requires that 
materials mechanical characterization must be performed at multiple scales: at the level of the 
whole material (macro) as well as at the level of the individual struts that define the scaffold 
structure (micro). The significant porosity of the CG scaffolds results in often multiple orders of 
magnitude difference in these mechanical properties. The theory predicted stress–strain curves 
for low-density, elastomeric open cell foams in compression are characterized by three distinct 
regimes: a linear elastic regime (strut bending), a collapse plateau regime (struts buckling and 
pore collapse), and a densification regime (complete pore collapse) (Figure 1.10) (Gibson, 
Ashby et al. 2010). In tension, the initial linear elastic response is typically the same as is 
observed in compression for small strains; however as the strain increases, the struts become 
increasingly oriented in the direction of applied tension, increasing the material stiffness until 
tensile failure (Gibson, Ashby et al. 2010). Experimentally, the CG scaffold variants exhibited 
the theoretically predicted stress-strain behavior with distinct linear elastic, collapse plateau, and 
densification regimes (Figure 1.11). Experimental results show that CG scaffolds with equiaxed 
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pores (mean pore sizes: 96-151 µm) as well as CGCaP scaffolds (50 wt% CaP) are 
microstructurally and mechanically isotropic (Harley, Leung et al. 2007; Kanungo, Silva et al. 
2008). CG materials demonstrated compressive moduli of order 30 kPa (dry) and 200 Pa 
(hydrated), independent of pore size, while CGCaP scaffold demonstrated compressive moduli 
of order 750 kPa (dry). The independent effects of variables including hydration level, pore size, 
and crosslink density on the mechanical properties was also determined (Table 1.2, 1.3) (Harley, 
Leung et al. 2007; Kanungo, Silva et al. 2008). The Young’s modulus of the individual (CG, 
CGCaP) scaffold struts (Es) that define the scaffold microstructure was measured via AFM 
(Figure 1.12) (Harley, Leung et al. 2007; Kanungo, Silva et al. 2008).  
 
Using cellular solids theory, the Young’s modulus (E*) and elastic compressive strength (σel*, 
also called the compressive plateau stress) of low density, open-cell foams such as CG scaffolds 
are predicted to depend on the foam relative density, ρ*/ρs, the Young’s modulus of the solid 
from which the foam is made, Es (termed the strut modulus), and a constant of proportionality 
(C1 and C2) related to the cell geometry (Gibson, Ashby et al. 2010): For elastomeric cellular 
solids, E* and σel* are: 
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Data for a wide variety of open-cell foams give approximate values as C1 ~ 1 and C2 ~ 0.05 
(Gibson, Ashby et al. 2010). Interestingly, these equations show that the strain at which cell 
collapse by buckling occurs, εel* is constant value equal to C2/C1 = 0.05 and that both E* and σel* 
are expected to be independent of the pore size (Gibson, Ashby et al. 2010).  
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Experimental results of scaffold mechanical characterization and low density, open-cell foam 
model predictions for the scaffold E* and σel* (Equation 1.3, 1.4) for the standard series of 
isotropic CG scaffold variants (ρ*/ρs: 0.006; mean pore size: 96 – 151 µm) showed good 
agreement. Notably, CG scaffolds showed distinct linear elastic, collapse plateau, and 
densification regimes, and CG scaffold modulus was found to be independent of scaffold pore 
size, but highly dependent on scaffold ρ*/ρs (Harley, Leung et al. 2007). The effect of relative 
density on the mechanical properties of both mineralized and non-mineralized CG scaffolds has 
recently been evaluated (Harley, Leung et al. 2007; Kanungo, Silva et al. 2008; Kanungo and 
Gibson 2009; Kanungo and Gibson 2010). Non-mineralized CG scaffolds over a range of 
relative densities (0.0062-0.0239) showed significant increases in compressive modulus and 
strength as well as tensile modulus with increasing relative density (Table 1.4) (Harley, Leung et 
al. 2007; Kanungo and Gibson 2010). While the model correctly predicted the relationship 
between Es and E*, it over-predicted E* at higher relative densities. This is likely due to 
difficulties in fabricating CG scaffolds with high solids content, which often leads to areas of 
microstructural heterogeneities (Harley, Leung et al. 2007). Likewise, mineralized CG scaffolds 
with relative densities from 0.045-0.187 had significantly increased compressive modulus and 
strength (both dry and hydrated) with increasing relative density (Table 1.4) (Kanungo and 
Gibson 2009). Meanwhile, modeling consistently over-predicted E* and σel* for the mineralized 
CG scaffolds. These discrepancies can be explained by the presence of voids, cracks, and 
disconnections within the scaffold microstructure (Kanungo, Silva et al. 2008). Experimentally, 
CGCaP scaffolds with higher mineral content (75 wt% CaP) displayed inferior mechanical 
properties to the 50 wt% CaP scaffolds (Kanungo, Silva et al. 2008). This behavior is possibly 
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caused by the retention of residual moisture, even after extensive freeze-drying, due to the 
dehydration of 33% of the CaP mineral content from brushite to monetite in the 75 wt% CaP 
scaffold (Kanungo, Silva et al. 2008).  
 
1.3.4 CG scaffold degradation kinetics and byproducts 
The degradation kinetics of tissue engineering scaffolds must be carefully tuned so that the 
scaffold structure remains intact throughout the duration of the regenerative process to prevent 
wound contraction, while degrading rapidly enough so as not to impede the healing process 
(Hutmacher 2000; Yannas 2001; Harley and Gibson 2008; Liu, Ramanath et al. 2008) . This 
optimization has been termed the isomorphous tissue replacement model, where the biomaterial 
degradation half life of the scaffold (td) must equal the healing half life of the tissue (th) in which 
it is implanted. Scaffold degradation that happens too quickly (td > th) or too slowly (td < th) is 
detrimental to the tissue regeneration process (Yannas 2001). In addition to degradation kinetics, 
byproducts must also be carefully considered in scaffold design. Many synthetic scaffolds 
degrade to cytotoxic byproducts, limiting their in vivo applicability (Harley and Gibson 2008; 
Liu, Ramanath et al. 2008). However, CG scaffolds, like most scaffolds made of natural 
materials, break down into harmless byproducts already found in abundance in the body (Yannas 
and Burke 1980).  
 
The degradation kinetics of CG scaffolds can be tuned by altering chemical composition 
(collagen to GAG ratio), relative density, or most commonly through differential crosslinking 
(see previous section for more details), where increasing crosslinking densities are used to slow 
scaffold degradation (Pek, Spector et al. 2004; Harley and Gibson 2008). Pek et al. have 
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evaluated the degradative process of CG scaffolds treated with one of four conventional 
crosslinking techniques: noncrosslinked (Nx), DHT (Dx), EDAC (Ex), and DHT/EDAC (DEx) 
in real time (Pek, Spector et al. 2004). Here, scaffolds displayed an inverse relationship between 
swelling ratio and crosslink density, as is characteristic of random polymeric materials. ESEM 
observation of Nx and Dx scaffolds degraded with collagenase showed micropitting and eventual 
collapse of scaffold struts, leading to complete loss of mechanical integrity after a week while Ex 
and DEx samples maintained their structure and showed only minor micropitting (Pek, Spector et 
al. 2004). Degradation by chondroitinase led to distinct structural (but not mechanical) changes 
for the Nx and Dx scaffolds that were predicted to be more prone to GAG removal: scaffold 
struts were observed to swell and thereby reduce the open pore interconnectivity of the 
microstructure. This effect was not nearly as pronounced for the Ex and DEx variants (Pek, 
Spector et al. 2004). 
 
 
1.4 In Vitro Applications 
1.4.1 Cell attachment and viability 
CG tissue engineering scaffolds must have a mean pore size that is large enough for efficient 
metabolite exchange and cell infiltration, but small enough to provide ample surface area 
(ligands) to achieve adequate cell attachment. Distinct optimal pore sizes have been 
hypothesized for different cells, biomaterial chemistries, and clinical applications. CG scaffolds 
with uniform, well characterized microstructures (pore sizes 85-325 µm) have been used as a 
platform to begin to investigate the relationship between pore microstructure and scaffold 
specific surface area with cell attachment, viability, and the uniformity of their distribution 
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throughout the material (O'Brien, Harley et al. 2005; Kanungo and Gibson 2010; Murphy, Haugh 
et al. 2010). These scaffolds were seeded with MC3T3-E1 mouse clonal osteogenic cells and 
then cultured for anywhere between 1 and 7 days to determine viable cell number and 
distribution. Increased early cell adhesion (24-48 h) was correlated with increased scaffold 
specific surface area (Figure 1.13) (O'Brien, Harley et al. 2005). Modulating scaffold relative 
density (0.0062 to 0.0239) to alter scaffold SA/V also gave a linear relationship between scaffold 
specific area and MC3T3-E1 cell attachment (R2 = 0.97 at 24 h) (Kanungo and Gibson 2010). 
These results indicate a strong correlation between specific surface area and early MC3T3-E1 
cell attachment for this set of CG scaffolds. However, for longer culture periods (7 days), a 
higher number of cells are observed in scaffolds with larger pores (> 300 µm). This result has 
been hypothesized to be due to the competing influence of scaffold proliferation and metabolic 
support via diffusion that both increase with increased scaffold pore size: larger pore sizes allow 
for easier cell proliferation and migration throughout the entire scaffold, especially at later time 
points (7 days). These results have helped confirm that scaffolds with larger pore sizes, 325 µm, 
may be more optimal for long term bone tissue engineering applications (Murphy, Haugh et al. 
2010).  
 
Fabrication flexibility also has enabled investigation of the effect of CG scaffold chemical 
composition on initial cell attachment and viability. MC3T3-E1 attachment and viability have 
been shown to depend on scaffold chemical composition (collagen and GAG concentration) 
(Tierney, Jaasma et al. 2009) and mechanical properties (Tierney, Haugh et al. 2009). Here, 
scaffolds were fabricated over a range of concentrations of collagen (0.25-1% w/v) and GAG (0-
0.088% w/v), seeded with cells, and cultured for 6 h to 7 days. Lower concentrations of collagen 
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and GAG showed high initial cell attachment, likely due to a temporary increase in surface area 
due to loss of structural integrity (pore collapse) (Tierney, Jaasma et al. 2009). However, the 
higher concentration of surface ligands on the 1% collagen scaffolds supported the highest cell 
attachment after 7 days. 0.088% GAG scaffolds also had better cell infiltration than their 
counterparts.   
 
1.4.2 Cell contraction 
Cell-mediated contraction plays an integral role in many physiological and pathological 
processes, notably organized contraction and scar formation during wound healing. One of the 
key functions of CG and other tissue engineering scaffolds is to block wound contraction to 
prevent scar tissue proliferation, instead allowing for regeneration of functional tissue (Yannas 
2001). This objective requires a comprehensive understanding of the forces and kinetics 
associated with cell contractile processes within the scaffold microstructure so that scaffolds can 
be designed with the requisite mechanical integrity to withstand contraction for a critical period 
of time. Most studies of cell contraction in vitro have used two-dimensional substrates. Here, 
contractile force is calculated as a function of substrate deformation due to a population of cells 
and the elastic modulus of the substrate (Harris 1980; Lee, Leonard et al. 1994; Oliver, Dembo et 
al. 1995; Dembo and Wang 1999; Roy, Petroll et al. 1999; Tan, Tien et al. 2003; Lemmon, 
Sniadecki et al. 2005). This technique has been used to show that substrate elastic modulus 
significantly affects cell behaviors such as proliferation, differentiation, migration speed, 
directional persistence, and applied traction forces (Wang, Butler et al. 1993; Pelham and Wang 
1997; Chen and Ingber 1999; Dembo and Wang 1999; Lo, Wang et al. 2000; Wang, Dembo et 
al. 2000; Beningo, Dembo et al. 2001; Munevar, Wang et al. 2001; Wang, Dembo et al. 2001; 
Beningo and Wang 2002; Tan, Tien et al. 2003; Engler, Sen et al. 2006). These methods yield 
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estimates of fibroblast contractile forces on the order of hundreds of nanoNewtons (Beningo and 
Wang 2002; Tan, Tien et al. 2003; Lemmon, Sniadecki et al. 2005). However, these results are 
not likely comparable to in vivo contractile forces given the fact that the shape and cytoskeletal 
organization of cells on these two-dimensional substrates (amorphous, spread) is significantly 
different than that of fibroblasts observed in wound sites within the natural ECM (elongated 
spindle-shaped) (Zahalak, Wagenseil et al. 2000; Guilak, Erickson et al. 2002; Marquez, Genin 
et al. 2005; Harley, Freyman et al. 2007).  
 
CG scaffolds have been used in a number of investigations to quantify the macroscopic (bulk 
construct) and microscale (individual strut) contractile behavior of cell populations as well as the 
relationship between distinct integrin-ligand interactions, cytoskeletal organization, and cell 
contraction. Macroscopically, the average contractile force generated by a known cell population 
can be calculated as a function of the gross deformation of the CG scaffold by that cell 
population and the scaffold’s elastic modulus. Total contractile force generated by a population 
of dermal fibroblasts within the CG scaffold was observed to reach an asymptote of 1.0 ± 0.2 nN, 
independent of the number of cells seeded, with an associated time constant of 5.2 ± 0.5 h 
(Freyman, Yannas et al. 2001). When the stiffness of the scaffold system was changed, 
fibroblasts were observed to apply differential levels of strain but a constant average force to the 
CG scaffold, suggesting that dermal fibroblasts apply contractile forces independent of the local 
microenvironment (Figure 1.14) (Freyman, Yannas et al. 2002). Similar analysis has been 
performed for chondrocytes (Zaleskas, Kinner et al. 2004) and Schwann cells (Spilker, Asano et 
al. 2001). Fibroblasts displayed significant cytoskeletal reorganization during contraction within 
the CG scaffold; initially rounded after seeding they were observed to form attachments to single 
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struts as well as between multiple CG struts and elongated over time into spindle-shaped cells. 
The average aspect ratio (maximal cell length/maximal cell thickness) of the cells increased 
asymptotically from 1.4 to 2.8 during the first 15 h in the scaffold (Figure 1.14) with a similar 
time constant as observed for contractile force generation (Freyman, Yannas et al. 2001; 
Freyman, Yannas et al. 2001). In addition, the role of integrin-ligand complexes in the 
contraction of CG scaffolds has been examined using a culture force monitor (CFM) via specific 
inhibition of integrins and distinct cell adhesion proteins (fibronectin, vitronectin, and collagen) 
(Sethi, Yannas et al. 2002). Initial dermal fibroblast attachment and force generation (0-5 h) was 
found to be sequentially mediated primarily by fibronectin followed by vitronectin. Attachment 
and force profiles at later time points (6-20 h) were shown to be dominated by cell-collagen 
interactions (Sethi, Yannas et al. 2002). However, two significant assumptions are made with 
this analysis. First, the deformation of the cell-seeded, rectangular CG scaffold sample was 
measured in only one direction.  Second, the fraction of contractile cells versus the total cell 
population within the scaffold was not characterized. Since the average force per cell was 
calculated using the assumptions that all cells were contracting in a single direction and that all 
cells were contracting at the same time, the calculated average contractile force of 1.0 ± 0.2 nN is 
a lower bound.  
 
CG scaffolds have also been used to quantify the contractile forces generated by individual cells 
within a 3D ECM analog. Phase contrast microscopy has been used to generate time-lapse 
images of dermal fibroblasts differentially migrating through the scaffold, or contracting the 
local scaffold microstructure, resulting in buckling of the strut(s) to which the cell was attached 
(Figure 1.15) (Freyman, Yannas et al. 2001; Freyman, Yannas et al. 2001; Freyman, Yannas et 
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al. 2002). Improved mechanical and microstructural characterization of the individual CG 
scaffold struts (Harley, Freyman et al. 2007) and the application of cellular solids theory enabled 
the use of modified Euler column buckling relationships in order to quantify the magnitude of 
individual cell contractile forces within the CG scaffold (Harley, Freyman et al. 2007). The 
magnitude of the cell-mediated contraction forces generated by individual dermal fibroblasts 
within the CG scaffold was calculated from the observed strut deformation by individual dermal 
fibroblasts, strut dimensions and mechanical properties, and previous experimental and 
theoretical work describing the mechanics and collapse of open cell foams (Gibson, Ashby et al. 
2010). The critical load (Fc) at which a scaffold strut of length ls, average pore size d, Young’s 
modulus Es, and second moment of area I (strut geometry was approximated as a cylindrical 
fiber, I = πd4/64) buckles can be calculated by Euler’s formula and the hydrostatic compression 
end restraint (n2 = 0.34) (Triantafillou, Zhang et al. 1989; Harley, Freyman et al. 2007; Gibson, 
Ashby et al. 2010): 
2
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The contractile force generated by individual dermal fibroblasts that were able to buckle a CG 
scaffold strut was calculated to range between 11 and 41 nN, with an average contractile force 
(Fc) of 26 ± 13 nN (Harley, Freyman et al. 2007). The upper limit of fibroblast contractile 
capacity in CG scaffolds was established from data on a cell that was unable to buckle the strut it 
was attached to because that strut was significantly thicker than the average strut, thereby 
increasing its flexural rigidity (EsI) and buckling load (Fc). Analysis of this strut's microstructure 
indicates that the force required to buckle the strut was approximately 450 nN. These results 
suggest that while dermal fibroblasts can easily develop the ~25 nN force required to buckle 
conventional CG scaffold struts, they are unable to develop contractile forces at the level of 450 
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nN (Harley, Freyman et al. 2007). While developed with a well-characterized CG scaffold 
system, this technique can be used to study individual cell contraction and cell-scaffold 
interactions within a wide variety of tissue engineering scaffolds. 
 
1.4.3 Cell motility 
Cell motility plays an integral role in many physiologic and pathologic processes, notably 
organized wound contraction and fibroblast and vascular endothelial cell migration during 
wound healing (Yannas 2001), metastatic tumor cell migration (Condeelis and Segall 2003), 
stem cell mobilization and homing (Lapidot, Dar et al. 2005; Wilson and Trumpp 2006), and 
tissue remodeling (Yannas 2001). Cell migration is a complex process modulated by a range of 
spatiotemporally presented biochemical and biophysical signals, both extracellular and 
intracellular (Lauffenburger and Horwitz 1996; Friedl, Zanker et al. 1998). Studies of cell 
motility on 2D substrates have led to an improved understanding of how surface features, 
particularly substrate stiffness, affect migration through changes in cytoskeletal organization and 
applied traction forces (Lo, Wang et al. 2000; Munevar, Wang et al. 2001; Wang, Dembo et al. 
2001). However, 3D biomaterials enable the investigation of the complex set of biophysical and 
biochemical signals that can affect motility in a 3D environment that better resembles 
physiologically and pathologically relevant conditions. Understanding of the 
microenvironmental factors that govern cell motility is also critical for acellular biomaterials 
(like CG scaffolds) because they must be able to induce rapid cellular invasion.  
 
Cell motility in CG scaffolds relies on a phenomenon known as contact guidance. Since CG 
scaffold pore sizes are significantly larger than the characteristic length of the fibroblasts, cells 
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are forced to migrate along scaffold struts. External microstructural and mechanical stimuli from 
the scaffold provide physical cues (contact guidance) to regulate cell motility and other cell 
behaviors (Liu, Ramanath et al. 2008). NR6 mouse fibroblasts were seeded into CG scaffolds 
with pore sizes ranging from 96 µm to 151 µm but with constant mechanical properties (E* = 
208 ± 41 Pa), and single cell migration paths were tracked using 3D time-lapse confocal 
microscopy (Harley, Kim et al. 2008). Cell dispersion (Wind-Rose plot, Figure 1.16(a)) and 
motile fraction (Figure 1.16(b)) significantly decrease with increasing pore size (Harley, Kim et 
al. 2008). Cell speed was also shown to significantly decrease with increasing scaffold pore size 
(Figure 1.16(b)); cell speed is reduced almost by half over the range from 96 µm to 151 µm, 
from about 12 µm h-1 to 6 µm h-1. Further, as cell speed was calculated for only the motile 
population, which also decreased significantly with mean pore size, scaffold pore size has an 
even more significant influence on overall cell motility than is suggested by Figure 1.16(b) 
alone. The effect of scaffold stiffness on NR6 fibroblast motility was assessed in a series of 
DHT- and EDAC-crosslinked CG scaffolds of constant pore size (96 µm) but variable strut 
modulus (Es: 5.3 – 38 MPa). Cell migration speed exhibited a subtle biphasic behavior with strut 
modulus, increasing (significantly) from 11 to 15 µm h-1 for strut moduli between 5 and 12 MPa 
and then decreasing (significantly) back to 12 µm h-1 for strut moduli of 38 MPa (Figure 
1.16(b)). The effects of pore size and scaffold stiffness on cell migration speed correlated well 
with previous experimental and computational studies of cell motility in dense, three-
dimensional materials (Zaman, Kamm et al. 2005; Zaman, Trapani et al. 2006). Unlike with the 
dense materials used in those studies, cells were not exposed to significant steric hindrances in 
these porous, CG scaffolds, so the strong dependence of cell motility on pore size was not 
expected.  
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In addition to the practical need to better understand cell motility in CG scaffolds to enable more 
efficient cellular invasion, the fabrication, characterization, and modeling tools recently 
developed for CG scaffolds enabled a rigorous analysis of the independent effect of 
microstructural and mechanical scaffold features on cell motility. Modeling techniques were then 
used in an attempt to better explain the initially inexplicable effect of pore size on cell motility. 
Cellular solids modeling suggested that while the strut moduli (Es) and scaffold relative density 
(ρ*/ρs) are constant for the scaffolds of different pore size, scaffolds with a larger pore size have 
longer and thicker struts. So while the moduli (Es) of these struts is identical, the second moment 
of inertia (I) increases with increasing pore size, translating to a larger strut flexural rigidity (EsI) 
with increasing pore size. Cells are known to apply a constant contractile force to the CG 
scaffold regardless of the system stiffness (Freyman, Yannas et al. 2002) which suggests that 
cells probe their local mechanical environment by applying a constant traction force and 
measuring the resultant substrate deformation (Vogel and Sheetz 2006). These results suggested 
that strut flexural rigidity, not stiffness, is the more relevant mechanical signal to cells. So even 
though the struts have a constant elastic modulus, they may ‘feel’ stiffer in scaffolds with larger 
pore sizes because of an increased resistance to buckling. The 'apparent' stiffness, or flexural 
rigidity (EsI), of the scaffold with the largest pore size (151 µm) was calculated to be greater than 
the scaffold with the smallest (96 µm) pore size by a factor of 6.1. Thus, if strut flexural rigidity 
was the mechanism by which pore size affected cell motility, cell motility would be expected to 
decrease for the series of scaffolds of constant pore size but increasing scaffold modulus 
(changing Es in the flexural rigidity term (EsI)).  However, when strut modulus (Es) was 
increased over a range (between 5.3 and 38.0 MPa; Factor: 7.2) that closely approximated the 
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change in strut flexural rigidity with mean pore size (Factor: 6.1), motility did not decrease but 
instead displayed subtle biphasic behavior (Figure 1.16(b)) (Harley, Kim et al. 2008).  
 
After attempting to explain the significant influence of CG scaffold pore size on cell motility 
using predictions made by the cellular solids modeling regarding local scaffold mechanics, 
geometric insights from the cellular solids model regarding strut junctions (points in the scaffold 
where two or more struts meet) were investigated. The geometry of strut junctions within the 
scaffold was described as the mean spacing between junctions (Djxn) or the mean junction density 
(ρjxn, the number of strut junctions per unit cell divided by the volume of a unit cell). Djxn and ρjxn 
were calculated from the scaffold mean pore size (d) assuming a tetrakaidecahedral unit cell 
(Harley, Kim et al. 2008): 
785.2
dD jxn =                                                                                                 (Equation 1.6)  
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Replotting the pore size-dependent cell speed data against strut junction density, an exceptionally 
strong correlation between cell speed and strut junction density was observed (Figure 1.16(c)). 
Further, cells migrating in scaffolds with larger pore sizes, therefore larger Djxn and lower ρjxn, 
were observed to exhibit greater persistence times, indicating more directional motion along a 
scaffold strut (Figure 1.16(c)). In contrast, persistence times of cells migrating in scaffolds with 
smaller pore sizes and greater ρjxn are significantly lower, representative of erratic movement 
(time turning) that likely occurs more often at junctions when cells encounter higher surface 
ligand densities and can therefore move with increased speed. These results provided a 
mechanistic explanation for the initially counter-intuitive observation that cell motility decreases 
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as scaffold pore size increases (Harley, Kim et al. 2008), as well as an excellent example of the 
types of mechanistic questions that can be answered using the CG scaffold system due to the 
capacity to create uniform scaffold variants with independently-controlled microstructural and 
mechanical properties and to integrate rigorous characterization and modeling techniques. 
 
1.4.4 Mechanical stimulation 
Mechanical stimuli, derived from both physical extracellular binding sites and the movement of 
fluids within the ECM, is known to influence critical cell behaviors such as proliferation, 
differentiation, and gene expression (Wu and Chen 2000; Geris, Vandamme et al. 2008; 
McMahon, Reid et al. 2008). Experimental, computational, and modeling techniques have all 
been used with the CG scaffold system to improve our understanding of how these mechanical 
forces affect cell behavior. For example, the effects of pore size and mechanical stimulation on 
gene expression profiles for marrow stromal cells (MSCs) in CG scaffolds have recently been 
evaluated. Osteogenic markers collagen type I, osteocalcin, and osteopatin were all upregulated 
in MSCs seeded into CG scaffolds with larger pores (151 µm vs. 96 µm) (Byrne, Farrell et al. 
2008), indicating that larger pore sizes may be more optimal for bone tissue engineering. Also, 
scaffolds that were mechanically constrained to prevent contraction showed lower MSC RNA 
levels of osteocalcin, osteopatin, and bone sialoprotein, suggesting that prevention of cell-
mediated contraction may be detrimental to osteogenesis (Byrne, Farrell et al. 2008). 
 
CG scaffolds have also been used to investigate the role of direct mechanical stimulation on 
osteoblastic activity. Mechanical loading of MC3T3-E1 cells in culture is known to improve 
bone morphogenic activity within scaffolds. In addition, mechanical stimulation during in vitro 
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culture improves nutrient and waste transport within the scaffold while promoting cellular 
infiltration, which should lead more uniform tissue engineering constructs compared to static 
culture. Dynamic culture was shown to upregulate the gene for cyclooxygenase-2 (COX-2), a 
key enzyme for the production of early bone formation marker prostaglandin E2 (PGE2). The 
gene for osteopontin (OPN), a later marker of bone formation, was also upregulated (Jaasma and 
O'Brien 2008). In addition, incorporation of rest periods during dynamic culture has been shown 
to significantly increase OPN expression over both static and dynamic conditions (Partap, 
Plunkett et al. 2009). This suggests that mechanical stimulation via flow perfusion could be a 
useful technique for encouraging osteoblastic activity and bone formation in CG scaffolds.  
 
Three-dimensional computational fluid dynamics (CFD) modeling has further been utilized to 
estimate shear stress forces on cells seeded within CG scaffolds for bone tissue engineering 
during in vitro culture in perfusion bioreactors (Jungreuthmayer, Donahue et al. 2009; 
Jungreuthmayer, Jaasma et al. 2009). For bone, it is understood that applied wall shear stresses 
on cells are critical in activating matrix production and mineralization (Prendergast, Huiskes et 
al. 1997). Accurate simulations of applied shear stresses on cells would allow the selection of an 
optimal perfusion rate that correlates to physiologic shear stress levels. CFD showed that cells in 
CG scaffolds were exposed to a wide range of shear stresses while conventional analytical 
methods to estimate shear stress only reports a mean shear stress value. The analytical method 
also predicted shear stress values 10-20% higher than CFD and do not take into account the type 
of secondary cell deformation that can take place based on cell orientation within the scaffold 
(Jungreuthmayer, Donahue et al. 2009). CFD analysis of fluid velocity, hydrostatic pressure, and 
wall shear stress on common cell attachment profiles within CG scaffolds (stretched along one 
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strut or spread between two struts) show that low wall shear stresses (~20 mPa) are sufficient to 
activate bone growth mechanisms (Jungreuthmayer, Jaasma et al. 2009).  
 
While computational methods can be useful, the above analysis focused on small scaffold 
sections only as it was impractical to analyze an entire scaffold area (Stops, McMahon et al. 
2008; Jungreuthmayer, Donahue et al. 2009; Jungreuthmayer, Jaasma et al. 2009). Recent work 
by Stops et al. has developed a finite element approach to predict cellular strains within CG 
scaffold systems. Utilizing the tetrakaidecahedron unit cell and experimental data regarding 
scaffold deformation, cell attachment profiles, and cell sizes, a model was developed to predict 
individual cell strain as a function of pore size, cell length, and applied scaffold strain. This 
model correctly predicts individual cell strain within two standard deviations for 72% of cells 
(Stops, McMahon et al. 2008). This approach has also been applied to predict the differentiation 
of MSCs in CG scaffolds as a function of Young's modulus (Khayyeri, Checa et al. 2010). The 
model takes into account pore size, cell proliferation, angiogenesis, and shear stress/strain among 
other factors. Results over a range of 0.001 to 1000 MPa show that higher Young's modulus 
should lead to higher numbers of osteoblasts, indicating that stiffer CG scaffolds could be ideal 
for bone tissue engineering (Figure 1.17) (Khayyeri, Checa et al. 2010). All of these tools 
highlight the multi-scale experimental and analytical tools available when utilizing the CG 
scaffold system for studies of cellular mechanotransduction. 
 
1.4.5 Stem cell differentiation 
CG scaffolds have recently been started to be used to explore extrinsic modulation of stem cell 
fate decisions (differentiation, quiescence, and self-renewal). Adult mesenchymal stem cells 
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(MSCs) can differentiate into a myriad of tissues, including bone, cartilage, and tendon, making 
them a powerful tool for orthopedic tissue engineering. Farrell et al. has recently shown that 
adult MSCs in CG scaffolds could be induced to differentiate along osteogenic or chondrogenic 
lineages in the presence of osteogenic (dexamethasone, ascorbic acid, β-glycerophosphate) and 
chondrogenic (dexamethasone and TGF-β1) factors respectively (Farrell, O'Brien et al. 2006). 
The CG scaffold's demonstrated ability to support both bone and cartilage growth makes it a 
promising material for the treatment of osteochondral defects. Subsequent work has compared 
the osteogenic potential of MSCs on 2D substrates versus 3D CG constructs. While MSCs 
initially expressed collagen type I quicker on 3D substrates, the delayed expression of 
osteocalcin indicates that osteogenic differentiation is slower in CG scaffolds compared to 2D 
substrates (Farrell, Byrne et al. 2007). MSCs cultured in CG materials have also shown variable 
differentiation and gene expression profiles under mechanical strain. High strains (15%) led to 
enhanced α-smooth muscle actin expression but poorer differentiation into type I collagen 
positive cells compared to lower strain levels (5%) (Kobayashi and Spector 2009). Ongoing 
work is examining the utility of CG scaffolds to influence fate decisions of hematopoietic and 
cardiac stem cells. 
 
 
1.5 In Vivo Applications 
Since the development of the first clinically viable artificial skin (Yannas, Lee et al. 1989), CG 
scaffolds have been used in vivo to regenerate a wide variety of chronic and acute injuries 
involving skin, peripheral nerves, conjunctiva, cartilage, and other tissues (Yannas 2001). CG 
scaffolds, like other tissue engineering scaffolds, serve a multitude of functions in vivo including 
 37 
physical inhibition of wound contraction, mechanical support for cells and neo-tissue growth, 
and carrier of biochemical ligands and signaling molecules. CG scaffold mechanical, chemical, 
and microstructural properties have been rigorously characterized in vitro, leading to 
independent control of pore size and shape, elastic moduli, biodegradation rate, chemical 
composition, and other scaffold parameters. These variables can be tuned to create scaffolds 
optimized for the regeneration of specific tissues.  
 
1.5.1 Dermal regeneration applications 
The CG scaffold found to optimize skin regeneration is a monolithic, uniform structure (termed 
the dermal regeneration template (DRT)) that is fabricated from a CG copolymer with a 98:2 
ratio of type I collagen to GAG (chondroitin sulfate). This chemistry was developed in part due 
to the additional mechanical stability afforded by the GAG content as well as the processing to 
the collagen fibrils that allowed platelet attachment but that prevented activation of platelet 
degranulation processes (Sylvester, Yannas et al. 1989; Yannas, Lee et al. 1989). The DRT has 
isotropic pores with a 20-125 µm size range and a degradation time of 5-15 days. The DRT is 
typically implanted acellularly (without cells) along with a thin silicone coating to control 
moisture loss and bacterial infection at the wound site. This bioactive scaffold recruits epidermal 
cells from the wound site and encourages spontaneous regeneration of skin tissue layer by layer. 
Sequential regeneration results in a mature epidermis and basement membrane as well as near 
physiologic dermis that lacks hair follicles. This scaffold has regenerated full-thickness skin 
wounds in animal models and human burn victims (Yannas, Lee et al. 1989; Yannas 2001).  
 
1.5.2 Peripheral nerve regeneration applications 
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Peripheral nerve injuries are typically treated by entubulating transected nerve ends. Tubes made 
of type I collagen have been the most successful as defined by morphological and 
electrophysiological methods (Chamberlain, Yannas et al. 1998; Chamberlain, Yannas et al. 
1998; Chamberlain, Yannas et al. 2000; Yannas 2001; Harley, Spilker et al. 2004; Harley and 
Yannas 2006). While a tube is sufficient to induce regeneration across a gap of several 
millimeters, the addition of a porous material into the tube lumen can enhance the quality of 
regeneration and has been proven superior to other non-porous, non-permeable lumen designs 
(Figure 1.18) (Yannas 2001; Harley and Yannas 2006). This porous core acts as a physical 
support for the growing nerve while allowing migration of cells and cytokines across the nerve 
gap. In addition, this central scaffold core has also been shown to organized wound contraction 
and scar proliferation (Harley, Hastings et al. 2006). The CG scaffold optimized for peripheral 
nerve regeneration, termed the Nerve Regeneration Template (NRT), has axially elongated pores 
on the order of 10-20 µm that provide contact guidance for Schwann cell migration and axon 
formation between nerve stumps (Chamberlain, Yannas et al. 1998). These scaffolds, with an 
optimal degradation half life of 6 weeks (Chang, Yannas et al. 1990; Yannas 2001), were found 
to regenerate peripheral nerves at the same level as autografts, the current gold standard in the 
industry (Chamberlain, Yannas et al. 1998).  
 
1.5.3 Conjunctiva and corneal regeneration applications 
CG scaffolds have demonstrated the ability to alter the typical contraction and scar synthesis 
healing mechanisms associated with full thickness lesions of the conjunctiva in a rabbit animal 
model. Scaffolds were able to significantly reduce wound contraction (6.8% ± 3.2% fornix 
shortening versus 26.4% ± 5.0% for ungrafted wound sites) and promote the synthesis of a 
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nearly physiologic stroma layer (Hsu, Spilker et al. 2000). CG scaffolds have also been shown to 
be promising substrates for the development of artificial corneas. In vitro characterization of 
these scaffolds showed that stromal keratocytes, epithelial, and endothelial cells could be 
successively co-cultured over a period of 12 weeks (Vrana, Builles et al. 2008). The cells 
produced a new ECM, complete with an epithelium, basement membrane, and endothelial cell 
monolayer (Vrana, Builles et al. 2008).  
 
1.5.4 Cartilage and fibrocartilage disk tissue engineering applications 
CG scaffolds have been applied to the regeneration of a range of other orthopedic tissues 
including articular cartilage, meniscus, and the intervertebral disk. The effects of crosslinking 
density, chemical composition, and pore size of CG scaffolds, as well as the use of gene and 
growth factor seeded CG scaffolds, have been studied extensively in the context of articular 
cartilage regeneration (Samuel, Lee et al. 2002; Capito and Spector 2003; Lee, Grodzinsky et al. 
2003; Kinner, Capito et al. 2005; Vickers, Squitieri et al. 2006; Capito and Spector 2007). 
Recently, CG scaffolds populated with TGF-β1 transfected meniscus cells were used to 
successful fill avascular zone meniscus lesions with repair tissue (Steinert, Palmer et al. 2007). 
Other work has compared type I and type II CG scaffolds for intervertebral disk  tissue 
engineering applications, finding that type II CG scaffolds were preferential to type I on the basis 
of cell number as well as protein and GAG synthesis after eight weeks (Saad and Spector 2004). 
 
1.5.5 Bone, osteochondral regeneration applications 
Single phase and layered, multiphase CGCaP scaffolds have recently been developed for in vivo 
bone and osteochondral tissue engineering applications respectively (Harley, Lynn et al. 2005; 
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Lynn and Bonfield 2005; Harley, Lynn et al. 2010; Harley, Lynn et al. 2010; Lynn, Best et al. 
2010). These materials are currently undergoing in vivo examination as both bone scaffolds 
(single phase CGCaP form) and as full osteochondral scaffolds. CGCaP bone regeneration 
scaffolds are composed of type I collagen, chondroitin sulfate, and calcium phosphate. Initial in 
vitro and in vivo experiments have demonstrated that these scaffolds can successfully integrate 
into bone defects and show preliminary bony substitution and mineralization as early as six 
weeks post implantation (Lynn, Harley et al. 2005). 
 
The biphasic layered, gradient scaffold developed for the treatment of osteochondral defects has 
been shown to mimic aspects of the natural structure of articular joints (Harley, Lynn et al. 
2010), notably a continuous boundary that should induce the formation of interfacial tissue as 
seen in healthy joints between articular cartilage and subchondral bone (Figure 1.19). Utilization 
of this fabrication method also prevents complications often observed in layered scaffolds with 
abrupt interfaces including delamination, foreign body contamination (from glue or other 
adhesive), and inefficient cellular transport between scaffold phases (Harley, Lynn et al. 2010). 
Under mechanical loading, the osteochondral scaffolds perform as expected for a biphasic 
material, with the majority of deformation confined to the cartilagenous compartment and no 
evidence of delamination between the scaffold compartments during or following loading 
(Harley, Lynn et al. 2010). This scaffold is currently being developed as a clinical product that 
can be implanted using a mosaicplasty approach without the use of sutures, glue, or screws 
(Harley, Lynn et al. 2010). This scaffold system is currently undergoing Phase I clinical trials for 
primary and secondary (backfill of traditional mosaicplasty harvest sites) osteochondral defects 
in the knee. The developed technologies and techniques hold promise for the regeneration of not 
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only osteochondral defects, but also other physiological interfaces such as the tendon to bone 
insertion site.  
 
1.5.6 Brain tissue engineering applications 
CG scaffolds are currently being explored as substrates for neural defects in the brain. These 
scaffolds are fabricated via the conventional freeze-drying approach from type I or type II 
collagen and hyaluronic acid, a GAG that is the chief component of the brain ECM (Bignami, 
Hosley et al. 1993). Although the brain is almost entirely composed of HA, the collagen 
component of these CG scaffolds allows additional control of mechanical properties and 
biodegradation rates (Wang and Spector 2009). Altering the ratio of collagen to HA allowed 
manipulation of porosity over a wide range (75– 91%, brain = 76%) and compressive modulus 
(1.33 – 6.31 kPa, brain = 1.06 kPa) (Wang and Spector 2009). Neuronal stem cells showed the 
capacity to differentiate into neuronal cells in these HA-collagen scaffolds (Wang and Spector 
2009), and ongoing studies are continuing to optimize scaffold properties via a series of in vitro 
and in vivo experiments. 
 
1.5.7 Lung tissue engineering applications 
The cellular nature of CG scaffolds and the ability to modify scaffold porosity and pore size has 
made them candidate materials for regenerative medicine studies in the lung. CG scaffolds have 
been utilized as prospective materials to investigate design parameters for in vivo healing of lung 
tissue damage. Lung cells from Sprague-Dawley rats were seeded onto standard CG scaffolds 
(type I collagen, chondroitin sulfate) and cultured for 2-21 days. This in vitro culture led to the 
development of alveolar-like structures as well as cell-mediated contraction, possibly due to 
expression of α-smooth muscle actin (Chen, Marsilio et al. 2005). These results suggest that CG 
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scaffolds hold promise as an in vivo treatment for lung defects and that they also might be 
interesting model systems for ex vivo culture of cells associated with a wide range of lung-tissue 
abnormalities and diseases. 
 
1.6 Tendon Physiology and Pathology 
CG materials are currently being considered for a variety of new tissue engineering applications, 
including tendon and ligament repair. With over 32 million tendon and ligament injuries in the 
US each year with associated costs of $30 billion (Butler, Juncosa-Melvin et al. 2008) and an 
aging population that is remaining physically active later into life, the need for viable tendon 
repair strategies is becoming increasingly important.  
 
Tendons are specialized connective tissues that transmit tensile loads between bone and muscle. 
Tendon's ability to withstand tensile loads arises from its unique ECM. Tendon ECM is primarily 
composed of type I collagen arranged in a highly organized hierarchy of parallel, crosslinked 
fibrils (James, Kesturu et al. 2008; Liu, Ramanath et al. 2008) (Figure 1.20). The ECM is highly 
aligned in the direction of the tendon's tensile axis with tendon cells (TCs) distributed throughout 
the collagen fibers. The ECM also contains vascular, neural, and lymphatic components essential 
to TC bioactivity (James, Kesturu et al. 2008; Liu, Ramanath et al. 2008).  
 
Tendons can be damaged in a variety of ways, ranging from acute trauma to chronic lesions from 
repetitive strain. The Achilles, patellar, and supraspinatus in the rotator cuff are among the most 
commonly injured tendons. Some tendons, such as the Achilles, stretch and recoil in order to 
store and release elastic energy for more efficient locomotion. This type of tendon is most 
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susceptible to traumatic injuries (Birch 2007). Others, such as the patellar tendon, degenerate and 
undergo tendinosis while others, such as the supraspinatus tendon, are prone to failure at the 
tendon-bone interface due to high stress concentrations (Farrell, O'Brien et al. 2006; Harley and 
Gibson 2008; James, Kesturu et al. 2008; Liu, Ramanath et al. 2008; Xu and Murrell 2008; 
Gulotta and Rodeo 2009).  
 
While small tendon injuries can heal naturally through largely regenerative mechanisms, larger 
tendon injuries undergo a repair-mediated process; the repair tissue has inferior biomechanical 
properties due to the development of scar tissue as well as incongruencies in the collagen matrix 
(James, Kesturu et al. 2008; Liu, Ramanath et al. 2008; Xu and Murrell 2008). Current 
technologies to treat tendon injuries are inadequate and have poor clinical outcomes with failure 
rates as high as 94% (Galatz, Ball et al. 2004). These issues underlie the need for the 
development of optimized, instructive biomaterials to guide functional tendon regeneration.  
 
 
1.7 Thesis Organization 
 
In this chapter the development of CG materials and their applicability to a wide range of tissue 
engineering problems was discussed. This remainder of this thesis will discuss the design of CG 
biomaterials for a new target tissue: tendon. Chapter 2 will describe the development and 
characterization of a specialized CG scaffold with aligned pore microstructure mimicking 
tendon. It will also demonstrate the effects of growth factor candidates on various cell processes 
including chemotaxis and metabolic activity. Chapter 3 will describe the utilization of the 
aligned CG scaffold fabricated in Chapter 2 to develop novel scaffold-membrane core-shell 
materials with enhanced mechanical properties for tendon tissue engineering. Experimental 
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details of scaffold, membrane, and scaffold-membrane composite biophysical and biomechanical 
properties will be discussed. Chapter 4 will conclude this thesis with a summary of results and 
recommendations for future work.  
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1.8 Tables 
Freezing 
Temperature, oC Mean Pore Size, µm Citation 
-10 325 (Murphy, Haugh et al. 2010) 
-10 151 (O'Brien, Harley et al. 2005) 
-20a 190 (Murphy, Haugh et al. 2010) 
-20b 164 (Murphy, Haugh et al. 2010) 
-20 121 (O'Brien, Harley et al. 2005) 
-30 110 (O'Brien, Harley et al. 2005) 
-40 120 (Murphy, Haugh et al. 2010) 
-40 96 (O'Brien, Harley et al. 2005) 
-60 85 (Murphy, Haugh et al. 2010) 
a Initial freezing temperature followed by 48 hr anneal at -10 oC 
b Initial freezing temperature followed by 24 hr anneal at -10 oC  
 
Table 1.1. Mean pore size of isotropic, equiaxed CG scaffolds produced using a variety of 
thermal treatments. 
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Property Hydrated CG Scaffold 
Hydrated 
Mineralized (50%) 
CG Scaffold 
E* 0.208 ± 0.041 kPa 6.20 ± 1.51 kPa 
σel
* 0.021 ± 0.008 kPa 0.547 ± 0.089 kPa 
εel
* 0.10 ± 0.04 0.0960 ± 0.0302 
Δσ/Δε 0.092 ± 0.014 kPa 3.05 ± 0.392 kPa 
Es 5.28 ± 0.25 MPa 78.8 ± 8.5 MPa 
 
Table 1.2. Average (Mean ± St. Dev.) mechanical properties of the homogeneous CG scaffold 
variants (96 – 151 µm; 0.006 relative density; DHT crosslinking at 105oC for 24 hours; hydrated) 
and the mineralized CGCaP scaffold (202 µm; 0.038 relative density; DHT crosslinking at 105oC 
for 24 hours; hydrated) (Harley, Leung et al. 2007; Kanungo, Silva et al. 2008). 
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Crosslinking 
Treatment 
Scaffold Strut 
Elastic Moduli, 
MPa 
Relative 
Elastic 
Modulus 
Mineralized (50%) 
Scaffold Strut 
Elastic Moduli, 
MPa 
Relative 
Elastic 
Modulus 
Uncrosslinked 3.9 ± 0.20 0.74 49.1 ± 5.3 0.62 
DHT105/24 
(Standard) 5.28 ± 0.25 1.0 78.8 ± 8.5 1.0 
DHT120/48 5.7 ± 0.30 1.08 No Data No Data 
EDAC1:1:5 10.6 ± 0.50 2.0 No Data No Data 
EDAC5:2:5 11.8 ± 0.56 2.24 No Data No Data 
EDAC5:2:1 38.0 ± 1.8 7.2 193.2 ± 20.7 2.45 
 
Table 1.3. Elastic moduli of individual scaffold struts within hydrated CG and CGCaP scaffolds 
crosslinked via DHT and EDAC/NHS techniques (Harley, Leung et al. 2007; Kanungo, Silva et 
al. 2008). 
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Scaffold ρ*/ρs E* (kPa) σ* (kPa) ε* (%) Δσ/Δε (kPa) 
CG 1x 0.0062 ± 0.0008 32 ± 6 5.0 ± 1.1 15.8 ± 3.5 10.6 ± 1.0 
CG 2x 0.0120 ± 0.0016 61 ± 5
a 11.8 ± 2.4a 18.9 ± 2.5a 43.6 ± 2.5a 
CG 3x 0.0198 ± 0.0014 97 ± 17
aa 15.6 ± 3.1aa 15.9 ± 1.2 54.8 ± 9.3aa 
CG 4x 0.0239 ± 0.0021 127 ± 23
aa 19.0 ± 3.9a 14.6 ± 3.5 43.3 ± 5.6aa 
CGCaP 1x 0.045 ± 0.002 780 ± 95 39 ± 10 5.00 ± 1.00 480 ± 35 
CGCaP 2x 0.098 ± 0.004 3156 ± 760
b 132 ± 14b 4.00 ± 1.41 1300 ± 200b 
CGCaP 3x 0.137 ± 0.002 
6500 ± 
1270bb 242 ± 32
bb 4.00 ± 1.00 2680 ± 610bb 
CGCaP 4x 0.187 ± 0.027 3660 ± 820
b 275 ± 50bb 4.38 ± 1.15 1875 ± 525bbb 
 
Table 1.4. Mechanical properties (Mean ± Standard Deviation) of CG (relative density 0.0062-
0.0239) and CGCaP (0.045-0.187) scaffolds in the dry state. Superscripts a, aa, aaa (CG) and b, bb, 
bbb (CGCaP) denote statistically significant differences between groups. For example, E* for the 
CG 1X, 2X, and 3X scaffolds are significantly different from each other while 3X and 4X are not 
(Kanungo and Gibson 2009; Kanungo and Gibson 2010).  
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1.9 Figures 
 
 
Figure 1.1. Structural and chemical overview of collagen type I. (a) Typical primary amino acid 
sequence. (b) Secondary left handed helix and tertiary right handed triple-helix structure. (c) 
Staggered quaternary structure displaying characteristic 67 nm lateral offset between fibrils. 
Reprinted with permission (Friess 1998).  
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Figure 1.2. Three-dimensional structure of GAG. (a) Top: ball-and-stick depiction of a heparin 
oligosaccharide with –[I2S-HNS,6S]– repeat unit (carbon, oxygen, nitrogen, and sulfur atoms are 
colored gray, red, blue, and yellow, respectively). Bottom: chair conformation of the expanded 
disaccharide unit showing backbone atoms (colored red) and glycosidic torsion angles (f1, ψ1) 
and (f2, ψ2). (b) Helical wheel projection of the sulfate groups of the structure shown in (a). (c) 
Commonly observed low-energy ring conformations of iduronic acid (atoms colored the same 
way as in (a)). Reprinted with permission (Raman, Sasisekharan et al. 2005). 
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Figure 1.3. ESEM image of the pore structure of the CG scaffold (Tf = -40oC). Scale bar: 100 
µm. Reprinted with permission (Pek, Spector et al. 2004). 
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Figure 1.4. ESEM image of the pore structure of the tubular CG scaffold fabricated via spinning 
method. Scale bars: 1 mm (tube), 100 µm (wall). Reprinted with permission (Harley, Hastings et 
al. 2006). 
 53 
 
 
Figure 1.5. (a) SEM and µCT micrographs of CGCaP scaffold microstructure displaying an open 
pore structure with interconnected pores. (b) EDX analysis of CGCaP scaffold shows uniform 
distribution of both calcium (Ca) and phosphorous (P) throughout the scaffold. Scale bars: 1 mm. 
Reprinted with permission (Harley, Lynn et al. 2010).  
(a) 
(b) 
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Figure 1.6. Schematic of liquid phase co-synthesis method used to produce layered 
osteochondral CG scaffold with soft, continuous interface. Non-mineralized, type II collagen-
glycosaminoglycan (Type II CG) suspension is layered on top of mineralized, type I collagen-
glycosaminoglycan (CGCaP) suspension, allowed to interdiffuse, and then freeze-dried to 
produce a porous, layered scaffold that mimics natural articular joint physiology. Reprinted with 
permission (Harley, Lynn et al. 2010). 
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Figure 1.7. μCT scan of CG scaffold utilized in CFD simulations. Scale bar: 1 mm. Reprinted 
with permission (Jungreuthmayer, Jaasma et al. 2009). 
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Figure 1.8. Tetrakaidecahedral unit cell. d ≡ pore diameter; l ≡ strut length; t ≡ strut thickness. 
Reprinted with permission (Harley, Kim et al. 2008). 
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Figure 1.9. Comparison between experimental results (Kmeas, solid bars) and the predicted values 
obtained from the mathematical model (Kcalc, striped bars) for CG scaffold permeability under 
varying compressive strain (0, 14, 29, 40% strain, left to right for each pore size) for distinct pore 
sizes (96, 110, 121, 151 µm). Reprinted with permission (O'Brien, Harley et al. 2007). 
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Figure 1.10. Uniaxial stress–strain curve for an elastomeric cellular solid in compression 
showing linear elastic, collapse plateau, and densification regions as well as the linear elastic 
modulus (E*) and elastic collapse stress (σel*). Reprinted with permission (Gibson, Ashby et al. 
2010).  
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Figure 1.11. Characteristic stress-strain curves observed for the CG scaffold under compression 
for the entire tested strain range (a) ε: 0 – 0.95, and for a subregion of a hydrated CG scaffold (b) 
ε: 0 – 0.60. Linear regressions of the linear elastic and collapse plateau regimes are used to 
calculate the linear elastic modulus (E*) and the collapse plateau modulus (Δσ/Δε).The elastic 
collapse stress and strain are σel*, εel*. (c) Characteristic stress-strain curve observed for the 
(hydrated) CG scaffold variants under uniaxial tensile testing in the plane of the scaffold sheet. 
Reprinted with permission (Harley, Leung et al. 2007).  
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Figure 1.12. (a) AFM experimental setup to assess individual CG scaffold strut modulus. (b) 
Characteristic load-unload curve for bending tests performed via AFM on individual CG scaffold 
struts (non-mineralized variant) and (c) (mineralized variant). Reprinted with permission 
(Harley, Leung et al. 2007; Kanungo, Silva et al. 2008).  
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Figure 1.13. MC3T3-E1 cell attachment plotted against specific surface area showing a strong 
linear relationship at 24 (gray line) and 48 hours (black line) post-seeding. Reprinted with 
permission (O'Brien, Harley et al. 2005). 
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Figure 1.14. (a) Plot of the fibroblast aspect ratio and generated contractile force with time in the 
CG scaffold. The average cell aspect ratio increased up to 15 hours post-seeding in a manner 
similar to the total force generated by the cell population. (b) Plot of force per cell over time for 
different system stiffnesses. The displacement developed per cell increased as the system 
stiffness decreased but the force developed per cell was independent of the system stiffness. 
Reprinted with permission (Gibson, Ashby et al. 2010). 
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Figure 1.15. (a) Time lapse images of an individual dermal fibroblast within the CG scaffold. 
The sequence of images shows a dermal fibroblast (arrow A) elongating and deforming the 
surrounding scaffold struts (arrows B). Several struts are deformed over time (arrows C). Time, 
in hours and minutes, after cell seeding is indicated in the top right of corner of each image. 
Scale bar: 50 µm. (b) Schematic of a single cell applying a critical buckling load (Fc) to a 
scaffold strut within an idealized CG scaffold network (left). The surrounding struts inhibit 
rotation of the ends of the buckling strut (middle). A simplified model of CG scaffold strut 
buckling with the appropriate boundary conditions: the scaffold strut is restrained at its ends by a 
rotational spring that represents the surrounding strut network (right). Reprinted with permission 
(Harley, Freyman et al. 2007). 
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Figure 1.16. (a) 3D Wind-Rose plots of randomly chosen cell tracks showing cell dispersion; cell 
dispersion decreases as scaffold mean pore size increases. (b) Motile fraction and mean cell 
speed decreases as scaffold pore size increases. Cell speed shows a subtle biphasic relationship 
with scaffold strut modulus. (c) Cell speed increases proportionally with scaffold strut junction 
density. Cell persistence time increases with pore size (increasing distance between strut 
junctions). Reprinted with permission (Harley, Kim et al. 2008). 
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Figure 1.17. Percentage of MSC derived cell phenotypes inside CG scaffold as a function of 
Young's modulus as predicted by finite element modeling. The fraction of osteoblasts compared 
to fibroblasts increases with increasing modulus, suggesting that stiffer CG scaffolds may be 
preferred for bone tissue engineering. Adapted from (Khayyeri, Checa et al. 2010). 
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Figure 1.18. Histomorphometric, cross-sectional images of the nerve trunk regenerated using 
collagen tubes with tailored biodegradation rates. The images are arranged in order of lowest to 
highest crosslink density, or fastest to slowest degradation rate from A to E. Nerves trunks 
regenerated in devices C and D, characterized by intermediate levels of the crosslink density and 
degradation rate (device half life: 2–3 weeks), showed superior morphology, with significantly 
larger axons, a more well-defined myelin sheath, and a significantly larger N-ratio. Scale bar: 25 
µm. Reprinted with permission (Harley, Spilker et al. 2004), S. Karger AG, Basel, Switzerland. 
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Figure 1.19. (a) Structure of the natural articular joint showing articular cartilage and 
subchondral bone joined by a continuous interfacial region. (b) X-ray µCT image of the layered 
osteochondral scaffold showing distinct cartilaginous and osseous compartments (scale bar 1 
mm). (c) SEM images of the osteochondral scaffold showing the complete scaffold 
microstructure (left; scale bar 500 µm), and the interfacial region (middle; scale bar 200 µm) 
showing continuity between the osseous (tan dashed arrow) and cartilaginous (blue solid arrow) 
compartments including collagen struts extending across the transition (white arrows). No 
regional areas of delamination or debonding are observed between the compartments. 
Distribution of Ca mineral (P similar but not shown) content (red shading) superimposed over an 
SEM image of the osteochondral scaffold showed distinct mineralized (high CaP content, tan 
dashed arrow) and non-mineralized (low/zero CaP content, blue solid arrow) layers (right; black 
scale bar 400 µm). Reprinted with permission, (Harley, Lynn et al. 2010). 
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Figure 1.20. Collagen fiber bundle organization in healthy tendon. Reprinted with permission, 
(Liu, Ramanath et al. 2008) 
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CHAPTER 2: ALIGNED COLLAGEN-GAG WITH PDGF-BB AND IGF-1 SUPPORT 
INCREASED TENDON CELL MIGRATION, VIABILITY, AND METABOLIC 
ACTIVITY2
 
 
2.1 Introduction 
Tendon and ligament injuries are exceedingly common with over 32 million occurring each year 
(Butler, Juncosa-Melvin et al. 2008). While small tendon injuries can heal naturally through 
largely regenerative mechanisms, larger tendon injuries undergo a repair-mediated process; the 
repair tissue has inferior biomechanical properties due to the development of scar tissue as well 
as incongruencies in the collagen matrix (James, Kesturu et al. 2008; Liu, Ramanath et al. 2008; 
Xu and Murrell 2008). Current surgical and tissue engineering strategies have had limited 
success due to their inability to recapitulate the native microstructural and biomechanical 
properties of tendon. 
 
The adult healing mechanisms seen with tendon are largely similar to those observed for a wide 
range of soft and orthopedic tissues (Yannas 2001). The tendon wound healing process includes 
three overlapping phases: inflammation, proliferation, and remodeling (Figure 2.1). 
Understanding these wound healing responses sets the stage for developing comprehensive tissue 
engineering approaches to regenerate tendons following injury. The inflammatory stage begins 
immediately after injury and lasts for approximately 6 days (Molloy, Wang et al. 2003; Sharma 
and Maffulli 2005; Yannas, Kwan et al. 2007; James, Kesturu et al. 2008). This stage is 
characterized by stabilization of the wound site via a hematoma and the release of blood and 
immune cells (Molloy, Wang et al. 2003; James, Kesturu et al. 2008). These cells are responsible 
for phagocytosis of bacteria and necrotic tissue as well as producing a battery of growth factors 
                                                 
2 This chapter has been adapted from the following publication: 
Caliari, S. R. and B. A. Harley (in preparation). "Aligned collagen-GAG scaffolds with PDGF-BB and IGF-1 
support increased tendon cell migration, viability, and metabolic activity." 
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that induce local inflammatory processes and recruit extrinsic cells to protect the tissue from 
further injury (Molloy, Wang et al. 2003; James, Kesturu et al. 2008). The proliferation stage 
begins approximately 2 days post injury and continues for the next 2 weeks (Molloy, Wang et al. 
2003; Sharma and Maffulli 2005; Yannas, Kwan et al. 2007; James, Kesturu et al. 2008). During 
this phase, TCs are recruited to the wound site and undergo rapid proliferation, new ECM 
synthesis and remodeling occurs, and angiogenesis commences. Initially, type III collagen is 
produced in higher frequency than is found in mature tendon. Active vascular sprouting and 
organized angiogenesis creates a vascular network for nutrient transport to the proliferating cells 
(Molloy, Wang et al. 2003; James, Kesturu et al. 2008). The remodeling stage of tendon wound 
healing can begin as soon as 8 days after injury and continue for up to a year (Molloy, Wang et 
al. 2003; Sharma and Maffulli 2005; Yannas, Kwan et al. 2007; James, Kesturu et al. 2008). 
Successful remodeling can produce functionally regenerated tendon in the case of small tendon 
injuries, but rarely results in complete tendon recapitulation in the case of large injuries. During 
this phase, cell apoptosis increases, decreasing the hypercellularity of the neo-tendon associated 
with the proliferative stage. Type I collagen synthesis is upregulated and the type I to type III 
collagen ratio approaches physiologic levels. Although the remodeling phase improves tendon 
structure and function, the healed tendon is largely composed of scar tissue and is not as robust 
as normal tendon (Molloy, Wang et al. 2003; James, Kesturu et al. 2008).  
 
Autograft and allograft procedures represent the current clinical gold-standard for treating tendon 
injuries (Cole, Ginn et al. 2005). These treatments are plagued by the limited availability and 
stringent processing requirements for allograft tissue as well as the secondary wound site 
creation and resultant loss of function inherent with an autograft. Optimized biomaterial 
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constructs such as tissue engineering scaffolds represent an important, cost-effective alternative 
to current allograft and autograft treatment methods. Such materials could be used in the primary 
wound site, or in the secondary wound site created during autograft procedures, in order to speed 
healing and increase functional capacity. Tissue engineering scaffolds should ideally possess 
several key features, including high porosity and permeability, ligands for cells to attach onto, 
mechanical competence, and biocompatibility (Harley and Gibson 2008; Liu, Ramanath et al. 
2008). However, tendon tissue engineering materials are typically designed as woven or 
electrospun polymer mats instead of 3D scaffolds (Lu, Cooper et al. 2005; Liu, Ramanath et al. 
2008; Li, Xie et al. 2009; Moffat, Kwei et al. 2009). These mats are usually composed of 
synthetic polymers including poly(ε-caprolactone) (PCL), poly(ethylene oxide) (PEO), 
poly(vinyl alcohol) (PVA), poly(L-lactic acid) (PLLA), and poly(lactic-co-glycolic acid) 
(PLGA) (Pham, Sharma et al. 2006). Electrospun materials have the advantage of property 
tunability and can be designed with tensile elastic moduli approaching the level of tendon (Lu, 
Cooper et al. 2005; Liu, Ramanath et al. 2008; Moffat, Kwei et al. 2009). They also have 
numerous drawbacks including a lack of cell adhesion ligands, inadequate permeability and 
porosity, and cytotoxic degradation byproducts (Harley and Gibson 2008; Liu, Ramanath et al. 
2008). In order to develop more optimized constructs, a variety of techniques have emerged to 
supplement tendon scaffold bioactivity, namely contact guidance and growth factor 
supplementation.  
 
Past studies have determined that successful regeneration templates for aligned tissues such as 
tendon must provide contact guidance cues by recapitulating aspects of the native tissue 
anisotropy to guide functional repair. The contact guidance paradigm relies on external 
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microstructural and mechanical stimuli to physically provide cues to regulate cell alignment, 
motility, differentiation, and organized ECM synthesis (Liu, Ramanath et al. 2008; Yin, Chen et 
al. 2010). This concept has been applied to the regenerative repair of directional tissues such as 
peripheral nerves (Kim, Haftel et al. 2008) and myocardium (Engelmayr, Cheng et al. 2008) as 
well as tendon (Moffat, Kwei et al. 2009; Xie, Li et al. 2010).  In addition, several studies have 
demonstrated that aligned scaffolds have increased mechanical properties over isotropic controls 
along the axis of alignment (Chapter 3) (Moffat, Kwei et al. 2009; Shang, Yang et al. 2010; 
Caliari, Ramirez et al. in preparation). Recently, primary equine TCs were cultured on 2D 
micropatterned polymer substrates with a linear ridge pattern (ridge spacing: 50-250 µm) to 
assess the effects of contact guidance cues on TC behavior. TC morphology, orientation, 
proliferation, and collagen biosynthesis were all observed to be significantly affected by 
substrate topology with cells in the more restrictive channels (50 µm) displaying a higher degree 
of alignment as well as increased collagen synthesis and organization (Kapoor, Caporali et al. 
2010). These results suggest that structurally anisotropic (aligned) scaffolds could significantly 
improve TC bioactivity and scaffold regenerative potential relative to an isotropic (non-aligned) 
variant. 
 
Growth factor supplementation has been used in a myriad of tissue engineering approaches with 
encouraging results, both for tendon as well as other tissues and organs. Growth factors are 
cytokines that regulate diverse cellular processes including proliferation, differentiation, 
migration, neovascularization, and ECM biosynthesis. Numerous collagen scaffolds (Steffens, 
Yao et al. 2004; Borselli, Ungaro et al. 2009; Chiu and Radisic 2010) and synthetic materials 
(Davies, Dobner et al. 2008; DeVolder and Kong 2010) have demonstrated the critical role of 
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vascular endothelial growth factor (VEGF) in tissue neovascularization and angiogenesis. For 
bone tissue engineering, the bone morphogenetic protein (BMP) family of growth factors, 
specifically BMP-2 and BMP-7, has been shown to increase alkaline phosphatase activity and 
ectopic bone formation (Wei, Jin et al. 2007; Basmanav, Kose et al. 2008; Yilgor, Tuzlakoglu et 
al. 2009). Glial cell-derived neurotrophic factor (GDNF), nerve growth factor (NGF), and brain-
derived neurotrophic factor (BDNF) have all been shown to play integral roles in the 
development and repair of peripheral nerves (Price, Louria et al. 2005; Chew, Mi et al. 2007). 
Transforming growth factor-beta3 (TGF-β3) is known to stimulate chondrogenic differentiation 
of mesenchymal stem cells (MSCs) and promote improved outcomes in cartilage tissue 
engineering, including increased compressive modulus, increased GAG production, and better 
histological quality of tissue (Byers, Mauck et al. 2008; Thorpe, Buckley et al. 2010). 
 
In relation to tendon healing, insulin-like growth factor 1 (IGF-1) and platelet-derived growth 
factor-BB (PDGF-BB) have been implicated as key factors in reducing the initial inflammatory 
response and aiding the recruitment of TCs from the surrounding environment to the wound site 
during the inflammatory phase of wound healing. Gradients of PDGF-BB and IGF-1 have been 
shown to be most potent activators of MSC (TC precursor) chemotaxis compared to over 30 
other chemokines in both Transwell and scratch wound healing assays (Ozaki, Nishimura et al. 
2007; Ponte, Marais et al. 2007). IGF-1 enhances MSC migration via CXCR4 receptor signaling 
(Li, Yu et al. 2007) and has been shown to increase TC proliferation as well as ECM 
biosynthesis (Abrahamsson, Lundborg et al. 1991). PDGF-BB, more than other PDGF isoforms, 
has displayed the most potential for tendon healing (Yoshikawa and Abrahamsson 2001; 
Thomopoulos, Harwood et al. 2005). Further, synergistic effects of PDGF-BB with IGF-1 as 
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well as basic fibroblast growth factor (bFGF) on TC proliferation have been noted (Yoshikawa 
and Abrahamsson 2001; Thomopoulos, Harwood et al. 2005; Costa, Wu et al. 2006). Finally, 
PDGF-BB and IGF-1 have also been shown to improve in vivo rotator cuff healing in a rat model 
(Dines, Grande et al. 2007).  
 
Other factors involved in tendon healing have been shown to aid TC proliferation and organized 
ECM biosynthesis during the proliferation and remodeling phases of wound healing. Exogenous 
addition of bFGF has been shown to increase tendon wound closure speed (Chan, Fu et al. 2000) 
as well as improve fibroblast proliferation and collagen synthesis (Molloy, Wang et al. 2003; 
Thomopoulos, Harwood et al. 2005). TGF-β1 neutralization has been observed to reduce scar 
formation, proliferation, and tendon adhesion while encouraging organized ECM synthesis 
(Shah, Foreman et al. 1995; Murata, Zhou et al. 1997; Chang, Thunder et al. 2000; Soo, Beanes 
et al. 2003). Further, TGF-β1 and TGF-β2 neutralization coupled with TGF-β3 addition has been 
shown to be beneficial in early stages of wound healing (Shah, Foreman et al. 1995).  
 
This chapter describes the development of a collagen-glycosaminoglycan (CG) scaffold system 
that integrates both insoluble (contact guidance via alignment) and soluble (growth factor) cues 
as an optimized biomaterial for tendon tissue engineering. The aligned microstructure is 
hypothesized to improve construct regenerative capacity by providing contact guidance cues to 
cells. It is further hypothesized that growth factor supplementation can aid in the initial 
recruitment and proliferation of TCs to CG scaffolds. Growth factor candidates PDGF-BB and 
IGF-1 were chosen for their ability to induce cell chemotaxis, proliferation, and functional 
tendon repair (Abrahamsson, Lundborg et al. 1991; Yoshikawa and Abrahamsson 2001; 
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Thomopoulos, Harwood et al. 2005; Costa, Wu et al. 2006; Dines, Grande et al. 2007; Li, Yu et 
al. 2007; Ozaki, Nishimura et al. 2007; Ponte, Marais et al. 2007). CG scaffolds have previously 
been used in a variety of tissue engineering applications, both in vivo as regenerative templates 
for skin, peripheral nerves, conjunctiva, and cartilage (Yannas, Lee et al. 1989; Yannas 2001; 
Harley, Spilker et al. 2004) as well as in vitro as 3D microenvironments to probe fundamental 
questions about cell behaviors and cell-matrix interactions. These scaffolds have the requisite 
porosity (> 99%), bioactivity, and 3D structure for tissue regeneration while also being 
regulatory compliant (Harley and Gibson 2008). While these scaffolds have previously been 
integrated with gene delivery vehicles for in vitro meniscus and cartilage tissue engineering 
(Capito and Spector 2007; Steinert, Palmer et al. 2007), the effect of growth factor 
supplementation on cell behavior in CG scaffolds has not been explored. In this chapter, we 
demonstrate that CG scaffolds can be fabricated with aligned, elongated pores mimicking the 
microstructure of native tendon. Additionally we find that a series of aligned scaffolds can be 
fabricated over a wide range of mean pore sizes, but with constant relative density (ratio of 
porous scaffold density to solid collagen-GAG density: ρ*/ρs). We also show that coupling of the 
bioactive CG scaffold with PDGF-BB and IGF-1 can induce significant increases in TC 
migration, viability, and metabolic activity. 
 
 
2.2 Materials and Methods 
2.2.1 Aligned CG scaffold fabrication 
Aligned CG scaffolds (ρ*/ρs = 0.006) were fabricated via a combined directional solidification 
and lyophilization approach from a suspension of type I microfibrillar collagen from bovine 
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dermis (Devro Inc., Columbia, SC) and chondroitin sulfate derived from shark cartilage (Sigma-
Aldrich, St. Louis, MO) in 0.05 M acetic acid (Yannas, Lee et al. 1989). The suspension was 
held at 4°C during mixing to prevent collagen gelatinization.  
 
Degassed CG suspension was pipetted into holes inside a polytetrafluoroethylene (PTFE) mold 
(8 mm diameter, 15 mm deep) with a thin copper bottom plate and placed on a freeze-dryer shelf 
(VirTis, Warminster, PA) at a pre-cooled temperature (-10, -40, or -60°C) (Figure 2.2(a)). The 
drastic difference in thermal conductivities (kCu/kPTFE ~ 1600) promoted unidirectional heat 
transfer through the copper bottom during the freeze-drying process. The suspension was held at 
this temperature for 1-2 h to allow for complete freezing. Ice crystals were sublimated under 
vacuum (200 mTorr) at 0°C to produce CG scaffolds (8 mm diameter by 15 mm length) with 
aligned microstructure.  
 
Scaffolds were sterilized and dehydrothermally crosslinked at 105°C for 24 h under vacuum (< 
25 torr) in a vacuum oven (Welch Vacuum Technology, Niles, IL) prior to use. Scaffolds were 
then immersed in 100% ethanol overnight, washed with phosphate-buffered saline (PBS) several 
times, and then crosslinked using carbodiimide chemistry (Olde Damink, Dijkstra et al. 1996; 
Harley, Leung et al. 2007). Briefly, scaffold pieces were soaked for 30 min in a solution of 1-
ethyl-3-[3-dimethylaminopropyl]carbodiimide hydrochloride (EDAC) and N-
hydroxysulfosuccinimide (NHS) at a molar ratio of 5:2:1 EDAC:NHS:COOH where COOH 
represents the amount of collagen carboxyl groups. This was followed by two washes for 30 min 
in PBS. Scaffolds were stored in PBS until use. 
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2.2.2 SEM analysis 
Scanning electron microscope (SEM) analysis was performed to qualitatively assess scaffold 
pore size, shape, and overall microstructural organization. Scaffold pieces were cut with a razor 
blade and mounted on an aluminum sample holder using carbon tape. SEM analysis was 
performed with a JEOL JSM-6060LV Low Vacuum Scanning Electron Microscope (JEOL USA, 
Peabody, MA) using both a standard secondary electron (SE) detector and a backscatter electron 
(BSE) detector under low vacuum (variable pressure) mode, allowing scaffolds to be visualized 
without a conductive coating.  
 
2.2.3 Pore size and shape analysis 
The cylindrical CG scaffolds (8 mm diameter by 15 mm length) were cut into three 5 mm length 
sections (bottom (closest to freeze-dryer shelf), middle, and top) and embedded in 
glycolmethacrylate. Longitudinal and transverse scaffold sections (5 µm thick) were serially cut 
on a microtome and stained with aniline blue to allow visualization of the CG strut network. 
Images were acquired at 10x magnification on an optical microscope (Leica Microsystems, 
Germany) and analyzed using a linear intercept macro in Scion Image (O'Brien, Harley et al. 
2004). The macro calculated pore size by determining the distance and number of times a series 
of lines, staggered every 5 degrees, intercepted a pore wall. Using this information, the program 
calculated a best fit ellipse representation of the pores and gave fitting parameters that could be 
used to determine pore aspect ratio and equivalent pore diameter. 
 
2.2.4 Cell culture  
2.2.4.1 TC harvest and isolation 
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Primary TCs were harvested fresh from horses euthanized for reasons not related to 
tendinopathy. Digital flexor tendons were removed, diced, and incubated in collagenase for 24 h 
under agitation. The digest was strained through a filter, allowing isolation of TCs (Kapoor, 
Caporali et al. 2010). 
 
TCs were cultured in standard culture flasks in high glucose Dulbecco's modified Eagle's media 
(DMEM) supplemented with 10% fetal bovine serum (FBS), 1% L-glutamine, 1% 
penicillin/streptomycin, 1% amphotericin-B, and 25 µg/mL ascorbic acid (Kapoor, Caporali et 
al. 2010). Cells were fed every 3 days and cultured to confluence at 37°C and 5% CO2. Cells 
were then trypsinized and resuspended at a concentration of 5 x 105 cells per 20 µL media.  
2.2.4.2 Scaffold culture conditions 
 
CG scaffold plugs (8 mm diameter, ~5 mm thickness) were cut from the middle section of full 
length scaffolds and were placed in ultra-low attachment 6 well plates (Corning Life Sciences, 
Lowell, MA). Scaffolds were initially seeded with 10 µL of cell suspension, incubated at 37°C 
for 15 min, turned over, and seeded with an additional 10 µL of cell suspension. Scaffolds were 
incubated at 37°C and 5% CO2 for the duration of all experiments. Scaffolds were fed with 
complete DMEM (6 mL per well) that was changed every 3 days.  
 
For experiments involving soluble factors, scaffolds were cultured in serum-free DMEM to 
eliminate the influence of exogenous serum components. Human recombinant (rh) PDGF-BB 
and IGF-1 were purchased from R&D Systems and reconstituted in the manufacturer's 
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recommended solutions. Soluble factors were diluted to proper concentrations in serum-free 
media for culture experiments. Soluble factor supplemented media was changed every 3 days. 
 
Scaffolds from long term culture experiments at time points 7 and 14 days were fixed in 10% 
neutral buffered formalin for histological analysis. Fixed scaffolds were embedded in paraffin 
and sequentially sliced into 5 µm thick sections for analysis. Sections were stained with 
hematoxylin and eosin (H&E) to allow visualization of cells and scaffold struts.  
2.2.4.3 Histology 
 
2.2.5 Tendon cell chemotaxis assay 
The ability of TC chemotaxis mechanisms to improve the speed of cellular penetration into 
aligned CG scaffold constructs was tested with a modified Transwell membrane experiment. 
Briefly, CG scaffolds were placed in 24-well plates with conventional polycarbonate Transwell 
membrane inserts (8 µm pore size, 6.5 mm diameter; Fisher Scientific, Pittsburgh, PA) on top. 
Scaffolds were cut to size so that they could be placed in contact with membranes without being 
compressed while the bottom side of the membrane remained in contact with the scaffold. 
Serum-free DMEM supplemented with various doses of PDGF-BB and IGF-1 was placed below 
the membrane with the CG scaffold; 5 x 105 TCs were added to the top side of the Transwell 
membrane in serum-free, non-supplemented DMEM. Chemotaxis experiments lasted for 24 h. 
Scaffolds were then removed for subsequent cell metabolic activity and number assays. 
 
2.2.6 Determination of cell metabolic activity 
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A non-destructive alamarBlue assay was used to compare the metabolic activity of the cells in 
each scaffold at each time point (Tierney, Jaasma et al. 2009). Healthy cells continuously reduce 
resazurin, the active ingredient in alamarBlue, to the highly fluorescent compound resorufin; 
constant exposure times enable comparison of the gross metabolic activity of each cell-seeded 
construct. Cell-seeded scaffolds were incubated at 37°C in 1x alamarBlue (Invitrogen, Carlsbad, 
CA) solution with gentle shaking for 3 h (Tierney, Jaasma et al. 2009). Resorufin fluorescence 
was read at 570 nm excitation and 585 nm emission using a fluorescent spectrophotometer 
(Varian, Santa Clara, CA). A standard curve was created by measuring the metabolic activity of 
a range of known cell numbers. Scaffold fluorescence readings were interpolated on this curve to 
express results as a percentage of the total number of seeded cells.  
 
2.2.7 Determination of cell number 
A previously developed DNA quantification assay was used to determine the total number of 
cells attached to the scaffold (Kim, Sah et al. 1988). Scaffolds were first washed in PBS to 
remove any unattached cells and then placed in a papain solution to digest the scaffold and lyse 
the cells to expose their DNA. A Hoechst 33258 dye (Invitrogen, Carlsbad, CA) was used to 
fluorescently label double-stranded DNA (Kim, Sah et al. 1988). Fluorescence levels from each 
sample were then read using a fluorescent spectrophotometer (Varian, Santa Clara, CA): 352 nm 
excitation, 461 nm emission. Experimental readings were then compared to a standard curve 
created by measuring the fluorescence levels for a range of known cell numbers to determine cell 
attachment at each time point as a percentage of the total number of seeded cells.  
 
2.2.8 Statistical analysis    
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One-way analysis of variance (ANOVA) was performed on pore size and shape, cell metabolic 
activity, and cell number data sets respectively followed by Tukey-HSD post-hoc tests. 
Significance was set at p < 0.05. At least n = 6 scaffolds were analyzed at each time point for cell 
metabolic activity while n = 6 scaffolds were digested and assayed at each time point for cell 
number. Pore size and shape analysis was performed on transverse (n = 3) and longitudinal (n = 
3) scaffold sections. Error is reported in figures as the standard error of the mean unless 
otherwise noted. 
 
2.3 Results 
2.3.1 Pore size and shape analysis 
SEM analysis demonstrated that fabrication of CG scaffolds utilizing unidirectional heat transfer 
results in the formation of longitudinally aligned, elongated pores (Figure 2.2(e-g)) regardless of 
final freezing temperature. In contrast, pores in the transverse plane were rounder and more 
isotropic (Figure 2.2(b-d)). Pore sizes and aspect ratios of three aligned scaffold variants 
fabricated at three different freezing temperatures (-10°C, -40°C, and -60°C) were quantified 
using a stereological method (O'Brien, Harley et al. 2004). One-way ANOVA demonstrated that 
freezing temperature had a significant (p < 0.0001) effect on mean pore size (Table 2.1). -10°C 
scaffolds had significantly larger pores than either -40°C (p = 0.0002) or -60°C (p < 0.0001) 
scaffolds. -40°C scaffolds also had significantly larger mean pore size compared to the -60°C 
group (p = 0.0002). Mean pore size did not significantly vary through the length of the -10°C (p 
= 0.11) or -40°C (p = 0.84) groups. The bottom section of the -60°C group showed significantly 
smaller pores than the middle (p = 0.04) or top (p = 0.02) sections (Figure 2.3). Pore aspect ratio 
in the longitudinal planes was significantly greater (p < 0.0001) than transverse aspect ratio for 
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each freezing temperature (Table 2.1). Longitudinal aspect ratio for the -60°C scaffold group 
was significantly smaller than either the -10°C (p = 0.02) or -40°C (p = 0.001) groups. 
 
2.3.2 Tendon cell viability in long-term culture 
TCs were cultured over the course of 14 days in vitro on three aligned CG variants fabricated at 
different freezing temperatures (-10°C, -40°C, and -60°C) and an isotropic CG scaffold control (-
40°C, 8 mm diameter, mean pore size 86.6 ± 9.8 µm, aspect ratio 1.05 ± 0.03 (Martin, Caliari et 
al. submitted)) to assess the impact of microstructural cues on TC behavior. TC number and 
metabolic activity were assessed at days 1, 4, 7, and 14 (Figure 2.4(a-b)). At day 1, all three 
aligned scaffold variants showed significantly higher TC metabolic activity (all groups: p < 
0.0001) and TC number (-10°C: p = 0.006; -40°C: p = 0.02; -60°C: p = 0.0002) compared to the 
isotropic group. The -60°C group showed significantly lower metabolic activity than either the -
10°C (p = 0.02) or -40°C (p = 0.03) groups but significantly higher cell number (-10°C: p = 
0.006; -40°C: p = 0.002). At day 4, the -10°C and -40°C aligned groups had significantly higher 
TC metabolic activity than the isotropic group (-10°C: p < 0.0001; -40°C: p = 0.02) while the -
10°C and -60°C aligned groups had significantly higher TC number than the isotropic group (-
10°C: p = 0.01; -40°C: p = 0.01). Aligned scaffold metabolic activity showed a direct correlation 
with pore size; the -10°C group was significantly greater than either the -40°C (p = 0.0008) or -
60°C (p < 0.0001) groups. Also, the -40°C group metabolic activity was significantly higher than 
the -60°C group (p = 0.009). Day 7 results showed significantly lower TC metabolic activity for 
the -60°C group compared to the other three experimental groups (isotropic: p = 0.001; -10°C: p 
= 0.001; -40°C: p = 0.03) with no significant differences between those three groups. There was 
no significant difference in TC number observed between the experimental groups at either day 7 
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(p = 0.11) or day 14 (p = 0.06). At day 14, TC metabolic activity for the -60°C group remained 
significantly lower than the isotropic (p = 0.006) and -10°C (p = 0.02) groups.  
 
Scaffolds from each experimental group at day 14 were fixed, sectioned, and underwent H&E 
staining. Center sections from aligned scaffolds demonstrate adequate cell infiltration (Figure 
2.4(c-d)). 
 
2.3.3 Tendon cell chemotaxis towards PDGF-BB and IGF-1 gradients 
TC chemotaxis into aligned scaffolds at 24 h (freezing temperature: -10°C) was assessed for 
three concentrations of both PDGF-BB (10, 50, and 100 ng/mL) and IGF-1 (50, 100, and 500 
ng/mL) using a modified Transwell assay (Figure 2.5(a)). All three PDGF-BB groups showed 
significantly increased TC metabolic activity compared to the control group with no growth 
factor added (10 ng/mL: p = 0.04; 50 ng/mL: p = 0.0009; 100 ng/mL: p < 0.0001) (Figure 
2.5(b)). TC metabolic activity also exhibits dose-dependence on PDGF-BB with significant 
differences observed between the 10 ng/mL and 50 ng/mL groups (p = 0.03) as well as the 50 
ng/mL and 100 ng/mL groups (p = 0.003). IGF-1 had a significant effect on TC metabolic 
activity with significant increases over the control observed for the 50 ng/mL (p = 0.04) and 100 
ng/mL (p = 0.006) groups (Figure 2.5(b)). The 500 ng/mL IGF-1 group had higher TC 
metabolic activity than the control, but the difference was not significant (p = 0.07). There were 
no significant differences between the three IGF-1 concentration levels. 
 
There were no significant differences in TC number between the experimental groups (p = 0.10) 
although TC number in each growth factor supplemented group (except PDGF-BB 10 ng/mL) 
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was higher than the control (Figure 2.5(c)). In addition, the presence or absence of growth factor 
in the top compartment with TCs did not have a significant effect on the number of migrated TCs 
present in scaffolds (data not shown). 
 
2.3.4 Tendon cell viability and metabolic activity with PDGF-BB and IGF-1 supplementation 
TC number and metabolic activity were tracked over 7 days of in vitro culture in the presence of 
PDGF-BB (100 ng/mL) or IGF-1 (100 ng/mL). All three aligned scaffold variants (-10°C, -40°C, 
and -60°C) were tested. For each freezing temperature and at all three time points (1, 4, and 7 
days), both IGF-1 and PDGF-BB supplemented scaffolds displayed significantly higher TC 
metabolic activity compared to the non-supplemented control fabricated at the same freezing 
temperature (p < 0.05) (Figure 2.6(a-b)). In addition, the -60°C IGF-1 group had significantly 
lower TC metabolic activity than both the -10°C and -40°C IGF-1 groups at all three time points 
(p < 0.05). The same trend was seen for PDGF-BB at the 4 and 7 day time points. However, the -
40°C PDGF-BB group displayed significantly higher TC metabolic activity compared to the -
10°C and -60°C PDGF-BB groups at day 1 (p < 0.05) (Figure 2.6(a-b)).  
 
IGF-1 supplemented scaffolds had higher TC numbers for each freezing temperature at each time 
point, but these differences were not significant (day 1: p = 0.29; day 4: p = 0.14; day 7: p = 
0.67) (Figure 2.6(c)). PDGF-BB supplemented scaffolds also showed increased TC number for 
each freezing temperature at each time point (Figure 2.6(d)). These differences were not 
significant at day 1 (p = 0.12). At day 4, each PDGF-BB supplemented variant had significantly 
higher TC number than its counterpart control (p < 0.05) with the -40°C PDGF-BB group having 
significantly higher TC number than either the -10°C or -60°C PDGF-BB groups (p < 0.05). At 
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day 7 the -40°C PDGF-BB group had significantly higher TC number than all other experimental 
groups (p < 0.05). 
 
2.4 Discussion 
This chapter describes the development of an aligned CG scaffold with presentation of 
chemotactic growth factors PDGF-BB and IGF-1 for tendon tissue engineering. While 
exogenous addition of soluble factors had previously enhanced aspects of the tendon wound 
healing process, notably initial chemotaxis of cells into the wound site, cellular proliferation, 
matrix synthesis, and remodeling (Molloy, Wang et al. 2003; James, Kesturu et al. 2008; Liu, 
Ramanath et al. 2008), soluble factor supplementation had not yet been integrated with an 
engineered CG scaffold. Here, we include details of a fabrication technique to synthesize 
scaffolds with longitudinally aligned microstructure mimicking native tendon physiology. These 
scaffolds can be fabricated over a wide range of pore sizes while maintaining constant relative 
density (ρ*/ρs = 0.006). We also show that the presentation of both PDGF-BB and IGF-1 within 
aligned CG scaffolds has beneficial effects on TC migration, viability, and metabolic activity. 
 
Aligned CG scaffolds were fabricated using a PTFE freeze-drying mold with a thin copper plate 
bottom (Figure 2.2(a)). The thermal conductivity mismatch (kCu/kPTFE ~ 1600) induced 
directional solidification in the dominant direction (longitudinal) of heat transfer in the mold, 
resulting in the formation of longitudinally aligned, elongated pores. SEM analysis was used to 
show that pores were indeed aligned and elongated in the longitudinal plane for all three freezing 
temperatures (Figure 2.2(e-g)) while the pores in the transverse plane were round and isotropic 
(Figure 2.2(b-d)). The formation of an aligned biomaterial, in addition to increasing modulus in 
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the longitudinal plane (Chapter 3) (Caliari, Ramirez et al. in preparation), is hypothesized to be 
critical for cellular organization, ECM biosynthesis, and overall tendon regeneration (Liu, 
Ramanath et al. 2008; Moffat, Kwei et al. 2009; Kapoor, Caporali et al. 2010).  
 
We have also demonstrated that aligned CG scaffolds can be produced over a wide range of pore 
sizes by fabricating at three different freezing temperatures (-10°C, -40°C, and -60°C). Pore size 
has previously been shown to be governed by the final freezing temperature, where lower 
temperatures lead to smaller pores (Chang, Yannas et al. 1990; O'Brien, Harley et al. 2004). 
Final freezing temperature and degree of undercooling control the rate of ice crystal nucleation in 
the suspension. Longer solidification times lead to more significant coarsening, where ice 
crystals aggregate to reduce their surface energy, resulting in larger pores (Chapter 1.2) (O'Brien, 
Harley et al. 2005; Murphy, Haugh et al. 2010). CG scaffolds have previously been fabricated 
with equiaxed pores using a constant cooling rate technique that results in homogenous cooling, 
solidification, and pore formation throughout the CG suspension (O'Brien, Harley et al. 2004). 
Using this method combined with final freezing temperatures ranging from -10oC to -60oC, CG 
scaffolds have been fabricated with pore sizes from 85–325 µm but with constant relative density 
(ρ*/ρs = 0.006) (O'Brien, Harley et al. 2005; Murphy, Haugh et al. 2010). More heterogeneous 
solidification processes at lower temperatures (-80oC to -196oC (liquid nitrogen)) have also been 
used to fabricate CG scaffolds with pore sizes as low as 10-20 µm (Yannas, Lee et al. 1989; 
Chang, Yannas et al. 1990; Chamberlain, Yannas et al. 1998) as well as tubular CG scaffolds 
with radial gradients in porosity for peripheral nerve regeneration (Harley, Hastings et al. 2006). 
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We demonstrated here that final freezing temperature has a significant effect on mean pore size 
(Table 2.1) with higher freezing temperatures leading to larger pores as expected. Mean pore 
size was also shown to be relatively uniform throughout the entire length (15 mm) of the 
scaffolds, although pore size in the bottom section of the -60°C scaffold group was significantly 
smaller than the middle and top sections (Figure 2.3). The bottom section is closer than the other 
sections to the freeze-dryer shelf and therefore freezes with a shorter solidification time, leading 
to smaller pore size. Additionally, pore aspect ratios were significantly larger in the longitudinal 
plane compared to the transverse plane for scaffolds fabricated at each freezing temperature, 
indicating that pores have longitudinally elongated architecture. Pore aspect ratios for the -10°C 
and -40°C aligned scaffolds were significantly greater than -60°C scaffold aspect ratio. This is 
likely due to the longer solidification times at the higher freezing temperatures, allowing 
suspension ice crystals more time to aggregate as they stretch and grow in the longitudinal plane 
moving away from the freeze-dryer shelf. 
 
After successful fabrication of aligned scaffolds and characterization of pore size and shape, TCs 
were cultured on aligned scaffold variants to assess their ability to support sustained cell 
viability. TC metabolic activity and number were assessed at days 1, 4, 7, and 14 (Figure 2.4(a-
b)). Despite the fact that the majority of TCs are terminally differentiated fibroblasts (tenocytes), 
CG scaffolds display excellent bioactivity with TC number after 14 days reaching approximately 
three times the number of cells seeded at time zero. The aligned -60°C group consistently 
showed higher cell number, but lower metabolic activity compared to the other experimental 
groups. This can likely be explained using the cellular solids arguments outlined in Chapter 1.3. 
Specific surface area is a function of mean pore size and relative density; scaffolds in all 
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experimental groups had the same relative density (ρ*/ρs = 0.006) but different mean pore sizes. 
The -60°C group had the smallest pore size and therefore the highest specific surface area, 
providing a greater availability of surface ligands for cells to attach onto compared to other 
groups. In contrast, these same scaffolds showed lower metabolic activity. Metabolic activity, as 
determined by the alamarBlue assay used here, is a measurement of mitochondrial metabolic 
activity and an indicator of overall cell health. Permeability is directly related to mean pore size, 
so it is likely that TCs on scaffolds with smaller pores (lower permeability) are less healthy due 
to inefficient transport of oxygen and other nutrients. Pore size is also known to influence cell 
migration, although histological analysis of CG variants indicates adequate cell infiltration to the 
center of the constructs by day 14 (Figure 2.4(c-d)). 
 
TC metabolic activity and number are initially higher in aligned scaffolds compared to isotropic 
controls at day 1 and 4. This may suggest that TCs prefer an aligned microstructural 
environment. Isotropic TC number and metabolic activity caught up to the aligned group levels 
at later time points; this is likely due to contraction of aligned constructs. While aligned CG 
scaffolds are stronger than isotropic variants in the direction of alignment (Chapter 3) (Caliari, 
Ramirez et al. in preparation), they are also weaker in the orthogonal plane, leaving them more 
vulnerable to cell-mediated contraction. TCs are highly contractile and while EDAC crosslinking 
has previously been shown to impart resistance to TC-mediated contraction in CG scaffolds 
(Torres, Freyman et al. 2000), scaffold mechanical properties will likely have to be improved for 
future applications. This will be accomplished by increasing scaffold relative density and using 
other methods currently in development in our lab (Chapter 3) (Caliari, Ramirez et al. in 
preparation).  
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After it was demonstrated that aligned CG scaffolds could support long-term TC viability, TC 
migration into aligned CG scaffolds via chemotaxis assays involving PDGF-BB and IGF-1 was 
assessed. These experiments were done with an eye towards clinical translation; ideally, this 
scaffold system will be able to bypass lengthy, complicated, and expensive cellular hybridization 
approaches in favor of acellular deployment. Acellular implantation radically streamlines both 
regulatory compliance requirements (FDA 510k application only) as well as clinical translation 
(simplified storage requirements, implantation procedures). CG scaffolds, with their high 
porosity (> 99%), have previously been implanted acellularly for the treatment of skin, 
peripheral nerve, and osteochondral defects (Yannas 2001; Farole and Jamal 2008) and are an 
ideal candidate for an acellular tendon scaffold. It was hypothesized that PDGF-BB and IGF-1 
(both well known as potent chemoattractants of mesenchymal cell types) could aid in the 
migration of TCs to aligned CG scaffolds. It was also hypothesized that the -10°C aligned 
scaffold group would be the best choice for these experiments since larger pore size typically 
aids cell migration. Additionally, the -10°C aligned group was chosen for its higher permeability 
as well as its capacity to support higher TC metabolic activity and adequate TC numbers. 
 
Preliminary Transwell experiments that compared TC chemotaxis (growth factor present in 
bottom compartment only) versus TC random motility (growth factor present in equal 
concentrations in both the top and bottom compartments) showed no significant differences in 
migrated TC metabolic activity or number for both PDGF-BB and IGF-1 (data not shown).   
Mathematical models for PDGF gradient sensing by fibroblasts developed by Haugh et al. offer 
one possible explanation. These models imply that sharp gradients of PDGF do not necessarily 
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improve fibroblast migration rate; the simple presence of PDGF at a therapeutic dose may be 
sufficient to encourage migration (Schneider and Haugh 2005; Haugh 2006; Schneider and 
Haugh 2006).  
 
TC chemotaxis into -10°C aligned scaffolds at 24 h was measured for three concentrations 
spanning known therapeutic ranges of both PDGF-BB (10, 50, and 100 ng/mL) and IGF-1 (50, 
100, and 500 ng/mL) using a modified Transwell assay (Figure 2.5(a)). PDGF-BB elicited dose-
dependent significant increases in TC metabolic activity over a non-growth factor supplemented 
control. In particular, the high PDGF-BB dose group showed metabolic activity levels nearly 
three times the amount of the control (Figure 2.5(b)). IGF-1 also significantly increased 
migrated TC metabolic activity, although no dose-dependence was observed (Figure 2.5(b)). No 
significant differences in TC number were observed between all of the experimental groups (p = 
0.10) although PDGF-BB and IGF-1 supplementation correlated to higher TC numbers 
compared to the control group. 
 
The next group of experiments focused on assessing TC metabolic activity and number in 
aligned CG scaffolds in the presence of PDGF-BB and IGF-1 over the course of 7 days in 
culture. PDGF-BB (100 ng/mL) and IGF-1 (100 ng/mL) doses were chosen based on the results 
from chemotaxis experiments. Both IGF-1 and PDGF-BB induced significant effects on TC 
metabolic activity. Notably, both IGF-1 and PDGF-BB supplemented scaffolds showed 
significantly higher TC metabolic activity compared to the non-supplemented control fabricated 
at the same freezing temperature at all three time points (1, 4, and 7 days) (Figure 2.6(a-b)). 
Additionally, the -60°C IGF-1 group had significantly lower TC metabolic activity than both the 
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-10°C and -40°C IGF-1 groups at all three time points. This was also observed for the PDGF-BB 
group at days 4 and 7. As discussed earlier, this observed effect is likely due to the smaller pore 
size and reduced permeability of the aligned -60°C scaffold constructs.  
 
Although increases in TC number were observed for all IGF-1 supplemented groups at each time 
point, these differences were not statistically significant (Figure 2.6(c)). PDGF-BB also elicited 
increases in TC number at each time point (Figure 2.6(d)). These increases were not statistically 
significant at day 1 but were significant at day 4 for all three aligned variants and at day 7 for the 
-40°C group. These data demonstrate that while PDGF-BB and IGF-1 have only moderate 
effects on TC number in aligned CG scaffolds, the metabolic activity of these cells increases 
dramatically (in the case of PDGF-BB, over ten-fold at days 4 and 7).  
 
 
2.5 Conclusions 
This chapter introduces a technique to fabricate CG scaffolds with longitudinally aligned pore 
microstructure mimicking tendon over a wide range of pore sizes (55-243 µm), but with constant 
relative density (ρ*/ρs = 0.006). Analysis of TC viability in these scaffolds indicates that while 
scaffolds with smaller pore sizes can initially support higher TC numbers due to increased 
specific surface area, scaffolds with larger pores support higher TC metabolic activity due to 
higher permeability. Larger pore size is known to have other beneficial effects on construct 
bioactivity, including easier cell infiltration and migration, suggesting that an aligned CG 
scaffold variant with larger pores (> 100 µm) may be ideal for tendon tissue engineering. We 
have also shown that the growth factors PDGF-BB and IGF-1 can increase TC migratory 
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capacity, metabolic activity, and number. In particular, PDGF-BB was able to induce a more 
than three-fold increase in migratory capacity and a more than ten-fold increase in TC metabolic 
activity over a non-supplemented control, suggesting PDGF-BB supplementation could be used 
to increase overall CG scaffold bioactivity for tendon tissue engineering applications. Future 
work will continue to explore other soluble factor candidates and develop controlled release 
strategies while progressing towards in vivo application. 
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2.6 Tables 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 2.1. Mean transverse pore size and aspect ratios for three aligned CG scaffold variants. 
Pore size and shape analysis demonstrate that scaffold mean pore size can be tuned over a wide 
range by changing the freezing temperature during freeze-drying. Aspect ratios in the scaffold 
longitudinal plane are significantly (p < 0.0001) greater than transverse aspect ratio for each 
freezing temperature, indicating that pores are elongated in the direction of the scaffold 
longitudinal axis. Data expressed as Mean ± SD, n = 3. 
Pore aspect ratio Mean transverse 
pore size (µm) 
Scaffold 
(freezing 
temperature) 
Transverse: 1.07 ± 0.04 
Longitudinal: 1.41 ± 0.16* 
55.3 ± 17.6 
 
-60 °C 
Transverse: 1.17 ± 0.08 
Longitudinal: 1.63 ± 0.17* 
152.4 ± 25.1 
 
-40 °C 
Transverse: 1.19 ± 0.12 
Longitudinal: 1.57 ± 0.23* 
242.7 ± 28.8 
 
-10 °C 
*p < 0.0001 
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2.7 Figures 
 
Figure 2.1. Schematic of characteristic tendon wound healing process. This process includes 
three overlapping phases (inflammation, proliferation, and remodeling) characterized by distinct 
cellular events. 
Remodeling 
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Inflammation 
1 week 2 weeks 1 year Time post 
injury 
 
 
 
• Cellular invasion  
• Wound stabilization 
• Cell expansion and proliferation  
• Initial ECM synthesis 
• ECM synthesis and metabolism 
• Attempted return to native tissue state 
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Figure 2.2. Overview of aligned CG scaffold fabrication. A) A freeze-dryer mold with a 
mismatch in thermal conductivity is used to promote unidirectional heat transfer during freezing, 
resulting in longitudinally aligned, elongated pores. B-D) SEM of transverse middle cross-
section with best-fit ellipse representation of pore structure for scaffolds fabricated at -10°C (B), 
-40°C (C), and -60°C (D). E-G) SEM of longitudinal middle cross-section with best-fit ellipse 
representation of pore structure for scaffolds fabricated at -10°C (E), -40°C (F), and -60°C (G). 
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Figure 2.3. Distribution of pore sizes in scaffold sections. Pore sizes are shown for bottom, 
middle, and top 5 mm sections of 15 mm scaffolds fabricated at -10°C, -40°C, and -60°C. Data 
expressed as Mean ± SEM, n = 3. 
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Figure 2.4. 14 day TC culture without growth factor supplementation. A) TC number at 1, 4, 7, 
and 14 days in isotropic and aligned (freezing temperature: -10°C, -40°C, and -60°C) scaffold 
variants. B) TC metabolic activity at 1, 4, 7, and 14 days in isotropic and aligned (freezing 
temperature: -10°C, -40°C, and -60°C) scaffold variants. C-D) H&E stained cross-sections after 
14 day culture demonstrate cell infiltration to the center of the aligned scaffolds fabricated at -
40°C (C) and -60°C (D). Data expressed as Mean ± SEM, n = 6. 
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Figure 2.5. 24 hour TC chemotaxis into aligned CG scaffolds. A) Schematic of experimental set-
up. B) Normalized TC metabolic activity of migrated cells in aligned CG scaffolds. C) 
Normalized TC number of migrated cells in aligned CG scaffolds. (*) denotes significantly 
greater than control, (**) significantly greater than control and PDGF-BB (10 ng/mL), (***) 
significantly greater than control and PDGF-BB (50 ng/mL). Data expressed as Mean ± SEM, n 
= 5. 
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Figure 2.6. TC metabolic activity and number in aligned scaffolds supplemented with PDGF-BB 
and IGF-1. A-B) TC metabolic activity over 7 days in culture in aligned scaffolds supplemented 
with (A) IGF-1 (100 ng/mL) and (B) PDGF-BB (100 ng/mL). C-D) TC number over 7 days in 
culture in aligned scaffolds supplemented with IGF-1 (100 ng/mL) (C) and PDGF-BB (100 
ng/mL) (D). Data expressed as Mean ± SEM, n = 6. (*) denotes significance compared to media 
control fabricated at same freezing temperature. 
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CHAPTER 3: MECHANICS OF ALIGNED COLLAGEN-GAG SCAFFOLD-
MEMBRANE COMPOSITES FOR TENDON TISSUE ENGINEERING3
 
 
3.1 Introduction 
Current surgical strategies to treat tendon defects have had limited success, particularly when 
applied to tendon-bone insertion injuries. Repeat injuries and generally poor clinical outcomes 
are common with failure rates as high as 94% (Galatz, Ball et al. 2004). An integral reason for 
the failure of current approaches is their inability to recapitulate the microstructural and 
biomechanical properties of tendon. The deployment of optimized biomaterials, such as tissue 
engineering scaffolds, could represent a superior approach for functional tendon repair. 
 
Successful regenerative repair of tissue injuries requires preventing organized wound contraction 
as well as scar and fibrocartilage tissue formation that typically follows injury. This is typically 
accomplished using a porous scaffold that can simultaneously block contraction while supporting 
cell attachment, proliferation, and synthesis of a functional ECM. Here we propose to use a 
collagen-glycosaminoglycan (CG) scaffold system for tendon tissue engineering. CG scaffolds 
have previously been used in a variety of tissue engineering applications, both in vivo as 
regenerative templates for skin, peripheral nerves, conjunctiva, and cartilage (Yannas, Lee et al. 
1989; Yannas 2001; Harley, Spilker et al. 2004) as well as in vitro as 3D microenvironments to 
probe fundamental questions about cell behaviors and cell-matrix interactions. CG scaffolds 
possess the 3D structure, porosity (> 95%), and bioactivity required of an orthopedic 
regeneration template, but mechanically are 2 to 3 orders of magnitude softer than native tendon. 
Other bioactive materials, such as collagen membranes, lack the 3D structure and porosity of 
                                                 
3 This chapter has been adapted from the following publication: 
Caliari, S. R., M. Ramirez, et al. (in preparation). "Mechanics of aligned collagen-GAG scaffold-membrane 
composites for tendon tissue engineering." 
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scaffolds but display improved mechanical competence. Collagen membranes have previously 
been used in dental applications and to produce tissue engineered synovium (Xu, Cao et al. 
2010). Recently, collagen membranes were used in conjunction with a hydroxyapatite scaffold to 
treat bone defects. The collagen membrane wrap significantly increased bone formation in vivo 
by keeping nutrients and intrinsic factors from the bone marrow localized to wound site (Guda, 
Walker et al. 2010). 
 
One of the key challenges of orthopedic tissue engineering is to create scaffolds that are 
bioactive and can support tissue regeneration while remaining mechanically competent. The 
most common biomaterial designs for tendon and ligament tissue engineering are electrospun 
polymer mats (Li, Xie et al. 2009; Moffat, Kwei et al. 2009). These mats are typically composed 
of some combination of synthetic and natural polymers, including poly(ε-caprolactone) (PCL), 
poly(ethylene oxide) (PEO), poly(vinyl alcohol) (PVA), poly(L-lactic acid) (PLLA), poly(lactic-
co-glycolic acid) (PLGA), type I collagen, and elastin (Pham, Sharma et al. 2006). While these 
constructs can be designed with tensile moduli approaching the level of tendon, electrospun mats 
are dense and essentially 2D materials with inadequate permeability, porosity, and 
biodegradability. Highly porous scaffolds are alternative biomaterials that could potentially 
supersede many of these drawbacks. Porous scaffolds have excellent permeability and can be 
fabricated from natural, biodegradable materials. However, these types of materials are typically 
orders of magnitude too weak for tendon applications (native tendon: E* ~ 102-103 MPa) 
(Dressler, Butler et al. 2006; Shearn, Juncosa-Melvin et al. 2007). To attempt to overcome this 
limitation, there are several common methods of scaffold mechanical enhancement that do not 
have adverse effects on construct bioactivity. For tendon and ligament scaffolds these include the 
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creation of aligned microstructure and mechanical stimulation of cell-seeded scaffold constructs. 
Several groups have shown that aligned scaffolds have increased mechanical properties along the 
axis of alignment and promote the formation of more tendon-like tissue compared to non-aligned 
constructs (Moffat, Kwei et al. 2009; Shang, Yang et al. 2010). Mechanical stimulation has been 
implicated as a key factor in tenogenic differentiation of MSCs (Kuo and Tuan 2008) and 
improvement of tendon scaffold mechanical properties both in vitro and in vivo (Juncosa-Melvin, 
Shearn et al. 2006; Chokalingam, Juncosa-Melvin et al. 2009; Saber, Zhang et al. 2010). While 
these methods can marginally improve construct mechanical properties, they have not been 
successful in reaching levels of native tendon.  
 
While the multi-scale properties of tendon itself cannot be replicated by current biomaterials 
technologies, nature provides an alternative design scheme: core-shell composites. Plant stems 
combine a porous core with a dense shell to aid osmotic transport (core) while maintaining 
sufficient tensile/bending stiffness (shell); many bird beaks also combine a dense shell and 
porous core to enhance compressive strength and mechanical efficiency, respectively (Gibson 
2005). This type of material has been also been utilized to engineer high strength metal tubing 
(Utsunomiya, Koh et al. 2008), but to our knowledge has not been utilized for tissue engineering 
applications.  
 
Using this strategy, we have created core-shell CG composites by combining high density (high 
tensile strength) CG membranes with low density (porous) aligned CG scaffolds into a single 
biomaterial via a liquid-solid phase co-synthesis method (Harley, Lynn et al. 2010). For the low 
density core we have synthesized a highly porous CG scaffold via freeze-drying. These scaffolds 
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can be reliably fabricated with relative densities (ρ*/ρs) of 0.5 – 5% (95 – 99.5% porosity) 
(Harley, Leung et al. 2007; Harley and Gibson 2008; Harley, Lynn et al. 2010). We have 
recently developed a method to fabricate these scaffolds with longitudinally aligned pore 
structures (Chapter 2) (Caliari and Harley in preparation). The aligned microstructure is 
hypothesized to improve construct regenerative capacity by increasing the modulus in the 
direction of alignment and by providing contact guidance cues to cells. The dense shell was 
created from a novel CG membrane. This membrane is identical in composition to the core but is 
synthesized through an evaporative process, resulting in a dense CG sheet with thickness on the 
order of tens to hundreds of microns. Here we demonstrate that these membranes possess unique 
biophysical properties and that they can be integrated with aligned CG scaffolds to form core-
shell composites. Our work demonstrates that these composites have significantly improved 
biomechanical competence while maintaining adequate bioactivity for tendon tissue engineering. 
 
 
3.2 Materials and Methods 
3.2.1 Aligned CG scaffold fabrication 
Aligned CG scaffolds (ρ*/ρs = 0.006) were fabricated via a combined directional solidification 
and lyophilization approach from a suspension of type I microfibrillar collagen from bovine 
dermis (Devro Inc., Columbia, SC) and chondroitin sulfate derived from shark cartilage (Sigma-
Aldrich, St. Louis, MO) in 0.05 M acetic acid (Yannas, Lee et al. 1989). The suspension was 
held at 4°C during mixing to prevent collagen gelatinization.  
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Degassed CG suspension was pipetted into holes inside a polytetrafluoroethylene (PTFE) mold 
with a thin copper bottom plate and placed on a freeze-dryer shelf (VirTis Genesis, Gardiner, 
NY) at a pre-cooled temperature (-10 or -60°C). The drastic difference in thermal conductivities 
(kCu/kPTFE ~ 1600) promoted unidirectional heat transfer through the copper bottom during the 
freeze-drying process. The suspension was held at this temperature for 1-3 h to allow for 
complete freezing. Ice crystals were sublimated under vacuum (200 mTorr) at 0°C to produce 
CG scaffolds (6 or 8 mm diameter, 15 or 30 mm length) with aligned microstructure. Mechanical 
tests used 6 mm diameter by 30 mm length scaffolds to facilitate placement of the constructs 
within the mechanical tester grips. 
 
3.2.2 Membrane fabrication and integration 
Membranes were fabricated via an evaporative process. Briefly, degassed CG suspension was 
pipetted into Petri dishes and allowed to air dry in a fume hood. The amount of suspension added 
correlated to the thickness of the resultant membrane. To create scaffold-membrane constructs, 
membrane pieces were cut to size, rolled, and placed directly into the PTFE-copper mold. CG 
suspension was pipetted inside the rolled membrane and allowed to hydrate the membrane for ~ 
15 min. The mold was then placed in the freeze-dryer as before. This hydration step and 
subsequent freeze-drying promote the integration of the membrane within the scaffold core 
structure (Harley, Lynn et al. 2010). All scaffold-membrane constructs used for mechanical tests 
were fabricated at a final freezing temperature of -10°C. 
 
3.2.3 SEM analysis 
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Scanning electron microscope (SEM) analysis was performed to qualitatively assess scaffold and 
membrane microstructural organization. Scaffold and membrane pieces were cut with a razor 
blade and mounted on an aluminum sample holder using carbon tape. SEM analysis was 
performed with a JEOL JSM-6060LV Low Vacuum Scanning Electron Microscope (JEOL USA, 
Peabody, MA) using both a standard secondary electron (SE) detector and a backscatter electron 
(BSE) detector under low vacuum (variable pressure) mode, allowing scaffolds and membranes 
to be visualized without a conductive coating.  
 
3.2.4 Crosslinking 
Scaffolds or membranes were sterilized and dehydrothermally (DHT) crosslinked at 105°C for 
24 h under vacuum (< 25 torr) in a vacuum oven (Welch Vacuum Technology, Niles, IL) prior to 
use. Scaffolds were then immersed in 100% ethanol overnight, washed with phosphate-buffered 
saline (PBS) several times over 24 h, and then crosslinked using carbodiimide chemistry (Olde 
Damink, Dijkstra et al. 1996; Harley, Leung et al. 2007). Briefly, scaffold pieces were soaked for 
60 min in a solution of 1-ethyl-3-[3-dimethylaminopropyl]carbodiimide hydrochloride (EDAC) 
and N-hydroxysulfosuccinimide (NHS) at a molar ratio of 5:2:1 EDAC:NHS:COOH where 
COOH represents the amount of collagen carboxyl groups. This was followed by two washes for 
30 min in PBS. Scaffolds were stored in PBS until use. Membranes were hydrated directly in 
PBS and crosslinked using EDAC chemistry at a molar ratio of either 1:1:5 or 5:2:1 
EDAC:NHS:COOH. Membranes were stored in PBS until use. 
 
3.2.5 Membrane characterization 
3.2.5.1 Thickness 
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Membrane thicknesses were measured using SEM as described earlier. Membrane pieces were 
cut, mounted vertically (thickness side up), and visualized in BSE mode. Six 500x magnification 
images were taken for each membrane type, and the thickness of the membrane was measured 
using a multipoint measuring tool within the SEM software. 
 
To assess membrane relative density, membranes were cut in 2 cm by 2 cm squares and weighed 
using a Mettler Toledo XS105 dual range balance. The membrane density was calculated by 
dividing the mass of the membrane by the volume (2 cm x 2 cm x measured thickness). The 
membrane relative density was calculated by dividing the membrane density by the density of 
solid collagen (1.3 g cm-3) (Yannas and Tobolsky 1967; Yannas, Burke et al. 1980). 
3.2.5.2 Relative density 
 
Swelling ratio was measured by first weighing six dry 2 cm by 2 cm membrane pieces using a 
Mettler Toledo XS105 dual range balance. Membranes were then completely submerged in PBS. 
At time intervals of 5, 10, 15, 30 and increasing 30 min intervals until 240 min each membrane 
was weighed again. A normalized curve was calculated using the average of these new values for 
each time interval. The time required for complete hydration was determined as the point where 
the normalized curve began to plateau.  
3.2.5.3 Swelling ratio 
 
Nanoindentation of hydrated membranes was performed in distilled water with a Hysitron UBI 
nanoindenter in displacement control using a 250 µm spherical tip and a ramp-hold creep profile 
3.2.5.4 Nanoindentation 
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(Galli, Comley et al. 2009; Galli and Oyen 2009). Constitutive poroelastic parameters 
(hydraulic/intrinsic permeability, Poisson's ratio) were calculated via a poroelastic finite element 
(FE) model (Galli, Comley et al. 2009). 
 
3.2.6 Mechanical characterization 
Tensile tests were performed on membranes (12 mm width, 45 mm length), scaffolds (6 mm 
diameter, 30 mm length), and core-shell composites (6 mm diameter, 30 mm length). Hydrated 
samples were immersed in PBS for 24 h prior to testing. Samples were pulled to failure at a rate 
of 1 mm/min using an MTS Instron 2 (Eden Prairie, MN) with rubberized grips to prevent slip. 
Tensile elastic modulus was calculated from the slope of the stress-strain curve over a strain 
range of 5-10% (Gibson, Ashby et al. 2010).  
 
3.2.7 Cell culture 
3.2.7.1 Tendon cell harvest and isolation
TCs were harvested fresh from horses euthanized for reasons not related to tendinopathy. Digital 
flexor tendons were removed, diced, and incubated in collagenase for 24 h under agitation. The 
digest was strained through a filter, allowing isolation of TCs (Kapoor, Caporali et al. 2010). 
  
 
TCs were cultured in standard culture flasks in high glucose Dulbecco's modified Eagle's media 
(DMEM) supplemented with 10% fetal bovine serum (FBS), 1% L-glutamine, 1% 
penicillin/streptomycin, 1% amphotericin-B, and 25 µg/mL ascorbic acid (Kapoor, Caporali et 
3.2.7.2 Scaffold culture conditions 
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al. 2010). Cells were fed every 3 days and cultured to confluence at 37°C and 5% CO2. Cells 
were then trypsinized and resuspended at a concentration of 5 x 105 cells per 20 µL media.  
 
CG scaffold plugs (8 mm diameter, ~5 mm thickness, with and without outer membrane) were 
cut from the middle section of full length scaffolds and placed in ultra-low attachment 6 well 
plates (Corning Life Sciences, Lowell, MA). Scaffolds were initially seeded with 10 µL of cell 
suspension, incubated at 37°C for 15 min, turned over, and seeded with an additional 10 µL of 
cell suspension for a total of 5x105 cells per scaffold. Scaffolds were incubated at 37°C and 5% 
CO2 for the duration of all experiments. Scaffolds were fed with complete DMEM (6 mL per 
well) that was changed every 3 days.  
 
3.2.8 Quantifying cell attachment 
A previously developed DNA quantification assay was used to determine the total number of 
cells attached to the scaffold (Kim, Sah et al. 1988). Scaffolds were first washed in PBS to 
remove any unattached cells and then placed in a papain solution to digest the scaffold and lyse 
the cells to expose their DNA. A Hoechst 33258 dye (Invitrogen, Carlsbad, CA) was used to 
fluorescently label double-stranded DNA (Kim, Sah et al. 1988). Fluorescence levels from each 
sample were then read using a fluorescent spectrophotometer (Varian, Santa Clara, CA): 352 nm 
excitation, 461 nm emission. Experimental readings were then compared to a standard curve 
created by measuring the fluorescence levels for a range of known cell numbers to determine cell 
attachment at each time point as a percentage of the total number of seeded cells.  
 
3.2.9 Characterizing cell bioactivity 
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A non-destructive alamarBlue assay was used to compare the metabolic activity of the cells in 
each scaffold at each time point (Tierney, Jaasma et al. 2009). Healthy cells continuously reduce 
resazurin, the active ingredient in alamarBlue, to the highly fluorescent compound resorufin; 
constant exposure times enable comparison of the gross metabolic activity of each cell-seeded 
construct. Cell-seeded scaffolds were incubated at 37°C in 1x alamarBlue (Invitrogen, Carlsbad, 
CA) solution with gentle shaking for 3 h (Tierney, Jaasma et al. 2009). Resorufin fluorescence 
was read at 570 nm excitation and 585 nm emission using a fluorescent spectrophotometer 
(Varian, Santa Clara, CA). A standard curve was created by measuring the metabolic activity of 
a range of known cell numbers. Scaffold fluorescence readings were interpolated on this curve to 
express results as a percentage of the total number of seeded cells.  
 
3.2.10 Statistical analysis    
One-way analysis of variance (ANOVA) was performed on membrane and mechanical data sets 
followed by Tukey-HSD post-hoc tests. Paired student t-tests were used to compare the two 
groups in cell viability experiments. Significance was set at p < 0.05. At least n = 6 scaffolds or 
membranes were used for all analyses. Error is reported in figures as the standard error of the 
mean. 
 
 
3.3 Results 
3.3.1 Aligned scaffold-membrane composite fabrication 
SEM analysis of CG scaffolds shows elongated, aligned pores in the scaffold longitudinal plane 
as a result of unidirectional heat transfer during the freeze-drying process (Figure 3.1(c)). In 
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contrast, pores in the scaffold transverse plane are circular and more isotropic (Figure 3.1(b)) 
(mean pore size: 243 µm) (Chapter 2) (Caliari and Harley in preparation). The CG membrane 
displays a dense network of fibrillar collagen content (Figure 3.1(d)) and shows excellent 
integration with the CG scaffold in scaffold-membrane composites (Figure 3.1(e)). The 
membrane does not delaminate from the scaffold core during the freeze-drying process or after 
hydration.  
 
3.3.2 Membrane thickness and relative density 
CG membranes were produced using an evaporative process over a thickness range of 23-240 
µm. The thickness was tuned by increasing the collagen-GAG wt% in the suspension and/or by 
increasing the volume of suspension used. The experimental groups included membranes 
fabricated from 0.5 wt% CG suspension (0.5% 1x volume and 0.5% 2x volume) and 1 wt% CG 
suspension (1% 1x volume and 1% 2x volume). Despite differences in thickness, the relative 
density is consistently in the 75-80% range. The only significant differences were between the 
1% 1x group and the 0.5% 2x group (p = 0.003) and 1% 2x group (p = 0.009) (Figure 3.2), 
although these differences do not appear to suggest any trend. The 240 µm thick membrane was 
fabricated by sequentially adding 1 wt% suspension (1x volume) five times in succession. This 
membrane was also used for nanoindentation analyses. 
 
3.3.3. Swelling ratio results 
Swelling ratio tests revealed that all four membrane variants tested (0.5% 1x, 0.5% 2x, 1% 1x, 
and 1% 2x) were at least 90% hydrated after 30 min in PBS (data not shown). 
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3.3.4 Nanoindentation 
Preliminary results of nanoindentation on the 240 µm membrane variant indicate a transverse 
compressive modulus of 50–60 kPa, two orders of magnitude below the in-plane tensile modulus 
(~5 MPa); ongoing methodological development will enable calculation of constitutive 
poroelastic parameters (hydraulic/intrinsic permeability, Poisson’s ratio) via a poroelastic FE 
model and further analysis of the effect of collagen-GAG ratio and fiber alignment (Table 3.1). 
Results indicate that while CG membrane fluid mobility is several orders of magnitude less than 
CG scaffolds, it is comparable to cartilage as well as small intestine submucosa (SIS). 
 
3.3.5 Scaffold and membrane mechanical properties  
Aligned CG scaffolds fabricated at two different freezing temperatures (-10ºC and -60ºC) 
displayed significantly higher Young's modulus in tension compared to isotropic CG controls (p 
= 0.03 for -10ºC and p = 0.02 for -60ºC) (Figure 3.3(a)). As predicted by cellular solids theory, 
tensile elastic moduli for the aligned CG scaffolds fabricated at two different freezing 
temperatures (corresponding to two distinct mean pore sizes: -10ºC: 243 ± 29 µm; -60ºC: 55 ± 
18 µm) (Chapter 2) (Caliari and Harley in preparation) but with identical relative density (0.5%) 
were not significantly different (p = 0.96) (Gibson, Ashby et al. 2010).  
 
Membranes were demonstrated to be isotropic in plane. Dry, 1% 1x samples were cut in sections 
and were pulled to failure from either a parallel or perpendicular orientation. Tensile modulus in 
the perpendicular orientation (636 ± 47 MPa) was not significantly different from the tensile 
modulus in the parallel orientation (693 ± 20 MPa) (p = 0.06). 
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The effect of various crosslinking treatments on tensile modulus was determined for both 0.5% 
and 1% CG membranes. Four groups were examined for each membrane type: no crosslinking 
(NS), dehydrothermal crosslinking only (DHT), DHT plus EDAC crosslinking at a 1:1:5 
EDAC:NHS:COOH molar ratio (EDAC 1:1:5), and DHT plus EDAC crosslinking at a 5:2:1 
EDAC:NHS:COOH molar ratio (EDAC 5:2:1). For the 0.5% CG membranes, no significant 
difference was observed between the NS and DHT groups (p = 0.86). However, there were 
significant differences between the DHT and EDAC 1:1:5 groups (p = 0.01) as well as the 
EDAC 1:1:5 and EDAC 5:2:1 groups (p = 0.008) (Figure 3.3(b)). The tensile modulus for the 
1% CG membranes was significantly increased with each increasing level of crosslinking (NS-
DHT: p = 0.02; DHT-EDAC 1:1:5: p = 0.002; EDAC 1:1:5-EDAC 5:2:1: p = 0.001) (Figure 
3.3(c)). 
 
3.3.6 Core-shell composite mechanical properties 
CG scaffold-membrane composites were created using membranes over a range of thicknesses 
from 23 µm (0.5% 1x) to 154 µm (1% 2x wrapped twice around scaffold). These scaffolds 
demonstrated dramatically increased tensile moduli over CG scaffold controls with a 36-fold 
increase observed for the 154 µm membrane thickness. Layered composites theory was used  to 
accurately predict the tensile properties of these composites from the relative size of scaffold and 
membrane components and their separate moduli (Allen 1969) (Figure 3.4). CG core-shell 
composite Young's modulus (E*composite) can be predicted as a function of scaffold core Young's 
modulus (E*scaffold), membrane shell Young's modulus (E*membrane), composite radius (r), and 
membrane thickness (t) (Allen 1969): 
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Experimental results closely mirror theoretical predictions, indicating the scaffold core and 
membrane shell are adequately integrated together. 
 
3.3.7 Tendon cell attachment and bioactivity in core-shell composite scaffolds 
TC number and metabolic activity were assessed over a 14 day in vitro culture period in aligned 
CG scaffolds, both with (CG-membrane) and without (CG) membrane shells. Early (1 day) 
results demonstrate that the membrane shell does not significantly affect bioactivity (p = 0.10) 
(Figure 3.5(a)) while cell number is significantly increased in CG-membrane scaffolds (p = 
0.007) (Figure 3.5(b)).  
 
Both groups at day 7 show marked increases in cell number and cell bioactivity compared to day 
1. CG-membrane scaffolds maintain higher cell number compared to CG scaffolds, although this 
difference is not significant (p = 0.22) (Figure 3.5(b)). While metabolic activity in CG scaffolds 
is significantly higher (p = 0.01) (Figure 3.5(a)), CG-membrane scaffolds still show elevated 
metabolic activity levels compared to day 1. There were no significant differences between the 
two groups in either TC metabolic activity (p = 0.08) or TC number (p = 0.33) at day 14. 
 
 
3.4 Discussion 
CG scaffolds have been utilized as ECM analogs for regeneration of various tissues (Yannas, 
Lee et al. 1989; Yannas 2001; Harley, Spilker et al. 2004) and as 3D microenvironments to probe 
the effects of microstructure and mechanics on cell behaviors (Torres, Freyman et al. 2000; 
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Harley, Freyman et al. 2007; Harley, Kim et al. 2008). This chapter describes the development of 
a novel CG core-shell composite for tendon tissue engineering. The composite core is composed 
of highly porous (> 99%) CG material with longitudinally aligned microstructure to mimic the 
native anisotropy of tendon tissue. The dense shell is identical in chemical composition to the 
porous core but is synthesized via an evaporative method. Using liquid-solid phase co-synthesis 
(Harley, Lynn et al. 2010), the core and shell are integrated into a single continuous biomaterial 
that combines excellent porosity, permeability, and bioactivity with increased mechanical 
competence necessary for tendon applications.  
 
The key motivation behind the development of the core-shell composite paradigm was to avoid 
the typical tradeoff for porous tissue engineering scaffolds between mechanical properties 
(Young's modulus) and bioactivity (specific surface area, porosity, and permeability). Cellular 
solids modeling approaches have been a useful tool to describe, characterize, and predict these 
physical properties for CG scaffolds (Chapter 1.3) (Gibson, Ashby et al. 2010). Expressions 
derived from these approaches clearly demonstrate that in order to increase CG scaffold elastic 
modulus by the 2 or 3 orders of magnitude necessary for tendon applications, the corresponding 
increase in relative density would have adverse affects on overall scaffold bioactivity (porosity 
and permeability). Taking inspiration from core-shell structures in nature, our scaffold-
membrane composite design can help overcome these limitations. For example, in nature plant 
stems are typically composed of a dense outer shell of sclerenchyma cells surrounding a highly 
porous core (Gibson, Ashby et al. 2010). The outer shell provides mechanical competence and 
resistance to buckling while the porous core permits adequate water and nutrient transport. 
Similarly, the scaffold-membrane composite design is hypothesized to allow efficient cell 
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migration and metabolite diffusion through the scaffold core while the membrane shell enables 
maintenance of composite structural integrity. 
 
Aligned CG scaffolds were fabricated using a previously described method (Chapter 2) (Caliari 
and Harley in preparation). Briefly, a multicomponent freeze-drying mold with a mismatch in 
thermal conductivity is utilized to induce unidirectional heat transfer, resulting in the formation 
of aligned pores. SEM confirmed the aligned microstructure of the scaffold in the longitudinal 
plane (Figure 3.1(b)) while the transverse microstructure is more isotropic (Figure 3.1(c)). CG 
membranes were fabricated via an evaporative process. We have demonstrated the ability to 
fabricate these membranes with thicknesses varying over an order of magnitude (23-240 µm) 
with relative densities of ~ 75-80% (CG scaffold relative density: 0.5%) (Figure 3.2). SEM 
analysis of the CG membrane showed a layered, fibrillar organizational hierarchy (Figure 
3.1(d)). Importantly, the CG membrane can be integrated into the CG scaffold structure to form 
continuous scaffold-membrane composites (Figure 3.1(e)). The degree of membrane 
incorporation can be tuned by adjusting the hydration time of the membrane in the scaffold 
suspension prior to freeze-drying.  
 
After successful fabrication of aligned CG scaffolds, CG membranes, and CG scaffold-
membrane composites, the mechanical properties of these materials were characterized using 
experimental and theoretical techniques. Aligned tissue engineering scaffolds have consistently 
demonstrated superior mechanical properties in the direction of alignment compared to isotropic 
controls (Moffat, Kwei et al. 2009; Shang, Yang et al. 2010). Here we showed that aligned CG 
scaffolds fabricated at two different freezing temperatures (-10ºC and -60ºC) had Young's 
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moduli in tension nearly three times greater than isotropic CG controls (Figure 3.3(a)). Previous 
work has established that CG mean pore diameter is controlled by final freezing temperature; 
higher freezing temperatures lead to longer solidification times, which give rise to larger pore 
sizes as a result of ice crystal coarsening (O'Brien, Harley et al. 2005; Caliari and Harley in 
preparation). Cellular solids theory predicts that elastic modulus is a function of relative density 
but not pore diameter (Gibson, Ashby et al. 2010). This was confirmed by showing that aligned 
scaffolds fabricated with identical relative densities but two different freezing temperatures and 
pore sizes had nearly identical tensile moduli. 
 
Next, the effect of various crosslinking treatments on CG membrane mechanics was examined. 
Both physical (DHT) and chemical (EDAC) crosslinking methods were used. DHT and EDAC 
crosslinking have both been used extensively for in vitro and in vivo applications of CG scaffolds 
(Chapter 1.2) (Yannas, Lee et al. 1989; Harley, Leung et al. 2007). Four experimental groups 
were examined for both 0.5% and 1% CG membranes: no crosslinking (NS), dehydrothermal 
crosslinking only (DHT), DHT plus EDAC crosslinking at a 1:1:5 EDAC:NHS:COOH molar 
ratio (EDAC 1:1:5), and DHT plus EDAC crosslinking at a 5:2:1 EDAC:NHS:COOH molar 
ratio (EDAC 5:2:1). As expected, significantly higher tensile moduli were observed in the EDAC 
treatment groups for both 0.5% (Figure 3.3(b)) and 1% (Figure 3.3(c)) CG membranes. The 
EDAC 5:2:1 group displayed ~ 7 fold increase in modulus over non-crosslinked controls; this is 
comparable to previous work with CG materials (Harley, Leung et al. 2007).  
 
After separate mechanical characterization of aligned CG scaffolds and CG membranes, CG 
scaffold-membrane composites were fabricated and characterized using membranes ranging in 
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thicknesses from 23 µm (0.5% 1x) to 154 µm (1% 2x wrapped twice around scaffold). These 
scaffolds demonstrated dramatically increased tensile moduli over CG scaffold controls (no 
membrane shell) with a 36-fold increase observed for the 154 µm membrane thickness. 
Experimental results were compared to predictions from layered composites theory. Layered 
composites theory has previously been used to accurately predict the tensile properties of 
multicomponent materials based on the relative size of the individual components and their 
separate moduli (Allen 1969). Experimental results correlate well with theoretical predictions, 
especially for composites with the two thicker membranes (77 µm, 154 µm). The two thinner 
membrane types (23 µm, 46 µm) fall somewhat short of theoretical predictions (Figure 3.4). 
This is likely due to superior incorporation of the thicker membranes within the scaffold core. 
The close agreement of the experimental results with the theoretical predictions indicates that the 
core-shell scaffolds behave like layered composites, implying adequate integration of the 
membrane with the scaffold.  
 
Finally, the capability of CG scaffold-membrane composites to support TC attachment, 
proliferation, and long-term viability was assessed. TC metabolic activity and number were 
measured over a 14 day in vitro culture period in aligned CG scaffolds with (CG-membrane) and 
without (CG) membrane shells. Both CG and CG-membrane scaffolds were fabricated at a 
freezing temperature of -10ºC corresponding to a larger pore size. This freezing temperature was 
chosen because increasing pore size is predicted by cellular solids modeling to increase construct 
permeability without compromising mechanical competence (Gibson, Ashby et al. 2010). 1 day 
results demonstrated that addition of the membrane shell did not significantly affect metabolic 
activity (Figure 3.5(a)). Interestingly, cell number was significantly increased in CG-membrane 
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scaffolds (Figure 3.5(b)). This is likely due the effect of the dense membrane shell in preventing 
the cell solution from leaking out of the porous scaffold after seeding. This hypothesis is 
supported by previous work demonstrating that collagen membrane wraps can effectively keep 
nutrients and soluble factors localized to the wound site in vivo (Kimura, Hokugo et al. 2008; 
Guda, Walker et al. 2010). Both groups at day 7 showed dramatic increases in cell number and 
metabolic activity compared to day 1. CG-membrane scaffolds maintained higher cell number 
compared to CG scaffolds, although this difference was not significant (Figure 3.5(b)). 
Metabolic activity in CG scaffolds was significantly higher at day 7, although CG-membrane 
scaffolds still show elevated metabolic activity levels compared to day 1. After 14 days of 
culture there were no significant differences between the groups in TC metabolic activity or 
number (Figure 3.5(a-b)), indicating that the core-shell constructs have adequate permeability to 
support the nutrient and metabolite transport necessary for sustained cell viability and 
proliferation. 
 
 
3.5 Conclusions 
This chapter describes the fabrication of a novel CG core-shell composite that successfully 
integrates a high density outer shell (CG membrane) with a low density porous core (aligned CG 
scaffold) into a single biomaterial. The membrane thickness can be controlled over a wide range 
(23-240 µm) and the composite Young's modulus can be predicted by layered composites theory. 
The addition of a membrane shell on the order of 154 µm thick increases the Young's modulus 
by a factor of ~ 36. Nanoindentation analysis show that CG membrane permeability, while 
significantly lower than porous CG scaffolds, is comparable to native tissues (cartilage) and 
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common tissue engineering materials (SIS). These composites also demonstrate the capability to 
support TC attachment, proliferation, and viability out to 14 days at comparable levels to naked 
CG scaffolds, indicating CG membranes have adequate permeability. Future work will continue 
to optimize membrane design and integration while progressing towards clinical application. 
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3.6 Tables 
 
 
Table 3.1. Membrane physical properties. CG membranes are nearly an order of magnitude 
stiffer in tension than compression. Nanoindentation analyses indicate CG membranes, while 
displaying lower fluid mobility than CG scaffolds, are comparable to cartilage and SIS. Data 
expressed as Mean ± SD. 
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3.7 Figures 
 
Figure 3.1. A) Schematic of CG core-shell composite design. B) SEM of transverse CG scaffold 
section displaying round, isotropic pore structure. C) SEM of longitudinal CG scaffold section 
displaying aligned, elongated pore structure. D) SEM of membrane cross-section illustrating 
dense, layered fibrillar organization. E) SEM of scaffold-membrane interface showing 
integration of two materials. 
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Figure 3.2. Membranes can be produced over a wide range of thicknesses (23-240 um) with 
consistent relative density (75-80%) (n = 17). Error bars: Mean ± SEM. 
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Figure 3.3. A) Aligned CG scaffolds have significantly higher tensile moduli than isotropic CG 
controls (isotropic mechanical data adapted from (Kanungo and Gibson 2010)) (n = 6). No 
significant difference was observed in tensile modulus between aligned CG scaffolds fabricated 
at two different final freezing temperatures (-10ºC, -60ºC). B) Effect of various crosslinking 
treatments on tensile modulus of 0.5% CG membranes (n = 6) and C.) 1% CG membranes (n = 
6). Error bars: Mean ± SEM. 
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Figure 3.4. Core-shell composite Young's modulus (n = 6) compares favorably to layered 
composites theoretical prediction. The close agreement is indicative of integration of the 
membrane shell with scaffold core. Error bars: Mean ± SEM. 
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Figure 3.5. A) CG-membrane scaffolds support significantly higher TC number at day 1 (n = 6) 
and similar cell number at days 7 and 14 (n = 6) compared to CG scaffolds. Both groups show 
large increases in TC number from day 1 to day 7 and day 7 to day 14. B) CG scaffolds display 
higher TC metabolic activity at day 1 (n = 18), significantly higher bioactivity at day 7 (n = 12), 
and higher TC metabolic activity at day 14 (n = 6). Both groups show large increases in TC 
metabolic activity from day 1 to day 7. Error bars: Mean ± SEM. 
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CHAPTER 4: CONCLUSIONS AND FUTURE WORK 
4.1 Conclusions 
Chapter 2 demonstrated that CG scaffolds with longitudinally aligned pore microstructure 
mimicking tendon could be fabricated with constant relative density (ρ*/ρs = 0.006) over a wide 
range of pore sizes (55-243 µm). Analysis of TC viability in these scaffolds indicates that while 
scaffolds with smaller pore sizes can initially support higher TC numbers due to increased 
specific surface area, scaffolds with larger pores support higher TC metabolic activity due to 
higher permeability. Larger pore size is known to have other beneficial effects on construct 
bioactivity, including easier cell infiltration and migration, suggesting that an aligned CG 
scaffold variant with larger pores (> 100 µm) may be ideal for tendon tissue engineering. It was 
also shown that the growth factors PDGF-BB and IGF-1 could increase TC migratory capacity, 
metabolic activity, and number. In particular, PDGF-BB was able to induce a more than three-
fold increase in migratory capacity and a more than ten-fold increase in TC metabolic activity 
over a non-supplemented control, suggesting PDGF-BB supplementation could be used to 
increase overall CG scaffold bioactivity for tendon tissue engineering applications.  
 
Chapter 3 introduced a novel technique to fabricate CG core-shell composites that successfully 
integrate a high density outer shell (CG membrane) with a low density porous core (aligned CG 
scaffold) into a single biomaterial. The membrane thickness can be controlled over a wide range 
(23-240 µm) and the composite Young's modulus can be predicted by layered composites theory. 
The addition of a membrane shell on the order of 154 µm thick increases the Young's modulus 
by a factor of ~ 36. Nanoindentation analysis show that CG membrane permeability, while 
significantly lower than porous CG scaffolds, is comparable to native tissues (cartilage) and 
 127 
common tissue engineering materials (SIS). These composites also demonstrate the capability to 
support TC attachment, proliferation, and viability out to 14 days at comparable levels to naked 
CG scaffolds, indicating CG membranes have adequate permeability.  
 
4.2 Future Work 
It is well established that immobilization and controlled release of growth factors can improve 
scaffold bioactivity relative to bolus delivery by limiting diffusive dilution through localization 
of soluble factor levels as well as by extending factor half-life in vivo by slowing cellular uptake 
(Mann, Schmedlen et al. 2001; Shen, Shoichet et al. 2008). It is also known that successful tissue 
regeneration strategies will likely require the ability to spatially and temporally control the levels 
of multiple growth factors within a defined scaffold microenvironment (Barkefors, Le Jan et al. 
2008; Freeman and Cohen 2009; Wang, Wenk et al. 2009; Borselli, Storrie et al. 2010; Chen, 
Zhang et al. 2010). Breaking down tendon wound healing into inflammatory, proliferative, and 
remodeling phases and identifying key soluble factors associated with each sets the stage for 
development of controlled release strategies in a defined CG scaffold structure as a means 
towards improving tendon functional regeneration. Chapter 2 focused on PDGF-BB and IGF-1 
as key soluble factor candidates for early tendon healing (inflammatory and proliferative phases). 
For identification of soluble factor candidates for future work, fetal healing may serve as a model 
for regeneration strategies. In contrast to adult healing, fetal tendons can heal with little 
inflammation, no significant changes in cytokine activities, and full restoration of mechanical 
properties (Favata, Beredjiklian et al. 2006). This suggests that intrinsic cells in fetal tendon may 
have regenerative capabilities. Notably, fetal platelets at the wound site display reduced 
expression of TGF-β1, TGF-β2, PDGF, and bFGF as well as increased VEGF and TGF-β3 
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compared to adult platelets (Yannas, Kwan et al. 2007). Another study tracked the expression 
patterns of key genes in tendon development using a chick model. Interestingly, TGF-β1 was not 
expressed at all during this process while TGF-β2 and TGF-β3 were expressed at differential 
levels (Kuo, Petersen et al. 2008), suggesting that TGF-β1 agonists may be a relevant candidate 
for future work.  
 
Future work will also focus on optimizing membrane design and integration in order to improve 
tensile modulus while maintaining sufficient permeability for cell viability and protein 
biosynthesis. One straightforward way to increase the tensile modulus would be to increase the 
relative density of the scaffold core. The relative density of 0.5% was chosen based on previous 
work with CG materials. However, facile methods exist to increase this relative density by at 
least a factor of 4 (2%) (Kanungo and Gibson 2010), which would correspond to a theoretical 
increase in Young's modulus by a factor of 16. Coupling the 2% scaffold with the 154 µm 
membrane would produce a composite with a predicted modulus approaching 100 MPa (within 
an order of magnitude of tendon), making the composite strong enough for in vivo implantation. 
Increasing the relative density to this level would still maintain high porosity (98%) and 
permeability necessary for tissue engineering applications. The scaffolds developed in this thesis 
should also enable acellular utilization. While hydrogel-membrane composites have been 
previously fabricated for intervertebral disk applications (Nerurkar, Baker et al. 2009), the dense 
gel network prevents acellular deployment of these composites; acellular implantation of our 
core-shell composites will greatly reduce regulatory compliance issues. 
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Several alternate membrane configurations are currently being considered that would not 
completely envelope the porous core; these include membrane stripes on the core outer surface 
area, a central membrane through the center of the scaffold core, and a series of longitudinally 
aligned membrane ribbons within the scaffold (similar to concrete rebar). These designs offer 
additional mechanical support while permitting higher permeability than the current design. 
While the CG membranes are mechanically isotropic in plane, methods to fabricate mechanically 
anisotropic membranes are also being explored.  
 
Histology and other methods will be used in the future to quantify TC alignment, infiltration, and 
distribution as well as matrix synthesis within aligned CG scaffold variants. Finally, future work 
will aim to integrate the core-shell composite design (Chapter 3) with ongoing work involving 
immobilization, spatial patterning, and controlled release of tendon-relevant soluble factors such 
as PDGF-BB and IGF-1 (Chapter 2, Appendix A) (Caliari and Harley in preparation; Martin, 
Caliari et al. submitted). These strategies will be applied to single compartment (tendon) and 
multicompartment (tendon-bone) tissue engineering scaffolds (Harley, Lynn et al. 2010) while 
progressing towards in vivo and clinical applications. 
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APPENDIX A: BIOPHOTOLITHOGRAPHIC METHOD FOR GENERATING 
BIOMOLECULAR PATTERNS IN HIGHLY POROUS COLLAGEN-GAG 
SCAFFOLDS4
 
  
A.1 Introduction 
The extracellular matrix (ECM) is a complex organization of structural proteins such as 
collagens and proteoglycans found within tissues and organs. The ECM plays a significant role 
in defining the overall mechanics of a tissue, is responsible for conducting mechanical stimuli 
from the organ-scale to individual cells, can influence cell behavior through integrin-ligand 
complexes, and can influence diffusion of soluble regulators (i.e., cytokines, growth factors, 
hormones, other paracrine and endocrine signals) through its fibrillar network. With the 
understanding that cells natively exist within a complex three-dimensional structure, a wide 
variety of tissue engineering scaffolds have been created for a multitude of fundamental 
biological and biomedical applications. Scaffold microstructure (porosity, mean pore size, pore 
shape, interconnectivity, specific surface area) (Yannas, Lee et al. 1989; Wake, Patrick et al. 
1994; Nehrer, Breinan et al. 1997; Yannas 2001; Zeltinger, Sherwood et al. 2001; O'Brien, 
Harley et al. 2005; Jaworski and Klapperich 2006; Harley, Kim et al. 2008; Tierney, Haugh et al. 
2009; Tierney, Jaasma et al. 2009; Murphy, Haugh et al. 2010) and mechanical properties 
(Young’s modulus, yield stress) (Pelham and Wang 1997; Grinnell, Ho et al. 1999; Torres, 
Freyman et al. 2000; Freyman, Yannas et al. 2001; Grinnell, Ho et al. 2003; Engler, Bacakova et 
al. 2004; Jiang and Grinnell 2005; Peyton and Putnam 2005; Yeung, Georges et al. 2005; Zaman, 
Trapani et al. 2006) have been shown to significantly influence cell behaviors such as adhesion, 
growth, and differentiation. Scaffold microstructure and stiffness have also been shown to affect 
the bioactivity of scaffolds used for in vivo tissue regeneration applications (Yannas 2001).  
                                                 
4 This chapter has been adapted from the following publication: 
Martin, T. A., S. R. Caliari, et al. (submitted to Biomaterials). "Biophotolithographic method for generating 
biomolecular patterns in highly porous collagen-GAG scaffolds." 
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Heterogeneous tissues with spatially and temporally modulated properties play an important role 
in organism physiology where their complex properties are essential for proper function (Mikos, 
Herring et al. 2006). For example, the graded interfaces found between bone and tendon or 
ligament in the musculoskeletal system contain complex compositional, microstructural, and 
mechanical patterns, which allow transmission of mechanical loads without high failure rates by 
minimizing stress at the interface (Kurosaka, Yoshiya et al. 1987; Woo, Debski et al. 2000; 
Thomopoulos, Williams et al. 2003; Thomopoulos, Williams et al. 2003; Thomopoulos, Marquez 
et al. 2006; Woo, Abramowitch et al. 2006; Woo, Takakura et al. 2006; Moffat, Sun et al. 2008; 
Wopenka, Kent et al. 2008). Proximal-distal concentration gradients of growth factors in injured 
peripheral nerves are known to significantly impact regenerative capacity (Derby, Engleman et 
al. 1993; Kapur and Shoichet 2004; Yannas, Zhang et al. 2007). Functional organization of the 
adult central nervous system is coordinated by spatially patterned neuronal cell populations along 
the spinal cord (Ulloa and Briscoe 2007). Precise cell patterns within C. elegans have also been 
quantified in the context of developmental biology investigations (Chung, Crane et al. 2008; 
Crane, Chung et al. 2009; Crane, Chung et al. 2010). With the understanding that the ECM is 
both dynamic and that it typically is spatially patterned or heterogeneous in microstructure, 
mechanics, and composition over the length-scale of traditional biomaterials, there has recently 
been a significant effort in the fields of tissue engineering and regenerative medicine aimed at 
moving away from static, monolithic biomaterials and towards the development of instructive 
biomaterials with tailored chemical, microstructural, and mechanical properties that provide 
specialized cell behavioral cues in a spatially and temporally defined manner (Lutolf and 
Hubbell 2005; Huebsch and Mooney 2009; Place, Evans et al. 2009). These materials aim to 
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recapitulate aspects of the dynamic and spatially heterogeneous constellation of cues presented 
by the ECM that can individually and synergistically influence cell behavior. The majority of 
this effort has been applied towards the development of patterned two-dimensional substrates as 
well as 3D hydrogel constructs. Examples of 2D patterns include multidirectional surface 
gradients to study cell motility patterns (Gunawan, Choban et al. 2005; Gunawan, Silvestre et al. 
2006; Silvestre, Kenis et al. 2009) and multicomponent biomolecular patterns to examine cell 
activity (Toh, Fraterman et al. 2009). Gradient makers have been used in conjunction with 
pHEMA hydrogel systems to create regio-specific concentrations of neurite growth factor in 
order to guide outgrowth from axons in 3D (Kapur and Shoichet 2004; Luo and Shoichet 2004). 
Recently, Anseth et al. have demonstrated a number of novel technologies to create, modify, 
and/or remove microenvironmental patterns in PEG-based hydrogels (DeForest, Polizzotti et al. 
2009; Kloxin, Kasko et al. 2009; Kloxin, Benton et al. 2010; Kloxin, Tibbitt et al. 2010).  
 
While hydrogels have been successfully used for a range of tissue engineering applications, 
similar methods for achieving biomolecular patterning have yet to be achieved for scaffold-based 
biomaterials. Scaffolds offer advantages in the form of independent modulation of scaffold 
microstructural, mechanical, and compositional properties. Their open-cell nature also enables 
improved speed of cell infiltration and metabolite diffusion compared to hydrogels. Collagen-
glycosaminoglycan (CG) scaffolds have long been utilized as ECM analogs for the regeneration 
of skin (Yannas, Lee et al. 1989) and are currently being considered for the regeneration of nerve 
(Harley, Spilker et al. 2004), conjunctiva (Hsu, Spilker et al. 2000), as well as cartilage (Vickers, 
Squitieri et al. 2006; Capito and Spector 2007) and osteochondral tissues (Harley, Lynn et al. 
2010; Harley, Lynn et al. 2010; Lynn, Best et al. 2010). Recently a series of CG scaffolds with 
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uniform pore microstructures have been developed with a range of sizes of equiaxed pores to 
study the effect of scaffold microenvironment on cell behaviors such as attachment, migration, 
and contraction. Experimental characterization and theoretical modeling techniques have been 
used to describe the pore microstructure, specific surface area, tensile and compressive 
mechanical properties, cell attachment, and permeability of these variants (O'Brien, Harley et al. 
2004; O'Brien, Harley et al. 2005; Harley, Freyman et al. 2007; Harley, Leung et al. 2007; 
O'Brien, Harley et al. 2007; Harley, Kim et al. 2008). Growth factors (Shen, Shoichet et al. 
2008), plasmids (Sun, Jeng et al. 2009), and genes (Capito and Spector 2007) have been 
immobilized in collagen-based scaffolds using crosslinking techniques, but these methods do not 
offer the capability to spatially modulate biomolecule distribution within a single construct. 
While soluble and insoluble presentation of biomolecular factors have both been studied in the 
context of biomaterials for tissue engineering applications, here we concentrate on methods to 
create spatial patterns of surface-immobilized biomolecules. Adhesion ligands, growth factors, 
and other biomolecules are typically sequestered, as opposed to freely soluble, within the ECM 
(Liu, Chen et al. 2006). Biomolecule immobilization has further been shown to induce increased 
bioactivity relative to bolus or even controlled delivery of soluble growth factors (Mann, 
Schmedlen et al. 2001; Shen, Shoichet et al. 2008). Explanations for these observation include 
extended half-life (> 1 h) in vivo (Chew, Mi et al. 2007), elimination of diffusive dilution 
(especially within larger constructs) (Shen, Shoichet et al. 2008), and an avoidance of cellular 
uptake that limits long-term bioactivity.  
 
Given the importance of immobilized gradients in defining in vivo biological interfaces, the 
development of molecularly general approaches to spatially controlling the presentation of 
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multiple biomolecules within porous scaffolds is an important goal for creating advanced models 
of cellular microenvironments. Spatial patterning of biomolecules onto solid surfaces has been 
achieved by a number of techniques including microcontact printing (Song, McMillan et al. 
2009; Xu, Ling et al. 2009; Mendelsohn, Bernards et al. 2010) and chemical attachment schemes 
in which biomolecules are directed to specific locations on the surface via microfluidic 
architectures (Gunawan, Silvestre et al. 2006; Irimia, Liu et al. 2006; Hwang, Kwon et al. 2010). 
These techniques work by spatially defining regions at which biomolecules can be attached to 
the surface. In contrast, this level of spatial confinement would be impossible to achieve within a 
three-dimensional network such as that found in porous scaffolds. Recently, we reported a direct, 
biophotolithographic method of covalently attaching biomolecules onto surfaces in which 
substrates are uniformly immersed in the biomolecule of interest, and immobilization is 
controlled solely by the presence (or absence) of incident light (Toh, Fraterman et al. 2009). 
Since the spatial confinement of light is the only requirement for successful biomolecular 
patterning, we reasoned that this technique could be extended to porous, 3D scaffolds. 
 
This biophotolithographic method takes advantage of the photochemistry of surface-attached 
benzophenone (BP). BP can be excited by UV light (λ ≈ 350-365 nm) to form a diradical that 
has a lifetime of ~180 µs (Dorman and Prestwich 1994). While in the excited state, BP can react 
with a nearby C-H bond from an adjacent biomolecule, forming a new C-C covalent bond. When 
BP is attached to a surface, the new C-C bond represents a covalent tether between the 
biomolecule and the substrate. Importantly, if BP does not react with a nearby molecule within 
the excited state lifetime, it relaxes back to the ground state from which it could be re-excited 
with subsequent optical pumping. Since the attachment occurs only where light is incident, 
 135 
geometric patterns and gradient of biomolecules can be generated on surfaces by simply 
controlling the spatial exposure of light across the substrate, as shown in Figure A.1.  
 
This chapter describes the extension of this biophotolithographic approach for the spatial 
patterning of biomolecules within the 3D CG scaffolds. While CG scaffold microstructural, 
mechanical, and bulk compositional properties, as well as monolithic immobilization of growth 
factors, plasmid, and gene delivery vectors, have been shown to affect scaffold bioactivity 
(O'Brien, Harley et al. 2005; O'Brien, Harley et al. 2007; Murphy, Haugh et al. 2010), spatial 
patterning of key biomolecular regulators within the scaffold structure has not previously been 
achieved. Here we investigate the effects of this BP-based biophotolithographic patterning 
method on the microstructural and mechanical properties as well as the native bioactivity of a 
CG scaffold variant. We then show that specific patterning of the adhesion ligand fibronectin to 
the CG scaffold increases early MC3T3-E1 osteoblast cell attachment relative to the native 
scaffold or a CG scaffold with non-specifically adsorbed fibronectin. Our findings, on the whole, 
establish the use of BP biophotolithography as a novel methodology for generating scaffolds 
with spatially patterned biomolecules that can improve construct bioactivity. 
 
A.2 Materials and Methods 
All reagents were purchased from Sigma-Aldrich (St. Louis, MO) unless otherwise noted. 
A.2.1 CG scaffold fabrication 
CG scaffolds were fabricated via freeze-drying from a suspension of type I microfibrillar 
collagen from bovine dermis (Devro Inc., Columbia, SC) and chondroitin sulfate derived from 
shark in 0.05 M acetic acid (Harley and Gibson 2008). This process has been previously 
optimized to produce a range of CG scaffold variants with a uniform pore microstructure with 
 136 
regular, polyhedral pores (O'Brien, Harley et al. 2004; O'Brien, Harley et al. 2005; Harley, 
Leung et al. 2007; O'Brien, Harley et al. 2007; Harley, Kim et al. 2008). Briefly, a degassed CG 
suspension was added to an aluminum mold and placed in a freeze-dryer (VirTis Genesis, 
Gardiner, NY) at room temperature. The suspension was cooled at a constant rate (1.0oC/min) to 
-4°C and held there for 2 h to allow the suspension temperature to equilibrate; the suspension 
was then further cooled to a final freezing temperature of -40°C at 1.0oC/min, resulting in a 
continuous, interpenetrating network of ice crystals surrounded by the CG co-precipitate. Ice 
crystals were removed via sublimation under vacuum (200 mTorr) to produce a highly porous 
CG scaffold structure that is defined by individual fibers of CG content, termed struts (O'Brien, 
Harley et al. 2004). Scaffolds were dehydrothermally crosslinked and sterilized at 105°C for 24 h 
under vacuum (< 25 torr) in a vacuum oven (Welch Vacuum Technology, Niles, IL) prior to use 
(Harley, Spilker et al. 2004). 
 
A.2.2 Chemical attachment of BP to CG scaffolds 
A 20 mM solution of benzophenone-4-isothiocyanate (made via an established method) 
(Sinsheimer, Jagodic et al. 1975) was made in dimethyl formamide (DMF), containing 0.5 M 
N,N-diisopropylethylamine. As prepared CG scaffolds were added to the solution and allowed to 
react at room temperature in the dark for 48 h. Scaffolds were thoroughly rinsed three times in 
DMF, 200 proof ethanol, and then water (ELGA LabWater Reservoir, Veolia Water Systems, 
Buckinghamshire, UK) each for 1 h and stored under water and in the dark. 
 
A.2.3 Photoattachment of biomolecules onto BP-presenting CG scaffolds 
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Biotinylated concanavalin A (ConA-biotin) was purchased from Vector Laboratories 
(Burlingame, CA), fibronectin (FN) was purchased from Invitrogen (Carlsbad, CA) and N-
Cadherin (NC) was purchased from R&D Systems (Minneapolis, MN). Stock solutions of 
biomolecules were prepared by resuspending lyophilized protein in the manufacturer’s 
recommended buffer solutions to a concentration of 1 mg/mL. For ConA-biotin and FN, the 
buffer was phosphate buffered saline, pH=7.4 (PBS) and PBS containing Ca2+ and Mg2+ was 
used for NC. The solutions were aliquotted and stored at -20ºC. Immediately prior to use, the 
stock solutions were diluted in the respective buffers to yield the empirically determined final 
solution concentrations of 5 µg/mL or 100 µg/mL FN.  
 
BP-modified scaffolds were placed onto a microscope slide and surrounded by a rubber o-ring. A 
20 µL aliquot of protein solution was added to the top of the scaffolds and the chamber 
assembled by placing a glass cover slip on top. Scaffolds were soaked in protein solutions for 1 h 
at room temperature prior to photoimmobilization. 
 
Exposure of the scaffolds was performed with an argon ion laser (Coherent Innova 90-4, Laser 
Innovations, Santa Paula, CA) with UV optics providing illumination at 351.1-363.8 nm. The 
Gaussian beam profile was shaped and expanded to give a uniform illumination of the scaffold 
using a π-shaper (Molecular Technologies, Berlin, Germany) and beam expanding optics. The 
uniformity of illumination was ensured using beam profiler (Ophir-Spiricon, Logan, UT). The 
laser was adjusted to give a power of 20 mW/cm2 at the illumination scaffold surface. For 
biomolecular patterning, a chromium-coated quartz mask was placed metal side down onto the 
chamber housing the CG scaffold and the substrate irradiated for set times varying from 30 s to 5 
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min. Bulk exposure was achieved in the same way except without the photomask. Following 
irradiation, the scaffolds were immersed in a solution containing 0.2% pluronic F-127 in PBS for 
1 h. For 2-component patterning, scaffolds were subsequently incubated for 1 h in PBS and then 
1 h in the appropriate secondary component protein solution and the patterned as described 
above. After immobilization, scaffolds for structural characterization and cell experiments were 
stored in PBS. Scaffolds for microscopic visualization of biomolecular patterns were incubated 
in 1% (w:v) bovine serum albumin in PBS. 
 
A.2.4 Fluorescent visualization of biomolecular patterns 
Biomolecularly patterned scaffolds were removed from the storage buffer and placed in a 
solution containing a fluorescently-labeled binding partner for at least 1 h. Patterned ConA-
biotin was visualized after incubation with a solution of 5 µM Qdot 525 conjugated streptavidin 
(Invitrogen, Carlsbad, CA) in 1% BSA-PBS. NC patterns were visualized with a pre-mixed 
cocktail of sheep anti-human NC (1 µg/mL, R&D Systems, Minneapolis, MN) and Alexa Fluor 
647-conjugated donkey anti-sheep IgG (0.5 µg/mL, Invitrogen, Carlsbad, CA) in 1% BSA-PBS 
with Ca2+ and Mg2+. FN patterns were visualized with a pre-mixed cocktail of biotinylated rabbit 
anti-human FN (1 µg/mL, AbCam, Cambridge, MA) and Alexa Fluor 568-conjugated 
streptavidin (0.5 µg/mL, Invitrogen, Carlsbad, CA) in 1% BSA-PBS with Ca2+ and Mg2+. Two-
component patterns were simultaneously stained for both protein components. After staining, 
scaffolds were rinsed in PBS prior to imaging on a LSM 710 confocal microscope (Carl Zeiss 
Microimaging, GmbH, Germany). Image analysis was performed using Imaris 7.0 (Bitplane AG, 
Zurich, Switzerland) to render 3D fluorescent images. 
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A.2.5 Determination of photoimmobilized ligand density 
The amount of biomolecule photochemically attached to the scaffold was determined using a 
modified radioimmunoassay. Streptavidin was radiolabeled with [I125] using Pierce iodination 
tubes (Pierce, Rockford, IL), and purified using spin filter columns (Biorad, Hercules, CA). The 
percentage of free [I125] present in the sample was determined to be less than 3% (Gooden 2000) 
and the concentration of protein in the sample was determined using a Bradford assay. 
Separately, a ConA-biotin-containing solution was introduced to the scaffolds before exposure 
(bulk, no patterning) for varying amounts of time. The modified scaffolds were then incubated 
with an excess of [I125]-streptavidin for 1 h before unattached streptavidin was removed by 
soaking in PBS for 1 h. The scaffold was then covered with scintillation fluid (ScintiSafe Econo 
1, Fisher Scientific, Pittsburgh, PA) and the total radioactive counts per minute were measured 
from the scaffold using a Beckman LS 6500 liquid scintillation counter (Beckman Coulter, Brea, 
CA). This value was then converted to the number of streptavidin molecules on the scaffold via 
the specific activity and the amount of bound ConA-biotin determined by assuming a 1:1 binding 
relationship.  
 
The number of immobilized proteins was converted to a ligand density by dividing the number 
of conjugated molecules by the scaffold surface area as determined by cellular solids modeling. 
Cellular solids modeling has been a useful tool for the microstructural characterization of low 
density, open cell foams such as CG scaffolds (Gibson, Ashby et al. 2010). The specific surface 
area (surface area/volume; SA/V) of the scaffold was calculated as a function of pore diameter (d) 
and the relative density (ratio of the scaffold density to the density of the solid material it is 
composed from: ρ*/ρs) (O'Brien, Harley et al. 2005; Gibson, Ashby et al. 2010): 
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A.2.6 Microstructural, mechanical, and compositional analysis 
Mean pore sizes and aspect ratios were calculated for CG and CG–BP scaffold variants to 
determine the effect of BP functionalization on CG scaffold microstructure. The size and shape 
of CG scaffold variants were determined via a previously described stereology approach 
(O'Brien, Harley et al. 2004; O'Brien, Harley et al. 2005). Briefly, full thickness, 8 mm diameter 
samples were removed from the CG scaffolds with a biopsy punch (Miltex) and embedded in 
glycolmethacrylate. Longitudinal and transverse scaffold sections (5 µm thick) were cut on a 
microtome and stained with aniline blue to allow visualization of the CG strut network. Images 
were acquired from these specimens at 10x magnification on an optical microscope (Leica 
Microsystems, Germany) and analyzed using a linear intercept macro in Scion Image to 
determine both the mean pore size and the pore aspect ratio from a best fit ellipse representation 
of the average pore in each image.  
A.2.6.1 Scaffold pore size and shape 
 
Tensile tests were performed on hydrated CG and CG-BP scaffolds in order to determine the 
effect of BP functionalization on scaffold mechanical properties. Tests were performed on 
rectangular scaffold samples (8 mm x 25 mm x 3.5 mm thick); scaffolds were hydrated in PBS 
for 24 h and then tested in tension with an MTS Instron 2 (Eden Prairie, MN) using rubberized 
grips to prevent sample slip. Scaffolds were pulled to failure at a rate of 1 mm/min; scaffold 
A.2.6.2 Scaffold mechanical properties 
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tensile elastic modulus (Es, tension) was calculated from the slope of the stress-strain curve over a 
strain range of 5-10% (Gibson, Ashby et al. 2010).  
 
X-ray diffraction (XRD) analyses were used to determine whether any significant changes in CG 
crystallinity occurred with BP functionalization; XRD has previously been used to quantify CG 
scaffold composition following integration of variable levels of mineral content (0–80 wt%) 
(Harley, Lynn et al. 2010). XRD analyses were performed using a Cu Kα radiation source with a 
Rigaku D-Max diffractometer. Diffraction patterns for CG, CG-BP, and CG-BP-FN scaffolds 
were acquired using a step size of 0.028° 2θ and a dwell time of 10 s. 
A.2.6.3 Scaffold composition 
 
A.2.7 Cell culture and scaffold seeding 
MC3T3-E1 mouse clonal osteogenic cells were cultured in standard culture flasks in α-MEM 
supplemented with 10% fetal bovine serum, 1% L-glutamine, and 1% penicillin/streptomycin. 
Cells were fed every 3 days and cultured to confluence at 37°C and 5% CO2. Prior to each 
experiment, full-thickness (3.5 mm thick), 6 mm diameter CG scaffold samples were cut with a 
biopsy punch (Miltex) and then hydrated (>1 h) in culture media. MC3T3-E1 cells were then 
trypsinized and resuspended at a concentration of 3x105 cells per 20 µL media or PBS. 1.5x105 
cells in 10 µL media were seeded onto each side of the hydrated scaffold disks in a previously 
described manner (Harley, Kim et al. 2008) to a final concentration of 3x105 cells per scaffold. 
Cell-seeded scaffolds were then incubated in ultra-low attachment 6-well plates (Corning Life 
Sciences, Lowell, MA) at 37°C and 5% CO2 for the duration of all experiments. For longer (>30 
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min. attachment) experiments, 4 mL of supplemented α-MEM was added to each well and 
changed every 3 days. 
 
A.2.8 Quantifying cell attachment 
A previously developed cell attachment assay was used to determine the total number of cells 
attached to the scaffold (Kim, Sah et al. 1988). At each time point, scaffolds were first washed in 
PBS to remove any unattached cells and then placed in a papain solution to digest the scaffold 
and lyse the cells to liberate their DNA. A Hoechst 33258 dye (Invitrogen, Carlsbad, CA) was 
used to fluorescently label double-stranded DNA (Kim, Sah et al. 1988) and fluorescence levels 
from each sample were read using a fluorescence spectrophotometer (Varian, Santa Clara, CA): 
352 nm excitation, 461 nm emission. Experimental readings were then compared to a standard 
curve created by measuring the fluorescence levels for a range of known cell numbers to 
determine cell attachment at each time point as a percentage of the total number of seeded cells.  
 
A.2.9 Characterizing cell metabolic activity 
A non-destructive alamarBlue approach was used to compare the metabolic activity of the cells 
in each cell-seeded scaffold over time (Tierney, Jaasma et al. 2009). Healthy cells continuously 
reduce resazurin, the active ingredient in alamarBlue, to the highly fluorescent compound 
resorufin; consistent exposure times enable comparison of the gross metabolic activity in each 
cell-seeded construct. Cell-seeded scaffolds were incubated at 37°C in 1x alamarBlue 
(Invitrogen, Carlsbad, CA) solution with gentle shaking for 2 h (Tierney, Jaasma et al. 2009). 
Resorufin fluorescence was read at 570 nm excitation and 585 nm emission using a fluorescent 
spectrophotometer. A standard curve was created by measuring the metabolic activity of a range 
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of known cell numbers. Scaffold fluorescence readings were interpolated on this curve to express 
results as a percentage of the total number of seeded cells.  
 
A.2.10 Statistical analysis 
One-way analysis of variance (ANOVA) was performed on cell bioactivity, cell number, and 
mechanical data sets respectively followed by Tukey-HSD post-hoc tests. Paired student t-tests 
were used to compare CG and CG-BP scaffold pore size and shape. Significance was set at p < 
0.05. At least n = 6 scaffolds were analyzed at each time point for cell bioactivity while n = 6 
scaffolds were digested and assayed at each time point for cell number. Each group for 
mechanical tests contained n = 6 scaffolds. Pore size and shape analysis was performed on 
transverse (n = 3) and longitudinal (n = 3) scaffold sections from each scaffold variant (36 – 54 
discrete cross-sectional histology images). Error is reported as the standard error of the mean 
unless otherwise noted. 
 
 
A.3 Results 
A.3.1 Visualization of biomolecularly patterned CG scaffolds 
Single component ConA-biotin patterns of 100 µm stripes with 400 µm spacing, and the script 
“I” logo of the University of Illinois at Urbana-Champaign were visualized using confocal 
fluorescence microscopy (Figure A.2(a-b)). Patterns are clearly discernable from the 
background indicating successful photoimmobilization of ConA-biotin via the benzophenone 
groups presented on the CG scaffold. Multicomponent patterns of FN and NC were 
photopatterned in two steps by sequential exposure of each biomolecule through the same 
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photomask utilized for one component patterns (Figure A.2(c)). NC was patterned first (red, 
horizontal) followed by FN (green, vertical) with a 90o rotation of the mask in between 
exposures.  
 
A.3.2 Determining the amount of biomolecular immobilization 
Using cellular solids modeling and a modified radioimmunoassay, the density of a representative 
biomolecule, ConA-biotin, bound to the CG scaffolds was determined to be approximately 1000 
molecules/µm2 for maximum loading conditions.  
 
A.3.3 Scaffold microstructural analysis 
CG and CG-BP scaffolds were determined to have mean pore sizes of 86.6 ± 9.8 µm and 77.1 ± 
9.7 µm (mean ± standard deviation) as well as mean pore aspect ratios of 1.05 ± 0.03 and 1.06 ± 
0.03, respectively. No significant difference was observed in scaffold mean pore size (p = 0.13) 
or aspect ratio (p = 0.32) for CG versus CG-BP scaffolds. No significant difference was observed 
in scaffold pore size in the longitudinal versus transverse planes, (p = 0.14, 0.66 respectively). 
Pore diameters and aspect ratios were similar to previously characterized CG scaffolds fabricated 
using similar freezing conditions (O'Brien, Harley et al. 2005).  
 
A.3.4 Mechanics of CG, CG-DMF, and CG-BP scaffolds 
The DMF treatment stage of the BP functionalization process was observed to significantly 
increase scaffold tensile modulus (p = 0.0005, Figure A.3). The tensile modulus of CG scaffolds 
alone (54.7 ± 12.5 kPa; mean ± standard deviation) was significantly lower than that of the CG-
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DMF (87.6 ± 18.4 kPa) and CG-BP (102.8 ± 17.6 kPa) variants; no significant difference was 
observed between the tensile modulus of the CG-DMF and CG-BP scaffolds (p = 0.16). 
 
A.3.5 Scaffold compositional analysis 
Figure A.4 shows characteristic XRD patterns for the CG, CG-BP, and CG-BP-FN scaffolds. 
All three variants display a broad peak at 2θ = 20º representing the characteristic interchain 
spacing of the collagen triple helix (Davidenko, Campbell et al. 2010). No sign of collagen 
denaturation (loss of the broad collagen peak) was observed for any of the samples; the increase 
in peak height for the CG-BP and CG-BP-FN variants is indicative of increased crystallinity of 
the samples relative to the original CG scaffold due to increased crosslinking with DMF 
treatment, consistent with the observed increase in scaffold tensile modulus. 
 
A.3.6 MC3T3-E1 viability in CG-BP scaffolds 
The long term viability of MC3T3-E1 cells on CG, CG-DMF, and CG-BP scaffolds was 
determined for up to 7 days of in vitro culture in complete α-MEM media. One-way ANOVA 
indicates significant differences in cell metabolic activity at both day 2 and day 7 between the 
three groups (p < 0.0001) with the CG-BP group showing significantly higher bioactivity at both 
time points compared to the CG group (day 2: p = 0.0002, day 7: p < 0.0001). While there are no 
significant differences in total number of attached cells at day 2 (p = 0.44), the CG-BP group 
showed significantly higher cell attachment at day 7 (p = 0.04) (Figure A.5). These data suggest 
that the BP functionalization process does not have a negative impact on the native bioactivity of 
CG scaffolds.  
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A.3.7 MC3T3-E1 attachment and bioactivity in CG-BP-FN scaffolds 
Previous work has demonstrated that fibronectin is the key adhesion ligand required to mediate 
early (< 1 h) cell attachment to CG scaffolds (Sethi, Yannas et al. 2002). Here, MC3T3-E1 cell 
attachment was assessed after 30 min in CG, CG-FN, and CG-BP-FN scaffolds to assess the 
relative ability for BP functionalized CG scaffolds to alter the innate bioactivity of the CG 
scaffold. This experiment was performed in PBS to prevent non-specific adsorption of 
exogenous factors from the α-MEM media, insuring that any change in cell attachment was due 
to the covalent immobilization of fibronectin. Fibronectin treatment was observed to have a 
significant effect on early MC3T3-E1 attachment (p < 0.0001) (Figure A.6). Scaffolds with BP-
immobilized fibronectin (CG-BP-FN) showed significantly higher levels of cell attachment after 
30 min relative to CG scaffold alone (p < 0.0001) or CG scaffolds with passively adsorbed FN 
(CG-FN, p < 0.0001); no significant difference was observed in initial cell attachment for CG 
versus CG-FN groups (p = 0.12). 
 
 
A.4 Discussion 
Collagen-glycosaminoglycan (CG) scaffolds have found useful application as ECM analogs for 
regeneration of a variety of tissue types (Yannas, Lee et al. 1989; Yannas 2001; Harley, Spilker 
et al. 2004) and as experimental substrates to investigate microenvironmental regulation of cell 
behavior (Harley, Freyman et al. 2007; Harley, Kim et al. 2008). Here, we employed a 
benzophenone-based biophotolithographic method to spatially pattern biomolecules within 
defined CG scaffold microstructures, adding the capacity to provide spatially-tuned, instructive 
signals to cells with the scaffold microenvironment. Through a series of imaging and bioactivity 
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assays we observed that BP biophotolithography methods can be applied to 3D biomaterials in 
order to spatially pattern immobilized biomolecules in the CG scaffold structure, and that these 
factors can induce a resultant change in cell bioactivity in response to factor presentation. 
 
This study describes the development and application of a biophotolithographic method for 
covalently attaching multiple biomolecules onto CG scaffolds with spatial control over the 
immobilization. Validation of this patterning scheme was confirmed by fluorescence 
microscopy. Stripes of photoimmobilized ConA-biotin were incubated with fluorescent 
streptavidin. The microscope image in Figure A.2(a) clearly shows the successful attachment of 
this biomolecule, as represented by bright red stripes. Conversely, areas in between the stripes, in 
which light was blocked by the photomask are not fluorescent, since the BP molecules were not 
excited and thus did not conjugate ConA-biotin. The technique was also successfully used to 
create a non-geometric pattern by attaching ConA-biotin in the script “I” logo, as shown in 
Figure A.2(b). Again, a clear contrast between areas exposed to light define the pattern while 
fluorescence is not observed from the areas blocked during illumination. By taking advantage of 
the depth profiling capability of confocal microscopy it was determined that patterns extended 
approximately 300 µm into the scaffold (data not shown). Although the high porosity of the CG 
scaffold does allow for reasonable patterning depths, the scatter of photons at this wavelength 
currently limits the depth to which patterning can be achieved. Furthermore, this scatter also 
slightly diminishes the patterning resolution. We are currently exploring two photon patterning 
schemes which may improve on both of these accounts since longer wavelengths are scattered to 
a lesser degree. Sequential exposures of BP-presenting scaffolds in the presence of different 
biomolecules allow for the construction of multicomponent patterns. Figure A.2(c) shows an 
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example of a CG-scaffold patterned with vertical 100 µm stripes of FN and horizontal 100 µm 
stripes of NC. Notably, both FN and NC are co-immobilized at the intersections of the two stripe 
patterns, highlighting an interesting property of BP-photoattachment strategy as opposed to other 
schemes that rely upon deprotection or unmasking of reactive groups (Dillmore, Yousaf et al. 
2004; Petty, Li et al. 2007; Chan and Yousaf 2008). The diradical formed upon exposure to UV 
light has a finite lifetime of approximately 180 µs after which it relaxes back to the ground state. 
Therefore if an excited BP fails to react with a solution phase biomolecule during the exposure 
period, it can be re-exposed in the presence of a second biomolecule, which allows for the 
creation of overlapping patterns. The relative yield of these photoreactions can be controlled by 
exposure intensity and time, as well as the solution-phase biomolecule concentration, since the 
number of molecules in solution dictates the probability of interaction while the BP is in the 
excited state (Toh, Fraterman et al. 2009). The conditions used for two component patterning 
were controlled so that the first component exposure did not saturate the scaffold, facilitating the 
construction of overlapping patterns. Importantly, the ability to control the presented 
concentration of multiple biomolecules at a single spatial location will be of tremendous utility in 
downstream applications. The selection of FN and NC for two-component patterning was 
strategic in that both proteins are implicated in the proliferation and maintenance of the MC3T3 
osteoblast-like cells used in this study (Lee, Adams et al. 2007; Hay, Laplantine et al. 2009; 
Muhonen, Fauveaux et al. 2009). Two-component patterns of these two biomolecules could 
prove particularly useful in the engineering of tissue interfaces (e.g. cartilage-bone 
(osteochondral), ligament-bone, and tendon-bone) where the sub-millimeter gradients of 
chemical and mechanical properties found in vivo are difficult to recapitulate in synthetic model 
systems (Galatz, Ball et al. 2004; Lu and Jiang 2006). 
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Quantitative analysis of scaffold microstructural, mechanical, and chemical composition 
revealed that the processing steps required for BP conjugation to the CG scaffold induced some 
quantifiable changes in scaffold properties, but not in a manner that would suggest a negative 
biological response. Scaffold microstructure (pore size, pore aspect ratio), a key parameter in 
determining overall scaffold bioactivity, was not influenced by BP conjugation. Exposure of the 
CG scaffold to the DMF buffer required to mediate BP conjugation to the CG scaffold likely 
increased the crosslinking density of the CG scaffold, as reflected by the increase in scaffold 
tensile modulus (Figure A.3) and relative increase in material crystallinity (XRD, Figure A.4). 
However, no change in scaffold modulus or material crystallinity was observed due to FN 
functionalization to the BP. XRD spectra also did not exhibit a peak shift characterization of 
collagen gelatinization. These results suggest that the DMF buffer additionally crosslinks the CG 
scaffold, imparting improved mechanical properties, but does not fundamentally alter scaffold 
microstructural or compositional properties. These results also suggest that BP conjugation and 
biomolecular functionalization do not alter scaffold properties. While other groups have also 
used DMF-based solutions during fabrication of collagen-based biomaterials and demonstrated 
subsequent bioactivity after DMF treatment (Kim, Chung et al. 2008), ongoing work will include 
an alternative BP conjugation step that altogether avoids organic solvents. By understanding the 
effects of DMF on the base scaffold properties, we are able to assess the ability of 
photolithographically immobilized biomolecules to influence cell bioactivity within the 3D CG 
scaffolds, and in the future will allow for comparative experiments to adjust the crosslinking of 
CG scaffolds (Harley, Leung et al. 2007) to mimic the crosslinking effect of CG-BP scaffold 
variants. 
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After demonstrating that CG scaffolds could be patterned using BP biophotolithography methods 
without significant deterioration of physical properties, we examined the affect of BP 
conjugation to CG scaffolds on the overall material bioactivity. We were particularly concerned 
with the cytotoxicity of DMF and BP chemistries, but found no decrease in MC3T3-E1 pre-
osteoblast number or metabolic activity out to 7 days of culture in CG-DMF or CG-BP scaffolds 
relative to unmodified CG scaffolds (Figure A.5). These data indicate that BP conjugation and 
the organic solvents used in this process do not adversely influence cell attachment, bioactivity, 
and proliferative potential. The observed increase in MC3T3 number and bioactivity for CG-BP 
scaffolds relative to CG control is in fact likely due to differences in scaffold modulus. 
 
We then examined the ability of BP-biophotolithography to specifically alter a cellular response 
within the CG scaffold. Previous studies have shown that CG scaffold microstructure plays a 
significant role in influencing cell attachment (O'Brien, Harley et al. 2005; O'Brien, Harley et al. 
2007; Murphy, Haugh et al. 2010) and that cell attachment to the scaffold is mediated by 
sequential utilization of vitronectin, fibronectin and collagen binding motifs (Sethi, Yannas et al. 
2002); however the fibronectin binding motif was specifically implicated in mediating the initial 
cell attachment events to the scaffold within the first 2 h after cell-seeding (Sethi, Yannas et al. 
2002). Here we examined the cell attachment percentage 30 min after seeding the MC3T3-E1 
cells onto untreated CG scaffolds and BP-conjugated CG scaffolds where we covalently 
immobilized fibronectin via BP-biophotolithography to the entire scaffold (CG-BP-FN). As an 
additional control, we also tested CG scaffolds that were soaked in a fibronectin solution (CG-
FN) and then washed in PBS, where passive FN physisorption was the only mechanism for 
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surface patterning. The cell attachment study was performed in PBS rather than media to prevent 
nonspecific adsorption of additional proteins from the media that could alter cell adhesion 
profiles. No significant difference in cell attachment was observed for the CG versus FN-
physisorbed CG scaffold, while a greater than two-fold (p < 0.0001) increase in MC3T3-E1 cell 
attachment was observed for the CG-BP-FN scaffold versus the CG or CG-FN scaffolds (Figure 
A.6). These data demonstrate that BP-biophotolithography can be used to immobilize 
biomolecules to CG scaffolds in order to elicit a specific biological response. These results also 
demonstrate the advantage of covalent immobilization (CG-BP-FN) rather than physical 
adsorption (CG-FN) of fibronectin to mediate initial cell attachment events within 3D 
biomaterials.  
 
BP-biophotolithography has previously been used to spatially pattern a range of biomolecules on 
2D, planar surfaces. Here we show that BP-biophotolithography can be applied to the CG 
scaffold system to create a range of biomolecular patterns, that BP conjugation increased 
scaffold crosslinking but did not change scaffold microstructure or composition in a way that 
negatively affects cell viability, and that BP-biophotolithography can be used to improve cell 
bioactivity by covalent immobilization of an adhesive factor. Ongoing work is using multiple 
(stripes and gradients) orthogonal patterns of fibronectin and N-cadherin in order to further probe 
the capacity for BP-biophotolithography to alter cellular activity. These proteins are 
differentially implicated in the proliferation and maintenance (Lee, Adams et al. 2007; Hay, 
Laplantine et al. 2009; Muhonen, Fauveaux et al. 2009) of the MC3T3-E1 cells used in this 
study, and thus generating multiple orthogonal patterns of both proteins will provide a toolset to 
explore their separate and linked regulation of MC3T3 cell attachment and proliferation. 
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This technology could prove especially useful in the engineering of orthopedic tissue interfaces, 
such as cartilage-bone (osteochondral) (Harley, Lynn et al. 2010), ligament-bone, and tendon-
bone. These tissue interfaces natively have gradients of chemical and mechanical properties on 
sub-millimeter length scales that are difficult to reproduce with current biomaterials strategies. 
Approaches to treat injuries at these interfaces often fail to effectively mimic the heterogeneity of 
native interfaces, resulting in high failure rates (Galatz, Ball et al. 2004; Lu and Jiang 2006). 
Currently, we are using BP-biophotolithography to explore the use of exogenous growth factors 
to differentially regulate cell behavior (cell infiltration, matrix synthesis) in CG scaffolds for 
tendon and tendon-bone insertion tissue engineering applications. While such factors are often 
presented in a soluble phase for tissue engineering applications, within the native ECM these 
biomolecules are typically sequestered rather than freely soluble (Liu, Chen et al. 2006). Factor 
immobilization therefore provides a mechanism to elicit specific biological responses in many 
tissue engineering applications, and has been shown to increase the effectiveness of some 
biomolecules when applied in a uniform manner throughout the biomaterial (Haugh, Huang et al. 
1999). We are also utilizing BP-biophotolithography to create factor gradients to determine 
bioactive concentrations of matrix-bound biomolecules and then utilize spatial control over 
biomolecule presentation to improve scaffold bioactivity. 
 
The work presented here is also the basis for an expanded project developing tools to enable 
spatio-temporal patterning of biomolecular signals within 3D tissue engineering scaffold 
structures. The CG scaffold system is ideal for this application due to our previously documented 
capacity to generate scaffolds with independent control over microstructural, mechanical, and 
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compositional properties (O'Brien, Harley et al. 2005; Harley, Leung et al. 2007), utilize a 
modeling framework to describe scaffold structural and mechanical features (O'Brien, Harley et 
al. 2005; Harley, Freyman et al. 2007; Harley, Leung et al. 2007; Harley, Kim et al. 2008), and 
use these scaffolds as a model system to study mechanisms of cell behavior and to optimize 
imaging methods to enable high-speed, 3D interrogation of cell-scaffold interactions (O'Brien, 
Harley et al. 2005; Harley, Freyman et al. 2007; Kim, Ragan et al. 2007; Harley, Kim et al. 2008; 
Yannas, Tzeranis et al. 2010). We are now developing 2-photon based patterning methods to 
both increase our depth of penetration and enable true 3D biophotolithography patterns. Current 
BP chemistry allows insertion of a biomolecule, but not release; non-conjugated BP molecules 
relax after removal of the UV light thereby enabling multiple overlapping biomolecule patterns 
provided the BP molecules are not saturated, but the current conjugation step is permanent. We 
are therefore working to modulate the BP chemistry to enable signals to be inserted and removed 
upon excitation via multiple wavelengths. A future direction will be the use of BP 
biophotolithography to enable spatial control over the presentation of drug and gene delivery 
vectors, proving an additional avenue for spatio-temporal regulation.  
 
 
A.5 Conclusions 
We have demonstrated the ability to conjugate benzophenone to CG scaffolds and 
photochemically generate patterns of biomolecules in a controlled and spatially well-defined 
manner. Since this immobilization approach only requires the presence of a C-H bond, it is 
biomolecularly general and has broad applicability to a range of classes of biomolecules. The 
method offers a direct, photolithographic approach to generate complex, multicomponent 
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patterns or gradients of biomolecules to more accurately mimic the heterogeneity of the native 
ECM using biologically mimetic collagen scaffolds. Future work will focus on generating 
multicomponent patterns and gradients to investigate cell adhesion, migration, proliferation, 
differentiation, gene expression, and ECM biosynthesis in both single and multicompartment CG 
scaffolds.  
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A.6 Figures  
 
 
Figure A.1. BP Conjugation and Biomolecular Conjugation. A) BP-isothiocyanate is conjugated 
through free amino-groups on the collagen-GAG scaffold.  B) Scaffolds are immersed in a 
biomolecular solution of interest and exposed to UV light.  Covalent immobilization of 
biomolecules is dependent on the incidence of light. 
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Figure A.2. Photoimmobilization of Biomolecules. A) Photoimmobilized conA-biotin in 100 µm 
stripes with 400 µm spacing, visualized with Qdot525-streptavidin.  B) Photoimmobilized conA-
biotin in the “Script I” logo of the University of Illinois at Urbana-Champaign to demonstrate 
patterns of different shapes. C) Overlapping patterns of 100 µm stripes with 400 µm spacing of 
N-cadherin (horizontal, red) and fibronectin (vertical, green).   
500 µm 
500 µm 
A) 
B) C) 
500 µm 
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Figure A.3. Tensile Strength and Stress-Strain Curves. A) Mechanical testing of CG, CG-DMF, 
and CG-BP scaffolds shows that DMF treatment significantly increases tensile elastic modulus. 
B) Stress-strain curves for CG, CG-DMF, and CG-BP scaffolds. 
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Figure A.4. Crystallinity of Modified Scaffolds. XRD of CG, CG-BP, and CG-BP-FN scaffold 
variants. All four scaffolds display a broad peak at 2θ = 20 degrees representing the 
characteristic interchain spacing of the collagen triple helix. 
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Figure A.5. Metabolic Activity and Cell Attachment in Modified Scaffolds. A) MC3T3-E1 
attachment in CG, CG-DMF, and CG-BP scaffolds after 2 and 7 days of in vitro culture. B) 
MC3T3-E1 bioactivity CG, CG-DMF, and CG-BP scaffolds after 2 and 7 days of in vitro 
culture.  Conjugation of BP to the scaffolds or DMF exposure does not adversely affect cell 
activity or attachment. 
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Figure A.6. Cell Attachment Assay. CG-BP-Fn scaffolds showed significantly higher MC3T3-
E1 attachment compared to the control bare CG and CG-Fn scaffolds after 30 min. 
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APPENDIX B: EXPERIMENTAL PROTOCOLS 
B.1 CG Suspension Preparation Protocol 
 
Reference: (Yannas, Lee et al. 1989; O'Brien, Harley et al. 2004; Caliari and Harley in 
preparation) 
 
Reagents 
• Collagen from bovine Achilles tendon (Sigma-Aldrich C9879); store at 4oC 
• Chondroitin sulfate sodium salt from shark cartilage (Sigma-Aldrich C4384); store at 4oC 
• Glacial acetic acid (Sigma-Aldrich 71251) 
• Ethylene glycol (VWR BDH1125-4LP) 
• Deionized water 
 
Supplies and equipment 
• Recirculating chiller (Fisher Isotemp Model 900) 
• Rotor-stator (IKA 0593400) 
• Disperser (IKA 3565001) 
• Jacketed beaker (Ace Glass 5340-115) 
• Freeze-dryer (VirTis Genesis) 
• Beakers 
• Parafilm 
 
Procedure 
*This procedure describes how to make 300 mL of 0.5% CG suspension. Scale collagen and 
GAG content appropriately to create different volumes of suspension. 
 
1) Fill recirculating chiller with a 50/50 mix of ethylene glycol and deionized water, making sure 
that the cooling coils are completely immersed in the liquid. Set the recirculating chiller to 4oC. 
 
2) Attach recirculating chiller to jacketed beaker and give 20-30 min for temperature to 
equilibrate to 4oC. Maintaining this temperature is important, as it will prevent the collagen from 
denaturing during the blending process. 
 
3) Prepare a 0.05 M solution of acetic acid by adding 0.87 mL of glacial acetic acid to 300 mL of 
deionized water. 
 
4) Weigh 1.5 g of collagen and add to the jacketed beaker.  
 
5) Pour 250 mL of the 0.05 M acetic acid into the jacketed beaker. 
 
6) Assemble the rotor-stator and attach it to the disperser. Lower the rotor-stator into the 
suspension. The rotor-stator should be vertical and centered in the beaker. 
 
7) Blend the suspension at 15,000 rpm for 90 min at 4oC. The height of the rotor-stator may need 
to be adjusted during the blending process: If the rotor-stator is positioned too high, the holes on 
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its side will be visible; if it is too low, the suspension will bubble excessively. Periodically check 
to see if the rotor-stator is clogged with collagen; remove clogs with a spatula as needed. 
 
8) Add 50 mL of 0.05 M acetic acid to a 50 mL centrifuge tube. Weigh out 0.133 g of 
chondroitin sulfate (GAG) and add to the centrifuge tube. Vortex until the GAG is fully 
dissolved. Let the GAG solution rest in the refrigerator (4oC) for 10 min. 
 
9) Add the GAG solution drop-wise to the collagen suspension while it is being mixed at 15,000 
rpm at 4oC. It may be necessary to stop and unclog the rotor-stator with a spatula during this 
process.  
 
10) Once all of the GAG solution has been added, blend at 15,000 rpm for 90 min at 4oC. 
Periodically check to ensure the rotor-stator is lowered to the correct depth, as the suspension 
will gradually become less viscous and creep up the sides of the jacketed beaker. Periodically 
check to see if the rotor-stator is clogged; remove clogs with a spatula as needed. 
 
11) Store the suspension for 18-22 h at 4°C. 
 
12) Degas the suspension to remove any air bubbles prior to use. It is recommended to degas 
approximately 20 mL at a time, until the solution starts to boil, covering when necessary. 
 
13) Store the suspension at 4oC. Periodically check the CG suspension; if not homogenous, re-
blend at 15,000 rpm for 30 min at 4oC. 
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B.2 CG Membrane Fabrication Protocol 
 
Reference: (Caliari, Ramirez et al. in preparation) 
 
Reagents 
• CG suspension; store at 4oC 
 
Supplies and equipment 
• Chemical fume hood (Lab Fabricators Company) 
• Freeze-dryer (VirTis Genesis) 
• Petri dishes (100 mm diameter) 
• Beakers 
• Parafilm 
 
Procedure 
*This procedure describes how to make 1x volume membranes. Scale suspension volume and 
solids content to adjust final membrane thickness. 
 
1) Degas CG suspension in Parafilm-covered beaker by pulling vacuum inside freeze-dryer to 
remove all air bubbles. 
 
2) Carefully pipette 25 mL of degassed suspension inside Petri dish. 
  
3) Leave open Petri dish to dry in chemical fume hood for 3-4 days. Cover Petri dish once the 
membrane is dry and store at room temperature until use. 
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B.3 Aligned CG Scaffold Fabrication Protocol 
 
Reference: (Caliari and Harley in preparation; Caliari, Ramirez et al. in preparation) 
 
Reagents 
• CG suspension; store at 4oC 
• Welch DirecTorr Gold synthetic pump oil (Fisher 01-184-105) 
 
Supplies and equipment 
• Freeze-dryer (VirTis Genesis) 
• PTFE-copper freeze-drying mold 
• Beakers 
• Parafilm 
• Aluminum foil 
 
Procedure 
*This procedure describes the fabrication of 15 mm tall aligned scaffolds (with and without 
membrane shells). Check that oil is clean (not yellow) before and after each freeze-dryer run, 
replacing when necessary. 
 
1) Degas CG suspension in Parafilm-covered beaker by pulling vacuum inside freeze-dryer to 
remove all air bubbles. 
 
2) Begin to cool freeze-dryer shelves by running 'Tf = xx C shelf cool' program where xx is the 
desired freezing temperature (-10, -40, or -60°C). 
 
3) If making scaffold-membrane composites, cut membranes to size, roll, and place in PTFE-
copper freeze-drying mold holes. 
 
4) Pipette 970 µL (8 mm diameter holes) or 540 µL (6 mm diameter holes) of suspension into 
each hole in PTFE-copper freeze-drying mold. For scaffold-membrane composites, allow 
suspension to hydrate membranes for 15-30 min.  
 
5) Cancel shelf cool program and place freeze-dryer mold on the pre-cooled shelf. Shut the 
freeze-dryer door and run program 'Aligned Tf = xx' where xx is the desired freezing temperature 
(-10, -40, or -60°C). A typical freeze-drying schedule is shown for the fabrication of an aligned -
60°C scaffold: 
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Step Temperature 
°C 
Time, min Ramp/Hold Vacuum 
level, torr 
PCM 
Freezing hold -60 60 H ~600 N/A 
Drying ramp 0 60 R 0.2 150 
Drying hold 0 5 H 0.2 1 
Extra drying 0 60 H 0.2 0 
Storage ramp 20 20 R 0.2 0 
Storage hold 20 indefinite H 0.2 0 
 
PCM refers to the minimum reading difference between the Pirani and capacitance manometer 
pressure gauges that must be achieved before the program proceeds to the next step. In Pirani 
gauges, a filament in the gauge is heated so that it is at a constant temperature at a given 
pressure. As the pressure increases or decreases, the amount of gas molecule collisions with the 
filament will change accordingly. More collisions remove more heat from the filament, which 
lowers the temperature and changes the resistance of the filament. This change in resistance is 
converted to an output pressure. Pirani gauges are accurate to within around 7-8%. Capacitance 
manometers operate on the principle of a diaphragm held at a very low reference pressure (10-7 
mbar) that is deflected by changing pressure. This deflection changes the capacitance between 
the diaphragm and an electrode. This change is converted to pressure. These gauges are 
extremely accurate (1%). These gauges will read different pressures because they operate on 
very different principles.  The capacitance manometer is more accurate because it reads pressure 
independent of the type of gas present. In contrast, the temperature of the filament in the Pirani 
gauge is affected by the thermal conductivity of the colliding gas molecules. For example, the 
thermal conductivity of water vapor is higher than that of air, so for an equal number of water 
vapor and air molecules colliding with the filament the water vapor will remove more heat, 
causing the Pirani gauge to read a higher pressure than the true pressure. Once all of the water 
vapor is removed the differential between the two gauges should read about the same, indicating 
that the scaffolds are dry. 
 
6) Once the program has reached the storage hold stage, the program can be cancelled and 
scaffolds can be removed from the freeze-dryer. 
 
7) Allow scaffolds to sit in mold at room temperature for at least 1 h before carefully removing 
them with forceps and placing in an aluminum foil pouch. Label pouch with name, collagen type, 
collagen concentration, freeze date, freeze temperature, and any other relevant notes. 
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B.4 DHT Crosslinking Protocol 
 
Reference: (Yannas, Lee et al. 1989; Harley, Leung et al. 2007) 
 
Supplies and equipment 
• Sterile air filter (Millipore SLGP033RS) 
• Vacuum oven (Welch Vacuum, Fisher 13-262-52) 
 
Procedure 
*Note: vacuum pump oil levels and integrity of vacuum fittings should be checked periodically. 
Also, change sterile air filter on 'Purge' line regularly. 
 
1) Turn on vacuum oven and set desired temperature (usually 105°C). 
 
2) Once vacuum oven has reached temperature set point, place scaffolds in opened aluminum 
pouches carefully inside the oven. Close the oven door. 
 
3) Completely open the 'Vacuum' valve on the lower right front face of the vacuum oven while 
completely closing the 'Purge' valve. 
 
4) Turn on the vacuum pump and make sure vacuum is pulled to a sufficiently low level (< 1 in 
Hg). Allow scaffolds to crosslink for 24 h. 
 
5) After crosslinking is complete turn off the vacuum pump, close the 'Vacuum' valve, open the 
'Purge' valve, carefully remove scaffolds from the oven, and seal the aluminum pouches. Store 
sealed scaffolds (now sterile) in desiccator until time of use.  
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B.5 EDAC Crosslinking Protocol 
 
Reference: (Olde Damink, Dijkstra et al. 1996; Harley, Leung et al. 2007; Caliari, Ramirez et al. 
in preparation) 
 
Reagents 
• 1-ethyl-3-[3-dimethylaminopropyl]carbodiimide hydrochloride (EDAC, Sigma-Aldrich 
E7750); store at -20oC 
• N-hydroxysulfosuccinimide (NHS, Sigma-Aldrich H7377); store in desiccator 
• Sterile phosphate-buffered saline (PBS) 
• Sterile water 
• 100% ethanol 
 
Supplies and equipment 
• 6-well plates (Fisher 08-772-1B) 
• 50 mL centrifuge tubes (Fisher 14-432-22) 
• Syringe and syringe filter (Fisher 148232A) 
• MTS 2/4 digital microtiter shaker (IKA 3208001) 
• Dual range balance (Mettler Toledo XS105) 
• Razor blades  
 
Procedure 
* Note: all steps should be performed in the laminar flow hood unless otherwise noted. 
 
1) Cut scaffold or membrane samples to be crosslinked using a razor blade. 
 
2) Transfer scaffold or membrane pieces to sterile centrifuge tube, remove from laminar flow 
hood, and weigh pieces on dual range balance. 
 
3) Hydrate pieces in 100% ethanol overnight. 
 
4) Rinse pieces several times in PBS and then let soak in PBS for 24 h before crosslinking. 
 
5) Determine the EDAC and NHS concentrations to be used in crosslinking solution. The sample 
calculations in this protocol are done with a 5:2:1 EDAC:NHS:COOH molar ratio where COOH 
is carboxylic acid groups in CG material based on a conversion factor of 1.2 mmol COOH per 
gram of collagen (Olde Damink, Dijkstra et al. 1996). The mass of EDAC and NHS required can 
be calculated as follows: 
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6) Mix the EDAC and NHS in sterile water. Approximately 1 mL of solution will be needed per 
scaffold piece (6-8 mm diameter, 3-5 mm thick).  
 
7) In the laminar flow hood, sterile filter the solution and add to 6-well plates. 
 
8) Add scaffolds in crosslinking solution and place well plate on digital microtiter shaker in 
incubator at 37oC. Allow scaffolds to crosslink under moderate shaking for 30-120 min. 
Crosslinking time should be increased for less permeable constructs such as membranes and high 
solids content scaffolds. 
 
9) Remove EDAC/NHS solution and rinse scaffolds in sterile PBS under moderate shaking for 
10-15 min. 
 
10) Remove first PBS wash solution and rinse scaffolds in fresh PBS under moderate shaking for 
an additional 30-45 min. Store in fresh sterile PBS until use. 
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B.6 Scaffold Glycolmethacrylate Embedding Protocol 
 
Reference: (O'Brien, Harley et al. 2004; O'Brien, Harley et al. 2005; Caliari and Harley in 
preparation) 
 
Reagents 
• JB-4 embedding solution A (100 mL); store at 4oC for up to 1 week 
100 mL JB-4 embedding solution A (monomer) (Polysciences 0226A-800) 
1.25 g JB-4 catalyst (benzoyl peroxide, plasticized) (Polysciences 02618-12); 
store at 4oC 
• JB-4 embedding solution B (accelerator) (Polysciences 0226B-30) 
• 100% ethanol 
 
Supplies and equipment 
• Polyethylene molding cup trays (Polysciences 16643A-1) 
• JB-4 plastic block holders (Polysciences 15899-50) 
• DryFast vacuum pump (Welch Vacuum 2014B-01) 
• Pyrex desiccator (Fisher 08-626B) 
• Serological pipettes (Fisher 13-678-14B) 
• 6-well plates (08-772-1B) 
• Chemical fume hood (Lab Fabricators Company) 
• Razor blades 
 
Procedure 
 
1) Cut scaffold pieces to be analyzed using a razor blade. 15 mm aligned scaffolds are typically 
cut in thirds. Both transverse and longitudinal sections should be cut for analysis. 
 
2) Place samples in 6-well plates and hydrate in 100% ethanol under vacuum inside desiccator 
for 24 h. 
 
3) Add hydrated samples to JB-4 embedding solution A under vacuum inside desiccator at 4oC. 
After 24 h, replace with fresh JB-4 embedding solution A and hold under vacuum inside 
desiccator at 4oC for an additional 48 h. 
 
4) Mix 25 mL of JB-4 embedding solution A with 1 mL of JB-4 B solution and pipette ~3.5 mL 
into each well of the plastic embedding mold. 
 
5) Place each sample into a well. The JB-4 mixture will polymerize quickly (~30 min) so make 
sure the samples stay in the proper orientation.  
 
6) Place one labeled plastic stub in each well once the JB-4 mixture has become sufficiently 
viscous that the stubs don't completely sink.  
 
7) Keep embedding mold at 4oC overnight to allow polymerization to complete. Store samples at 
4oC until use. 
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B.7 Scaffold Pore Size Analysis: Aniline Blue Staining, Image Acquisition, and Linear 
Intercept Analysis Protocol 
 
Reference: (O'Brien, Harley et al. 2004; O'Brien, Harley et al. 2005; Caliari and Harley in 
preparation) 
 
Reagents 
• Aniline blue solution (100 mL) 
2.5 g aniline blue (Fisher AC40118-0250) 
2 mL glacial acetic acid (Sigma-Aldrich 71251) 
100 mL deionized water 
Mix well, filter before use 
• 1% Acetic acid (100 mL) 
1 mL glacial acetic acid (Sigma-Aldrich 71251) 
99 mL deionized water 
• Permount mounting medium (Fisher SP15-100) 
• 95%, 100% ethanol 
 
Supplies and equipment 
• Optical microscope with camera (Leica Microsystems DMIL LED with DFC295 camera) 
• Scion Image analysis software (Scion Co) 
• Beakers 
• Cover slips 
 
Aniline blue staining procedure 
 
1) Obtain slides of serially sectioned embedded scaffolds from histologist. 
 
2) Dip slides in aniline blue solution for 2-4 min. Analyze in groups of 12-18 slides. 
 
3) Place slides in 1% acetic acid for 1 min. 
 
4) Dip each slide several times in 95% ethanol until most of background staining goes away. 
 
5) Dip each slide several times in 100% ethanol to complete rinse and allow slides to dry. 
 
6) Mount each sample with 1 drop of Permount per slide section. Firmly press cover slip onto 
slide so as not to introduce any air bubbles. Allow slides to dry for 24 h before further analysis. 
 
Image acquisition procedure 
 
1) Visualize embedded, sectioned, and stained scaffold samples using optical microscope. 
 
2) Acquire three tiff images for each transverse section and two images for each smaller 
longitudinal section using camera.  
 
 171 
Linear intercept analysis procedure 
 
1) Transfer images for analysis to a folder with a short path length from C.  
 
2) Open Scion Image. Under 'Special' menu select 'Load macros' and open the 'pore 
characterization macros Steven' file. 
 
3) Open tiff file in Scion Image. Under 'Edit' menu, select 'Invert,' then under 'Options' menu 
select 'Threshold.' Adjust the threshold values to optimize the visualization of the scaffold strut 
network. Any extraneous spots can be cleaned with eraser tool although no artifacts under 5 
pixels will be detected by the pore analysis macro. 
 
4) Under the 'Process' menu select 'Make Binary' under 'Binary' sub-menu. Save the edited tiff 
file. 
 
5) Under the 'Analysis' menu select 'Set Scale.' For images taken at 4x magnification the correct 
scale is 347 pixels per mm. At 10x magnification the scale is 867 pixels per mm.  
 
6) Select an area of the image to be analyzed with the oval drawing tool. Try to select as much of 
the viable image as possible. 
 
7) Under the 'Special' menu, run the 'Linear Intercept' macro. The distance between the pore 
walls along lines at five degree angle increments from the center of the selected region are 
calculated. Next, run the 'Plot Intercepts' macro. This macro transforms the average distance 
between struts to a best-fit ellipse and calculates linear intercept coefficients C0, C1, and C2 for 
the ellipse. 
 
8) Transfer C0, C1, and C2 data to spreadsheet to calculate minor (a) and major (b) axes of best-
fit ellipse using the following equations: 
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a
boAspectRati =                                                                                                       (Equation B.5) 
 
9) Calculate the mean pore size (d) from values of the major and minor axes of the best-fit 
ellipse. To account for the fact that pores were not sectioned through their maximal cross-section 
the mean pore size is corrected by a factor of 1.5. To convert the pore radius to diameter the 
mean pore size is additionally multiplied by 2 for a total correction factor of 3: 
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Linear intercept macro code 
 
macro 'Linear Draw' 
{This macro is used for testing different line drawing routines for use  
with the macro 'Linear Intercept'} 
var 
  left,top,width,height,MinDim,nx,ny,i,j,k:integer; 
  ThetaStep,NSteps,PI,x1,x2,y1,y2,dy,dx:real; 
  Theta,valx,valy,plength,scale,AspectRatio:real; 
   IntLength,LineSum:real; 
  Intercepts:integer; 
   switch,indicator:boolean; 
   unit:string; 
begin 
   GetRoi(left,top,width,height); 
   if width=0 then begin 
      PutMessage('Selection required.'); 
      exit; 
   end; 
   if width<height  then MinDim:=width 
      else MinDim:=height; 
   PI:=3.141592654; 
   GetScale(scale,unit,AspectRatio); 
   NSteps:=GetNumber('Enter theta steps between 0 and 90 deg.',3,0); 
   ThetaStep:=PI/(2*NSteps); 
   for j:=0 to 2*NSteps-1 do begin 
      x1:=left; 
      y1:=top; 
     Theta:=j*ThetaStep; 
     nx:=5*sin(Theta)*width/height; 
     ny:=5*abs(cos(Theta)); 
     for i:=0 to nx do begin 
        if Theta=0 then begin 
                     x1:=left; 
                     x2:=x1+width; 
        end  else begin 
                     x1:=left+(width*i/(nx+1))+width/(2*(nx+1)); 
                     x2:=x1+(height*cos(Theta)/sin(Theta)); 
                  end; 
        y2:=top+height; 
        if x2>=left+width then begin 
           x2:=left+width; 
           y2:=y1+(x2-x1)*sin(Theta)/cos(Theta); 
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        end  else if x2<left then begin 
                             x2:=left; 
                            if Theta>PI/2 then y2:=y1+(x2-x1)*sin(Theta)/cos(Theta); 
                           end; 
         {plength is the length of the line to be drawn in pixels} 
        plength:=sqrt(sqr(x2-x1)+sqr((y2-
y1)/AspectRatio)); 
        valx:=x1; 
        valy:=y1; 
        dx:=(x2-x1)/plength; 
        dy:=(y2-y1)/plength; 
        switch:=true; 
        if plength>=MinDim then begin 
           for k:=0 to plength do  
               PutPixel(x1+k*dx,y1+k*dy,255); 
         end; 
     end; 
     for i:=1 to ny do begin 
        if Theta<=PI/2 then begin 
                   x1:=left; 
                   x2:=left+width 
          end  else begin 
                   x1:=left+width; 
                   x2:=left; 
          end; 
        y1:=top+height*i/(ny+1); 
        y2:=y1+(width*sin(Theta)/abs(cos(Theta))); 
        if y2>top+height then begin 
           y2:=top+height; 
           x2:=x1+((y2-y1)*cos(Theta)/sin(Theta)); 
         end; 
         {plength is the length of the line to be drawn in pixels} 
        plength:=sqrt(sqr(x2-x1)+sqr((y2-
y1)/AspectRatio)); 
        valx:=x1; 
        valy:=y1; 
        dx:=(x2-x1)/plength; 
        dy:=(y2-y1)/plength; 
        switch:=true; 
        if plength>=MinDim then begin 
           for k:=0 to plength do  
              PutPixel(x1+k*dx,y1+k*dy,255); 
        end;  {if} 
     end;{i}              
   end; {j} 
end; 
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macro 'Linear Intercept' 
{This macro measures the linear intercept distance over a giver ROI 
at intervals of angle} 
var 
  left,top,width,height,MinDim,nx,ny,i,j,k:integer; 
  ThetaStep,NSteps,PI,x1,x2,y1,y2,dy,dx:real; 
  Theta,valx,valy,plength,scale,AspectRatio:real; 
   IntLength,LineSum,dummy:real; 
  Intercepts:integer; 
   switch,indicator:boolean; 
   unit:string; 
begin 
   SetOptions('User1;User2'); 
   GetRoi(left,top,width,height); 
   if width=0 then begin 
      PutMessage('Selection required.'); 
      exit; 
   end; 
   if width<height  then MinDim:=width 
      else MinDim:=height; 
   PI:=3.141592654; 
   GetScale(scale,unit,AspectRatio); 
   NSteps:=18;{GetNumber('Enter # steps between 0 and 90 deg.',3,0);} 
   ThetaStep:=PI/(2*NSteps); 
 
{block out next line when doing cumulative measurements} 
 
   SetCounter(2*NSteps); 
   SetUser1Label('Theta(rad)'); 
   SetUser2Label('Lx10^3'); 
   for j:=0 to 2*NSteps-1 do begin 
      LineSum:=0; 
      Intercepts:=0; 
      x1:=left; 
      y1:=top; 
     Theta:=j*ThetaStep; 
     nx:=10*sin(Theta)*width/height; 
     ny:=10*abs(cos(Theta)); 
      for i:=0 to nx do begin 
        if Theta=0 then begin 
                     x1:=left; 
                     x2:=x1+width; 
        end  else begin 
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                     x1:=left+(width*i/(nx+1))+width/(2*(nx+1)); 
                     x2:=x1+(height*cos(Theta)/sin(Theta)); 
                  end; 
        y2:=top+height; 
        if x2>=left+width then begin 
           x2:=left+width; 
           y2:=y1+(x2-x1)*sin(Theta)/cos(Theta); 
        end  else if x2<left then begin 
                             x2:=left; 
                            if Theta>PI/2 then   y2:=y1+(x2-x1)*sin(Theta)/cos(Theta); 
                           end; 
         {plength is the length of the line to be drawn in pixels} 
        plength:=sqrt(sqr(x2-x1)+sqr((y2-
y1)/AspectRatio)); 
        valx:=x1; 
        valy:=y1; 
        dx:=(x2-x1)/plength; 
        dy:=(y2-y1)/plength; 
        switch:=true; 
        if plength>=MinDim then begin 
        LineSum:=LineSum+(plength/scale); 
           for k:=0 to plength do begin 
               if GetPixel(x1+k*dx,y1+k*dy)>0  
                    then indicator:=true 
                    else indicator:=false; 
               if (switch=true) and (indicator=true) then begin 
                   Intercepts:=Intercepts+1; 
                   switch:=false; 
               end; 
               if  (indicator=false) then switch:=true; 
           end; 
       end; 
     end; 
    for i:=1 to ny do begin 
        if Theta<=PI/2 then begin 
                   x1:=left; 
                   x2:=left+width 
          end  else begin 
                   x1:=left+width; 
                   x2:=left; 
          end; 
        y1:=top+height*i/(ny+1); 
        y2:=y1+(width*sin(Theta)/abs(cos(Theta))); 
        if y2>top+height then begin 
           y2:=top+height; 
           x2:=x1+((y2-y1)*cos(Theta)/sin(Theta)); 
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         end; 
         {plength is the length of the line to be drawn in pixels} 
        plength:=sqrt(sqr(x2-x1)+sqr((y2-
y1)/AspectRatio)); 
        valx:=x1; 
        valy:=y1; 
        dx:=(x2-x1)/plength; 
        dy:=(y2-y1)/plength; 
        switch:=true; 
        if plength>=MinDim then begin 
        LineSum:=LineSum+(plength/scale); 
           for k:=0 to plength do begin 
               if GetPixel(x1+k*dx,y1+k*dy)>0  
                    then indicator:=true 
                    else indicator:=false; 
               if (switch=true) and (indicator=true) then begin 
                   Intercepts:=Intercepts+1; 
                   switch:=false; 
               end; 
               if  (indicator=false) then switch:=true; 
           end; 
       end; 
     end;{i} 
    IntLength:=LineSum/Intercepts; 
   dummy:=rUser2[j+1]; 
    rUser1[j+1]:=180*Theta/PI; 
 
{to do cumulative measurements, type in 'dummy+ before Intlength in the next line} 
 
    rUser2[j+1]:=IntLength*1000; 
   end; {j} 
   ShowResults; 
end; 
 
macro 'Linear Intercept +' 
{This macro measures the linear intercept distance over a giver ROI 
at intervals of angle} 
var 
  left,top,width,height,MinDim,nx,ny,i,j,k:integer; 
  ThetaStep,NSteps,PI,x1,x2,y1,y2,dy,dx:real; 
  Theta,valx,valy,plength,scale,AspectRatio:real; 
   IntLength,LineSum,dummy:real; 
  Intercepts:integer; 
   switch,indicator:boolean; 
   unit:string; 
begin 
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   SetOptions('User1;User2'); 
   GetRoi(left,top,width,height); 
   if width=0 then begin 
      PutMessage('Selection required.'); 
      exit; 
   end; 
   if width<height  then MinDim:=width 
      else MinDim:=height; 
   PI:=3.141592654; 
   GetScale(scale,unit,AspectRatio); 
   NSteps:=18;{GetNumber('Enter # steps between 0 and 90 deg.',3,0);} 
   ThetaStep:=PI/(2*NSteps); 
 
{block out next line when doing cumulative measurements} 
 
   {SetCounter(2*NSteps);} 
   SetUser1Label('Theta(rad)'); 
   SetUser2Label('Lx10^3'); 
   for j:=0 to 2*NSteps-1 do begin 
      LineSum:=0; 
      Intercepts:=0; 
      x1:=left; 
      y1:=top; 
     Theta:=j*ThetaStep; 
     nx:=10*sin(Theta)*width/height; 
     ny:=10*abs(cos(Theta)); 
      for i:=0 to nx do begin 
        if Theta=0 then begin 
                     x1:=left; 
                     x2:=x1+width; 
        end  else begin 
                     x1:=left+(width*i/(nx+1))+width/(2*(nx+1)); 
                     x2:=x1+(height*cos(Theta)/sin(Theta)); 
                  end; 
        y2:=top+height; 
        if x2>=left+width then begin 
           x2:=left+width; 
           y2:=y1+(x2-x1)*sin(Theta)/cos(Theta); 
        end  else if x2<left then begin 
                             x2:=left; 
                            if Theta>PI/2 then   y2:=y1+(x2-x1)*sin(Theta)/cos(Theta); 
                           end; 
         {plength is the length of the line to be drawn in pixels} 
        plength:=sqrt(sqr(x2-x1)+sqr((y2-
y1)/AspectRatio)); 
        valx:=x1; 
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        valy:=y1; 
        dx:=(x2-x1)/plength; 
        dy:=(y2-y1)/plength; 
        switch:=true; 
        if plength>=MinDim then begin 
        LineSum:=LineSum+(plength/scale); 
           for k:=0 to plength do begin 
               if GetPixel(x1+k*dx,y1+k*dy)>0  
                    then indicator:=true 
                    else indicator:=false; 
               if (switch=true) and (indicator=true) then begin 
                   Intercepts:=Intercepts+1; 
                   switch:=false; 
               end; 
               if  (indicator=false) then switch:=true; 
           end; 
       end; 
     end; 
    for i:=1 to ny do begin 
        if Theta<=PI/2 then begin 
                   x1:=left; 
                   x2:=left+width 
          end  else begin 
                   x1:=left+width; 
                   x2:=left; 
          end; 
        y1:=top+height*i/(ny+1); 
        y2:=y1+(width*sin(Theta)/abs(cos(Theta))); 
        if y2>top+height then begin 
           y2:=top+height; 
           x2:=x1+((y2-y1)*cos(Theta)/sin(Theta)); 
         end; 
         {plength is the length of the line to be drawn in pixels} 
        plength:=sqrt(sqr(x2-x1)+sqr((y2-
y1)/AspectRatio)); 
        valx:=x1; 
        valy:=y1; 
        dx:=(x2-x1)/plength; 
        dy:=(y2-y1)/plength; 
        switch:=true; 
        if plength>=MinDim then begin 
        LineSum:=LineSum+(plength/scale); 
           for k:=0 to plength do begin 
               if GetPixel(x1+k*dx,y1+k*dy)>0  
                    then indicator:=true 
                    else indicator:=false; 
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               if (switch=true) and (indicator=true) then begin 
                   Intercepts:=Intercepts+1; 
                   switch:=false; 
               end; 
               if  (indicator=false) then switch:=true; 
           end; 
       end; 
     end;{i} 
    IntLength:=LineSum/Intercepts; 
   dummy:=rUser2[j+1]; 
    rUser1[j+1]:=180*Theta/PI; 
 
{to do cumulative measurements, type in 'dummy+ before Intlength in the next line} 
 
    rUser2[j+1]:=dummy+IntLength*1000; 
   end; {j} 
   ShowResults; 
end; 
 
Macro 'Plot Intercepts' 
{This macro plots the linear intercept distance as a function of angle 
in cylindrical coordinates 
It then finds the best-fit ellipse to a set of linear intercept distance vs. angle data 
using multiple linear regression of the equation Y=C0+C1*X+C2*Z, where 
Y=1/L^2 ,  where L is one half  the linear intercept distance at Theta 
X=cosine(2*Theta),    Z=sine(2*Theta) 
C0=(Mii+Mjj)/2 , C1=(Mii-Mjj)/2 , C2=Mij. 
The objective is to solve for M11, Mjj, and Mij 
The best-fit ellipse it then plotted on top of the linear intercept measurements} 
 
var 
   left,top,width,height,X0,Y0,X1,Y1,i,n:integer; 
   pscale,aspectRatio,dx1,dx2,dy1,dy2,maxdim:real; 
   unit:string; 
  sumX,sumY,sumZ,sumXZ,sumXY,sumYZ,sumZsqr,sumXsqr:real; 
  C0,C1,C2,Mii,Mjj,Mij,Y,X,Z,PI,Theta1,Theta2,L1,L2:real; 
  
begin  
  PI:=3.141592654; 
 SaveState; 
  SetForegroundColor(255); 
  SetBackgroundColor(0); 
  width:=400; 
  height:=400; 
  maxdim:=0; 
  for i:=1 to rCount do begin 
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     if rUser2[i]>maxdim then maxdim:=rUser2[i]; 
  end; 
  pscale:=.8*(width+height)/(2*maxdim); 
  SetNewSize(width,height); 
  MakeNewWindow('Linear Intercepts vs. Theta'); 
  SetLineWidth(1); 
  X0:=(width/2); 
  Y0:=(height/2); 
  MakeLineROI(0,Y0,width,Y0); 
  Fill; 
  MakeLineROI(X0,0,X0,height); 
  Fill; 
   for i:=1 to rCount do begin 
     dx1:=pscale*0.5*rUser2[i]*cos(rUser1[i]*PI/180); 
     dy1:=pscale*0.5*rUser2[i]*sin(rUser1[i]*PI/180); 
     if i<rCount then begin 
        dx2:=pscale*0.5*rUser2[i+1]*cos(rUser1[i+1]*PI/180); 
        dy2:=pscale*0.5*rUser2[i+1]*sin(rUser1[i+1]*PI/180); 
     end else begin 
        dx2:=-pscale*0.5*rUser2[1]*cos(rUser1[1]*PI/180); 
        dy2:=-pscale*0.5*rUser2[1]*sin(rUser1[1]*PI/180);     
     end; 
     MoveTo(X0+dx1,Y0+dy1); 
     LineTo(X0+dx2,Y0+dy2); 
     MoveTo(X0-dx1,Y0-dy1); 
     LineTo(X0-dx2,Y0-dy2); 
  end; 
  n:=rCount; 
  sumX:=0; 
  sumY:=0; 
  sumZ:=0; 
  sumXY:=0; 
  sumYZ:=0;   
  sumXZ:=0; 
  sumZsqr:=0; 
  sumXsqr:=0; 
  for i:=1 to n do begin 
     Y:=1/(sqr(rUser2[i]/2)); 
     X:=cos(2*PI*rUser1[i]/180); 
     Z:=sin(2*PI*rUser1[i]/180); 
     sumX:=sumX+X; 
     sumY:=sumY+Y; 
     sumZ:=sumZ+Z; 
     sumXY:=sumXY+(X*Y); 
     sumYZ:=sumYZ+(Y*Z);   
     sumXZ:=sumXZ+(X*Z); 
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     sumZsqr:=sumZsqr+sqr(Z); 
     sumXsqr:=sumXsqr+sqr(X); 
  end; 
  C1:=((sumXY*sumZsqr)-(sumXZ*sumYZ))/((sumXsqr*sumZsqr)-sqr(sumXZ)); 
  C2:=((sumYZ*sumXsqr)-(sumXY*sumXZ))/((sumXsqr*sumZsqr)-sqr(sumXZ)); 
  C0:=(sumY/n)-C1*(sumX/n)-C2*(sumZ/n); 
  for i:=1 to rCount do begin 
     Theta1:=rUser1[i]*PI/180; 
     if i<rCount then Theta2:=rUser1[i+1]*PI/180 
      else Theta2:=rUser1[1]*PI/180; 
     L1:=1/sqrt(C0+C1*cos(2*Theta1)+C2*sin(2*Theta1)); 
     L2:=1/sqrt(C0+C1*cos(2*Theta2)+C2*sin(2*Theta2)); 
     dx1:=pscale*L1*cos(Theta1); 
     dy1:=pscale*L1*sin(Theta1); 
     if i<rCount then begin 
        dx2:=pscale*L2*cos(Theta2); 
        dy2:=pscale*L2*sin(Theta2); 
      end else begin 
        dx2:=-pscale*L2*cos(Theta2); 
        dy2:=-pscale*L2*sin(Theta2); 
     end; 
     MoveTo(X0+dx1,Y0+dy1); 
     LineTo(X0+dx2,Y0+dy2); 
     MoveTo(X0-dx1,Y0-dy1); 
     LineTo(X0-dx2,Y0-dy2); 
  end; 
NewTextWindow('Results'); 
write(C0:8:8', '); 
write(C1:8:8', '); 
write(C2:8:8); 
end; 
 
 
macro 'Count Black and White Pixels [B]'; 
{ 
Counts the number of black and white pixels in the current 
selection and stores the counts in the User1 and User2 columns. 
} 
begin 
  RequiresVersion(1.44); 
  SetUser1Label('Black'); 
  SetUser2Label('White'); 
  Measure; 
  rUser1[rCount]:=histogram[255]; 
  rUser2[rCount]:=histogram[0]; 
  UpdateResults; 
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end; 
 
 
macro 'Compute Percent Black and White'; 
{ 
Computes the percentage of back and white pixels in the 
current selection. This macro only works with binary images. 
} 
var 
  nPixels,mean,mode,min,max:real; 
begin 
  RequiresVersion(1.44); 
  SetUser1Label('Black'); 
  SetUser2Label('White'); 
  Measure; 
  GetResults(nPixels,mean,mode,min,max); 
  rUser1[rCount]:=histogram[255]/nPixels; 
  rUser2[rCount]:=histogram[0]/nPixels; 
  UpdateResults; 
  if (histogram[0]+histogram[255])<>nPixels 
    then PutMessage('This macro requires a binary image.'); 
end; 
 
 
macro 'Compute Area Percentage [P]'; 
{ 
Computes the percentage of foreground 
pixels in the current selection. 
} 
var 
  mean,mode,min,max:real; 
  i,lower,upper,fPixels,nPixels,count:integer; 
begin 
  RequiresVersion(1.50); 
  SetUser1Label('%'); 
  Measure; 
  GetResults(nPixels,mean,mode,min,max); 
  GetThresholds(lower,upper); 
  if (lower=0) and (upper=0) and  
     ((histogram[0]+histogram[255])<>nPixels) 
     then begin 
       PutMessage('This macro requires a binary or thresholded image.'); 
       exit; 
     end; 
  if nPixels=0 then begin 
  end; 
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  if (lower=0) and (upper=0) then begin 
    if nPixels=0 
      then rUser1[rCount]:=0 
      else rUser1[rCount]:=(histogram[255]/nPixels)*100; 
    UpdateResults; 
    exit; 
  end; 
  fPixels:=0; 
  nPixels:=0; 
  for i:=0 to 255 do begin 
    count:=histogram[i]; 
    nPixels:=nPixels+count; 
    if (i>=lower) and (i<=upper) 
      then fPixels:=fPixels+count; 
  end; 
  rUser1[rCount]:=(fPixels/nPixels)*100; 
  UpdateResults; 
end; 
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B.8 Incubator Disinfection Protocol 
 
Reagents 
• Steris staphene spray (Fisher 14-415-15) 
• 70% ethanol 
 
Procedure 
 
1) Shut off the CO2 tanks and turn off the incubator. 
 
2) Prepare the sterile hood by covering the inside with bench-coat. 
 
3) Cover the chemical fume hood with fresh bench-coat. 
 
4) Disassemble all removable parts from the incubator chamber. Spray all pieces from the 
incubator inside the chemical fume hood with staphene. Spray the inside of the inside of the 
incubator with staphene. Let stand for 15 min with the incubator door cracked open ~2 in.  
 
5) Spray the inside of the incubator with 70% ethanol. Wipe off the excess staphene with paper 
towels.  
 
6) Spray all internal pieces of the incubator in the chemical fume hood with 70% ethanol and 
wipe off the excess staphene. Spray each part generously with ethanol again and place into the 
sterile hood to dry. Do not wipe anything down. Allow all parts to air dry for 15-30 min.  
 
7) Spray the inside of the incubator with 70% ethanol and allow all parts to dry for 15-30 min; do 
not wipe anything down.  
 
8) Reassemble all internal pieces of the incubator, taking care to move each piece from the sterile 
hood to the incubator as quickly as possible.  
 
9) Spray the inside of incubator again with 70% ethanol. Shut the foot and allow all parts to dry; 
do not wipe anything down.  
 
10) Turn on the incubator power and open the valves on the CO2 tanks. Allow the incubator to 
ventilate with the CO2 on for 24 h before using again.  
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B.9 Tendon Cell Culture Protocol 
 
Reference: (Kapoor, Caporali et al. 2010; Caliari and Harley in preparation; Caliari, Ramirez et 
al. in preparation) 
 
Reagents 
• Complete tendon cell media (500 mL); store at 4oC 
435 mL high glucose DMEM (Fisher SH30022.FS); store at 4oC 
50 mL fetal bovine serum (Invitrogen 16140-071); store at -20oC 
5 mL pen-strep (Invitrogen 15140-122); store at -20oC 
5 mL L-glutamine (Invitrogen 25030-081); store at -20oC 
5 mL amphotericin B solution (MP Biomedical 091672348); store at -20oC 
25 mg ascorbic acid (Wako 014-04801) 
Sterile filter before use 
• Trypsin-EDTA (Invitrogen 25300-062); store at -20oC  
• Trypan blue (Sigma-Aldrich T8154) 
• DMSO (Fisher D128-500) 
• Sterile phosphate-buffered saline without Ca2+ or Mg2+ (PBS)  
 
Supplies and equipment 
• Hausser phase contrast hemacytometer (Fisher 02-671-5) 
• Tabletop centrifuge (VWR 53513-812) 
• Optical microscope (Leica Microsystems DMIL LED) 
• Water bath (37oC, Fisher 15-474-35) 
• Sterile filter 
• Sterile pipettes (5, 10, 25 mL) 
• T75 tissue culture flasks 
 
*Note: all steps should be performed in the laminar flow hood unless otherwise noted. 
 
Tendon cell thawing procedure 
 
1) Place complete tendon cell media in water bath and warm to 37oC. 
 
2) Thaw frozen cell vials in 37oC water bath for about 2 min. 
 
3) Transfer the thawed cells and freezing media to a 15 mL centrifuge tube. Add complete 
tendon cell media until the cerulean effect has dissipated, then bring the volume up to 9 mL. 
 
4) Remove a 10 µL cell suspension aliquot for counting. Gently re-suspend the cells in the 
diluted media and pellet the cells at 1000 rpm for 7 min. 
 
5) While cells are spinning down, mix the 10 µL cell suspension aliquot with 10 µL of Trypan 
blue. Pipette several times to mix the stain and cell suspension.  
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6) Place a cover slip on the hemocytometer and pipette 10 µL of the stain/cell suspension into the 
hemocytometer. 
 
7) Cell counts are performed in as many of the nine separate regions of the hemocytometer as is 
feasible. Average number of cells per region is used to calculate the total cell population. For this 
calculation, the dilution factor is typically 2 (1:1 ratio of cell suspension to Trypan blue). 
 
Total Cell Population = (Mean Cells per Region) * Dilution * 10,000 * (Cell Suspension 
Volume) 
 
8) Seed the cells at the required density (usually 10,000-50,000 cells/cm2). Use around 10-12 mL 
media for a 100 mm dish, 12-14 mL for a T75, or 7-8 mL for a T25. 
 
9) Place the flask(s) into the incubator. Check the confluence every 24 h and feed cells every 48-
72 h. 
 
Tendon cell feeding procedure 
 
1) Warm complete tendon cell media and sterile PBS in water bath to 37oC.  
 
2) When the media and PBS are warm, wipe them dry with paper towel and spray with 70% 
ethanol before placing in the sterile hood.  
 
3) Remove all old media from each T75 flask, taking care not to scrape the cells with the pipette 
tip. 
 
4) Add 10 mL of PBS per T75 flask and leave the PBS in the flask to rinse the cells for 30 s. 
Swirl gently to remove any excess media from the cells. 
 
5) Remove the PBS and add 12-14 mL of complete tendon cell media. Return the T75 flasks to 
the incubator and feed every 48-72 h. Adjust volumes of PBS and media accordingly for 
different sized flasks. 
 
Tendon cell passaging procedure 
 
1) Warm complete tendon cell media, sterile PBS, and 3 mL trypsin-EDTA per T75 flask to be 
passaged in water bath to 37oC.  
 
2) When the media, PBS and trypsin are warm, wipe them dry with paper towel and spray with 
70% ethanol before placing in the sterile hood.  
 
3) Remove all old media from each T75 flask, taking care not to scrape the cells with the pipette 
tip. 
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4) Add 10 mL of PBS per T75 flask and leave the PBS in the flask to rinse the cells for 30 s. 
Swirl gently to remove any excess media from the cells. Adjust volumes of PBS, media, and 
trypsin accordingly for different sized flasks. 
 
5) Remove the PBS and add 3 mL of trypsin per T75 flask. Return the flasks to the incubator for 
6 min to allow for the cells to detach from the tissue culture plastic (allow the cells to sit for 3-4 
additional min in the incubator if they do not detach after 6 min). Slap flasks a few times to 
detach cells. 
 
6) Add 6 mL of complete tendon cell media to each flask to neutralize the trypsin and to flush 
cells off of the tissue culture plastic. 
 
7) Remove the trypsin, additional media, and cells from the flask and put into a conical tube.  
Remove a 10 µL cell suspension aliquot for counting. Centrifuge the cells at 1000 rpm for 7 min.  
 
8) While cells are spinning down, mix the 10 µL cell suspension aliquot with 10 µL of Trypan 
blue. Pipette several times to mix the stain and cell suspension.  
 
9) Place a cover slip on the hemocytometer and pipette 10 µL of the stain/cell suspension into the 
hemocytometer. 
 
10) Cell counts are performed in as many of the nine separate regions of the hemocytometer as is 
feasible. Average number of cells per region is used to calculate the total cell population. For this 
calculation, the dilution factor is typically 2 (1:1 ratio of cell suspension to Trypan blue). 
 
Total Cell Population = (Mean Cells per Region) * Dilution * 10,000 * (Cell Suspension 
Volume) 
 
11) Aspirate off the media supernatant and add new media to dilute cells to desired 
concentration. 
 
12) Seed the cells at the required density (usually 10,000-50,000 cells/cm2). Use around 10-12 
mL media for a 100 mm dish, 12-14 mL for a T75, or 7-8 mL for a T25. 
 
13) Place the flask(s) into the incubator. Check the confluence every 24 h and feed cells every 
48-72 h. 
 
Tendon cell freezing procedure 
 
1) Grow cells to confluence and replace media the day before freezing. 
 
2) Warm complete tendon cell media, sterile PBS, and 3 mL trypsin-EDTA per T75 flask to be 
passaged in water bath to 37oC.  
 
3) When the media, PBS and trypsin are warm, wipe them dry with paper towel and spray with 
70% ethanol before placing in the sterile hood.  
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4) Remove all old media from each flask, taking care not to scrape the cells with the pipette tip. 
 
5) Add 10 mL of PBS per T75 flask and leave the PBS in the flask to rinse the cells for 30 s. 
Swirl gently to remove any excess media from the cells. Adjust volumes of PBS, media , and 
trypsin accordingly for different sized flasks. 
 
6) Remove the PBS and add 3 mL of trypsin per T75 flask. Return the flasks to the incubator for 
6 min to allow for the cells to detach from the tissue culture plastic (allow the cells to sit for 3-4 
additional min in the incubator if they do not detach after 6 min). Slap flasks a few times to 
detach cells. 
 
7) Add 6 mL of complete tendon cell media to each flask to neutralize the trypsin and to flush 
cells off of the tissue culture plastic. 
 
8) Remove the trypsin, additional media, and cells from the flask and put into a conical tube.  
Remove a 10 µL cell suspension aliquot for counting. Centrifuge the cells at 1000 rpm for 7 min.  
 
9) While cells are spinning down, mix the 10 µL cell suspension aliquot with 10 µL of Trypan 
blue. Pipette several times to mix the stain and cell suspension.  
 
10) Place a cover slip on the hemocytometer and pipette 10 µL of the stain/cell suspension into 
the hemocytometer. 
 
11) Cell counts are performed in as many of the nine separate regions of the hemocytometer as is 
feasible. Average number of cells per region is used to calculate the total cell population. For this 
calculation, the dilution factor is typically 2 (1:1 ratio of cell suspension to Trypan blue). 
 
Total Cell Population = (Mean Cells per Region) * Dilution * 10,000 * (Cell Suspension 
Volume) 
 
12) Aspirate off the media supernatant and calculate volume of freezing media needed to re-
suspend 1-3 x 106 cells per mL (freezing media: 50% DMEM, 40% FBS, 10% DMSO).  
 
13) Aliquot cells into 1 mL cryogenic tubes and place in -20oC freezer for 1 h. 
 
14) Place cryogenic tubes in -80oC freezer. Cells can be stored here for up to 6 months. For 
longer-term storage, keep cells at -80oC for at least 24 h and then carefully move to liquid 
nitrogen storage in IGB. 
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B.10 Tendon Cell Chemotaxis Protocol 
 
Reference: (Caliari and Harley in preparation) 
 
Reagents 
• Tendon cell media without serum (500 mL); store at 4oC 
485 mL high glucose DMEM (Fisher SH30022.FS); store at 4oC 
5 mL pen-strep (Invitrogen 15140-122); store at -20oC 
5 mL L-glutamine (Invitrogen 25030-081); store at -20oC 
5 mL amphotericin B solution (MP Biomedical 091672348); store at -20oC 
25 mg ascorbic acid (Wako 014-04801) 
Sterile filter before use 
• Trypsin-EDTA (Invitrogen 25300-062); store at -20oC  
• Trypan blue (Sigma-Aldrich T8154) 
• Human recombinant PDGF-BB (R&D Systems 220-BB-010); store at -20oC 
• Human recombinant IGF-1 (R&D Systems 291-G1-050); store at -20oC 
• Sterile phosphate-buffered saline without Ca2+ or Mg2+ (PBS) 
 
Supplies and equipment 
• 24-well plates with Transwell inserts (Fisher 07-200-150) 
• Hausser phase contrast hemacytometer (Fisher 02-671-5) 
• Tabletop centrifuge (VWR 53513-812) 
• Optical microscope (Leica Microsystems DMIL LED) 
• Water bath (37oC, Fisher 15-474-35) 
• Sterile pipettes (5, 10, 25 mL) 
 
*Note: all steps should be performed in the laminar flow hood unless otherwise noted.  
 
Procedure 
 
1) Warm tendon cell media, sterile PBS, and 3 mL trypsin-EDTA per T75 flask to be passaged in 
water bath to 37oC.  
 
2) Place hydrated scaffold pieces in fresh media to hydrate for at least 30 min. 
 
3) Prepare aliquots of growth factor supplemented media at required concentrations for 
experiment. Remember to include a control group with media containing no supplemented 
growth factors. Pipette 600 µL of media into each well in the plate (without inserts) and place 1 
scaffold piece in each well. Place Transwell inserts in wells so that scaffold is maximally 
contacted with membrane. 
 
4) When the media, PBS and trypsin are warm, wipe them dry with paper towel and spray with 
70% ethanol before placing in the sterile hood.  
 
5) Remove all old media from each flask, taking care not to scrape the cells with the pipette tip. 
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6) Add 10 mL of PBS per T75 flask and leave the PBS in the flask to rinse the cells for 30 s. 
Swirl gently to remove any excess media from the cells. Adjust volumes of PBS, media , and 
trypsin accordingly for different sized flasks. 
 
7) Remove the PBS and add 3 mL of trypsin per flask. Return the flasks to the incubator for 6 
min to allow for the cells to detach from the tissue culture plastic (allow the cells to sit for 3-4 
additional min in the incubator if they do not detach after 6 min). Slap flasks a few times to 
detach cells. 
 
8) Add 6 mL of complete tendon cell media to each flask to neutralize the trypsin and to flush 
cells off of the tissue culture plastic. 
 
9) Remove the trypsin, additional media, and cells from the flask and put into a conical tube.  
Remove a 10 µL cell suspension aliquot for counting. Centrifuge the cells at 1000 rpm for 7 min.  
 
10) While cells are spinning down, mix the 10 µL cell suspension aliquot with 10 µL of Trypan 
blue. Pipette several times to mix the stain and cell suspension.  
 
11) Place a cover slip on the hemocytometer and pipette 10 µL of the stain/cell suspension into 
the hemocytometer. 
 
12) Cell counts are performed in as many of the nine separate regions of the hemocytometer as is 
feasible. Average number of cells per region is used to calculate the total cell population. For this 
calculation, the dilution factor is typically 2 (1:1 ratio of cell suspension to Trypan blue). 
 
Total Cell Population = (Mean Cells per Region) * Dilution * 10,000 * (Cell Suspension 
Volume) 
 
13) Aspirate off the media supernatant and add new media to dilute to 5 x 105 cells per 100 µL 
media. 
 
14) Check that scaffolds are properly positioned under membranes. Add 100 µL of cell 
suspension to the upper compartment of each Transwell insert. 
 
15) Incubate at 37oC for 24 h. 
 
 191 
B.11 Tendon Cell Seeding on CG Scaffolds Protocol 
 
Reference: (Caliari and Harley in preparation; Caliari, Ramirez et al. in preparation) 
 
Reagents 
• Complete tendon cell media (500 mL); store at 4oC 
435 mL high glucose DMEM (Fisher SH30022.FS); store at 4oC 
50 mL fetal bovine serum (Invitrogen 16140-071); store at -20oC 
5 mL pen-strep (Invitrogen 15140-122); store at -20oC 
5 mL L-glutamine (Invitrogen 25030-081); store at -20oC 
5 mL amphotericin B solution (MP Biomedical 091672348); store at -20oC 
25 mg ascorbic acid (Wako 014-04801) 
Sterile filter before use 
• Trypsin-EDTA (Invitrogen 25300-062); store at -20oC 
• Trypan blue (Sigma-Aldrich T8154) 
• Human recombinant PDGF-BB (R&D Systems 220-BB-010); store at -20oC 
• Human recombinant IGF-1 (R&D Systems 291-G1-050); store at -20oC 
• Sterile phosphate-buffered saline without Ca2+ or Mg2+ (PBS) 
 
Supplies and equipment 
• Ultra-low attachment 6-well plates (Fisher 07-200-601) 
• Hausser phase contrast hemacytometer (Fisher 02-671-5) 
• Tabletop centrifuge (VWR 53513-812) 
• Optical microscope (Leica Microsystems DMIL LED) 
• Water bath (37oC, Fisher 15-474-35) 
• Sterile pipettes (5, 10, 25 mL) 
 
*Note: all steps should be performed in the laminar flow hood unless otherwise noted. For 
growth factor supplemented studies, use tendon cell media without serum.  
 
Procedure 
 
1) Warm complete tendon cell media, sterile PBS, and 3 mL trypsin-EDTA per T75 flask to be 
passaged in water bath to 37oC.  
 
2) Place hydrated scaffold pieces in fresh media for at least 30 min. 
 
3) Carefully remove excess media from scaffolds with a KimWipe and place 1-3 scaffold pieces 
in each well of Ultra-low attachment 6-well plates. 
 
4) When the media, PBS and trypsin are warm, wipe them dry with paper towel and spray with 
70% ethanol before placing in the sterile hood.  
 
5) Remove all old media from each flask, taking care not to scrape the cells with the pipette tip. 
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6) Add 10 mL of PBS per T75 flask and leave the PBS in the flask to rinse the cells for 30 s. 
Swirl gently to remove any excess media from the cells. Adjust volumes of PBS, media, and 
trypsin accordingly for different sized flasks. 
 
7) Remove the PBS and add 3 mL of trypsin per flask. Return the flasks to the incubator for 6 
min to allow for the cells to detach from the tissue culture plastic (allow the cells to sit for 3-4 
additional min in the incubator if they do not detach after 6 min). Slap flasks a few times to 
detach cells. 
 
8) Add 6 mL of complete tendon cell media to each flask to neutralize the trypsin and to flush 
cells off of the tissue culture plastic. 
 
9) Remove the trypsin, additional media, and cells from the flask and put into a conical tube.  
Remove a 10 µL cell suspension aliquot for counting. Centrifuge the cells at 1000 rpm for 7 min.  
 
10) While cells are spinning down, mix the 10 µL cell suspension aliquot with 10 µL of Trypan 
blue. Pipette several times to mix the stain and cell suspension.  
 
11) Place a cover slip on the hemocytometer and pipette 10 µL of the stain/cell suspension into 
the hemocytometer. 
 
12) Cell counts are performed in as many of the nine separate regions of the hemocytometer as is 
feasible. Average number of cells per region is used to calculate the total cell population. For this 
calculation, the dilution factor is typically 2 (1:1 ratio of cell suspension to Trypan blue). 
 
Total Cell Population = (Mean Cells per Region) * Dilution * 10,000 * (Cell Suspension 
Volume) 
 
13) Aspirate off the media supernatant and add new media to dilute cells to desired 
concentration. For 8 mm diameter, 5 mm thick scaffold pieces dilute to 5 x 105 cells per 20 µL 
media. 
 
14) Add 10 µL of cell suspension to each scaffold piece. Place scaffolds in incubator for 15 min. 
 
15) Remove scaffolds from incubator, flip over, add additional 10 µL of cell suspension to the 
other side of each scaffold, and return to incubate for additional 2 h. 
 
16) Carefully add 5 mL complete tendon cell media (or media with growth factors but without 
serum) to each well. Change media every 3 days over the course of the experiment. 
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B.12 AlamarBlue Metabolic Activity Protocol 
 
Reference: (Tierney, Jaasma et al. 2009; Caliari and Harley in preparation; Caliari, Ramirez et al. 
in preparation) 
 
Reagents 
• Complete tendon cell media (500 mL); store at 4oC 
435 mL high glucose DMEM (Fisher SH30022.FS); store at 4oC 
50 mL fetal bovine serum (Invitrogen 16140-071); store at -20oC 
5 mL pen-strep (Invitrogen 15140-122); store at -20oC 
5 mL L-glutamine (Invitrogen 25030-081); store at -20oC 
5 mL amphotericin B solution (MP Biomedical 091672348); store at -20oC 
25 mg ascorbic acid (Wako 014-04801) 
Sterile filter before use 
• AlamarBlue (Invitrogen DAL1100); store at 4oC 
• Sterile phosphate-buffered saline without Ca2+ or Mg2+ (PBS) 
 
Supplies and equipment 
• 24-well plates (Fisher 08-772-1) 
• 96-well plates (Fisher 12-565-369) 
• MTS 2/4 digital microtiter shaker (IKA 3208001) 
• Water bath (37oC, Fisher 15-474-35) 
• Fluorescent spectrophotometer (Varian) 
 
*Note: all steps should be performed in the laminar flow hood unless otherwise noted. The 
volumes of reagents used are correct for 8 mm diameter, 5 mm thick scaffold pieces. For growth 
factor experiments, use tendon cell media without serum. 
 
Generating standard curve procedure 
 
1) Warm media, sterile PBS, and alamarBlue in water bath to 37oC.  
 
2) Before starting an experiment, generate a standard curve with a known number of cells. The 
standard should have at least eight sample points: one well with just media, one well with media 
and alamarBlue, and six wells with media, alamarBlue, and a different number of cells. An 
example standard setup is shown: 
 
 Well 1 Well 2 Well 3 Well 4 Well 5 Well 6 Well 7 Well 8 
Media 1000 µL 900 µL 895 µL 890 µL 885 µL 880 µL 860 µL 840 µL 
Cell 
suspension 
0 µL 0 µL 5 µL 10 µL 15 µL 20 µL 40 µL 60 µL 
AlamarBlue 0 µL 100 µL 100 µL 100 µL 100 µL 100 µL 100 µL 100 µL 
 
Well 1 is a negative control, well 2 is a background control, and the other wells are used to make 
the standard curve.  
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3) Incubate at 37oC under gentle (~50 rpm) shaking for 2-4 h. During this time healthy cells 
convert the active ingredient in alamarBlue (resazurin) to the highly fluorescent resorufin. 
Longer incubation times are necessary for smaller cell concentrations, but make sure not to 
incubate cells too long or all of the resazurin will be reduced to resorufin.  
 
4) After incubation, pipette 100 µL in triplicate from each sample well into a 96-well plate. 
 
5) Measure fluorescence (excitation: 570 nm, emission: 585 nm) on the spectrophotometer in 
RAL 5. Use the 'Kinetics' program in the Cary Eclipse software to read plate '96 well clear.' For 
each data point, adjust the fluorescence reading by subtracting the reading from well 2 
(background control). The standard curve is created by plotting cell number as a function of 
adjusted fluorescent intensity. 
 
Quantifying metabolic activity on scaffolds procedure 
 
1) For measuring cell metabolic activity on scaffolds, pipette 900 µL media into each well (one 
well for each scaffold piece plus the two control wells). Add 100 µL alamarBlue to each well 
except for one negative control well. 
 
2) Remove scaffolds to be assayed and rinse in sterile PBS to remove excess media and 
unattached/dead cells. Add scaffolds to experimental wells and incubate at 37oC under gentle 
(~50 rpm) shaking for 2-4 h. The incubation time should be identical to the time used to make 
the standard curve.  
 
3) After incubation, pipette 100 µL in triplicate from each sample well into a 96-well plate. 
 
4) Measure fluorescence (excitation: 570 nm, emission: 585 nm) on the spectrophotometer in 
RAL 5. Use the 'Kinetics' program in the Cary Eclipse software to read plate '96 well clear.' 
Subtract the background control from the data points and extrapolate adjusted fluorescent 
intensity on the standard curve to give metabolic activity. 
 
5) This assay is non-destructive, so scaffolds can continue to be cultured and analyzed at later 
time points.  
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B.13 Hoechst DNA Quantification Protocol 
 
Reference: (Kim, Sah et al. 1988; Caliari and Harley in preparation; Caliari, Ramirez et al. in 
preparation) 
 
Reagents 
• Hoechst dye buffer (500 mL); store at 4oC for up to 3 months 
400 mL deionized water 
58.44 g sodium chloride 
0.605 g Tris base 
0.185 g disodium EDTA (Sigma-Aldrich E5134) 
Adjust pH to 7.4, bring total volume to 500 mL, sterile filter before use 
• Papain buffer (100 mL); store at 4oC 
100 mL PBS 
1 mL 0.5 M EDTA (pH = 8.0, Sigma-Aldrich EDS); store at 4oC 
79 mg cysteine-HCl (Sigma-Aldrich 00320) 
• Hoechst 33258 dye solution (1 mL); store at 4oC for up to 6 months 
1 mL sterile water 
1 mg Hoechst 33258 dye (Invitrogen H1398); store at 4oC 
• Papain from Carica papaya (Sigma-Aldrich 76218); store at -20oC 
• Sterile phosphate-buffered saline without Ca2+ or Mg2+ (PBS) 
 
Supplies and equipment 
• 96-well plates (Fisher 12-565-369) 
• Vortex (Fisher 02-215-365) 
• Water bath (60oC, Fisher 15-460-2SQ) 
• Fluorescent spectrophotometer (Varian) 
• Microcentrifuge tubes (1.5 mL) 
 
*Note: all steps should be performed in the laminar flow hood unless otherwise noted. The 
volumes of reagents used are correct for 8 mm diameter, 5 mm thick scaffold pieces. 
 
Generating standard curve procedure 
 
1) Once every several weeks a standard curve should be generated with a known number of cells. 
To make a standard curve spanning 5 x 103 to 1.5 x 106 million cells, make up active papain 
enzyme solution by dissolving 18-20 mg papain in 15 mL papain buffer in the 60oC water bath. 
 
2) Spin down two aliquots of 2 million cells each. Remove supernatant and add 12 mL papain 
enzyme solution to one tube and 400 µL to the other tube. Allow to digest for 24 h in the 60oC 
water bath. 
 
3) After 24 h, vortex tubes thoroughly. For the 12 mL tube, add cell lysate to labeled 
microcentrifuge tubes in 30 µL intervals (starting from a blank control) up to 300 µL. Bring all 
volumes to 300 µL with blank papain buffer. For the 400 µL tube, add cell lysate to labeled 
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microcentrifuge tubes in 2 µL intervals (starting from a blank control) up to 30 µL. Bring all 
volumes to 30 µL with blank papain buffer. 
 
4) Prepare Hoechst working dye solution by adding 1 µL dye solution to 10 mL sterile water. 
Vortex thoroughly. Add working dye solution to each tube to bring total volume to 630 µL. 
Vortex thoroughly. The Hoechst dye fluorescently binds to double-stranded DNA from the lysed 
cells, allowing quantification of DNA and thus cell number. 
 
5) Pipette 190 µL from each tube in triplicate into a 96-well plate. 
 
6) Measure fluorescence (excitation: 352 nm, emission: 461 nm) on the spectrophotometer in 
RAL 5. Use the 'Kinetics' program in the Cary Eclipse software to read plate '96 well clear.' For 
each data point, adjust the fluorescence reading by subtracting the reading from the blank 
control. The standard curve is created by plotting cell number as a function of adjusted 
fluorescent intensity. 
 
Quantifying cell number on scaffolds procedure 
 
1) For measuring cell number on scaffolds, pipette 300 µL of papain enzyme solution into 
microcentrifuge tubes (one for each scaffold plus two controls: one tube with just papain enzyme 
solution as a negative control and one tube containing a blank scaffold with no seeded cells as a 
background control).  
 
2) Remove scaffolds to be assayed and rinse in sterile PBS to remove excess media and 
unattached/dead cells. Add scaffolds to microcentrifuge tubes and incubate in 60oC water bath 
for 24 h. Vortex occasionally to facilitate digestion of scaffold. 
 
3) After incubation, pipette 600 µL Hoechst working dye solution in microcentrifuge tubes.  
 
4) Remove samples from water bath and vortex thoroughly. Add 30 µL from each tube to its 
corresponding tube containing working dye solution. Vortex thoroughly. 
 
5) Pipette 190 µL from each tube in triplicate from each sample well into a 96-well plate. 
 
6) Measure fluorescence (excitation: 352 nm, emission: 461 nm) on the spectrophotometer in 
RAL 5. Use the 'Kinetics' program in the Cary Eclipse software to read plate '96 well clear.' For 
each data point, adjust the fluorescence reading by subtracting the reading from the background 
control. Adjusted fluorescent intensity can be extrapolated on the standard curve to give a cell 
number. 
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